Mouse model for Charcot-Marie-Tooth as a tool to better understand the disease by Barneo Muñoz, Manuela
   
  
 
  
   
Doctoral Programme in Biomedicine and Biotechnology 
      
 
PhD thesis 
 
Mouse model for Charcot-Marie-Tooth as a 
tool to better understand the disease 
    
   Manuela Barneo Muñoz 
 
 
 
 
 
 
 
 
 
 
Directed by: 
   Francesc Palau Martínez 
   Paula Juárez Gómez 
Tutor: 
   David Ruiz Arahal 
 
   
 
 
 
 
 
 
This thesis has been possible thanks to a Formación Personal Investigador fellowship 
(BES-2010-040234) as part of Plan Nacional Poject named "Papel de la mitocondria en 
la neurodegeneración de las neuropatías periféricas hereditarias" (SAF2009-07063).  
Dr Coleman's laboratory stay was possible thanks to Estancias Breves Program (EEBB-
I-14-00467) named "Estudio del movimiento mitocondrial un el modelo murino para la 
enfermedad de Charcot-Maire-Tooth deficiente en Gdap1". 
 
 
 
In addition, as a result of part of this thesis a paper has been published named 
Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout 
mouse model of Charcot-Marie-Tooth neuropathy, Barneo-Muñoz M, Juárez P, Civera 
A, Yndriago L, Pla-Martin D, Zenker J, Cuevas C, Estela A, Sánchez-Aragó M, 
Forteza-Vila J, Cuezva JM, Chrast R, Palau P. (2015) PLOS Genetics  
DOI:10.1371/journal.pgen.1005115. 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ever tried. 
Ever failed. 
No matter. 
Try again. 
Fail again. 
Fail better. 
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ACh Acetylcholine 
AChR Acetylcholine receptors  
AD Autosomal dominant 
ANT Adenine nucleotide translocator  (ADP/ATP translocator) 
AR Autosomal recessive  
ATP Adenosine triphosphate 
BAX BCL2-associated X protein 
Bcl-2 B-cell CLL/lymphoma 2 
BDNF Brain-derived neurotrophic factor 
bp Base pairs 
Ca2+ Calcium 
cDNA Copy Deoxyribonucleic acid 
CDNB 1-chloro-2,4-dinitrobenzene  
CHN Congenital hypomyelination neuropathy  
CMAP Compound muscle action potential 
CMT Charcot–Marie–Tooth disease  
CMT1 Demyelinating Charcot–Marie–Tooth disease  
CMT2 Axonal Charcot–Marie–Tooth disease  
CMTI Intermediate Charcot–Marie–Tooth disease  
CMTX Charcot–Marie–Tooth disease X-linked  
CNS Central nervous system 
CO2 Carbon dioxide 
CoA Coenzyme A 
Complex I Ubiquinone oxidoreductase complex 
CypD Cyclophilin D  
DeSyn Delayed synapsing  NMJ 
DI CMT Dominant intermediate Charcot-Maire-Tooth 
div Days "in vitro" 
DNA Deoxyribonucleic acid 
DRG Dorsal Root Ganglia 
DRP1 Dynamin-related protein-1 
DSS Dejerine–Sottas syndrome  
EGR2 Early growth response 2 
ER  Endoplasmic reticulum 
ETC Electron transport chain 
FaSyn Fast Synapsing NMJ 
FIS1 Mitochondrial fission protein 1  
GD3 synthase  alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 
GDAP1 Ganglioside-induced differentiation-associated protein-1  
GDAP1L1 
Ganglioside-induced differentiation-associated protein-1 like 
1 
GJB1 Gap junction protein beta 1 
GSH Glutathione 
GST Glutathione S-transferase 
HD Hydrophobic domain 
HMN Hereditary motor neuropathies  
8 GDAP1-related CMT mouse model  
 
HMSN Hereditary motor and sensory neuropathies 
HPN Hereditary peripheral neuropathies  
HSAN Hereditary sensory and autosomic neuropathies  
HSN Hereditary sensory neuropathies 
HSPB1 Heat shock protein family B (small) member 1 
IMM Inner mitochondrial membrane 
IN Interneuron 
KHC Kinesin Heavy Chain  
KO Knockout 
MAPs Microtubule-associated proteins  
MFF Mitochondrial fission factor  
MFN1 Mitofusin-1  
MFN2 Mitofusin-2 
MN Motor neuron 
MNCV Motor nerve conduction velocity  
MPTP Mitochondrial permeability transition pore 
MPZ Myelin protein zero 
mRNA Messenger Ribonucleic acid  
mtDNA Mitochondrial DNA 
MTMR2 Myotubularin related protein 2 
Myo19 Myosin XIX 
Na+/K+ ATPase Sodium-potassium adenosine triphosphatase 
NADH Nicotinamide adenine dinucleotide (reduced form) 
NEFL Neurofilament, light polypeptide 
NF Neurofilament 
NGF Nerve growth factor 
NMJ Neuromuscular Junction 
NT3 Neurotrophin-3 
OMM Outer mitochondrial membrane 
OPA1 Optic Atrophy-1  
OXPHOS Oxidative phosphorylation 
P0 Myelin protein zero (MPZ) 
P1 Postnatal day 1 
PCR Polymerase Chain Reaction 
PMP22 Peripheral myelin protein 22 
PNS Peripheral Nervous System 
PRX Periaxin 
RAB6B Member RAS oncogene family 
RNA Ribonucleic acid  
ROS Reactive Oxygen Species  
RT-PCR Reverse Transcriptase Polymerase Chain Reaction 
SC Spinal Cord 
SCG Superior Cervical Ganglion  
SEM Standard Error of the Mean  
SN Sensory neuron 
SNAP Sensory nerve action potential  
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SNPH Syntaphilin  
SOCE Store-operated Ca2+ entry  
SOD Superoxide dismutase 
TCA Citric acid cycle 
TMD Transmembrane domain 
Trk Tropomyosinreceptor- kinase  
TSC Terminal Schwann cells  
UCP Mitochondrial uncoupling proteins 
VDAC Voltage-dependent anion channel 
WAVE1 WASP family verprolin homologous protein 1  
WT Wild type 
∆Ψm Inner mitochondrial membrane potential  
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Introducción 
La enfermedad de Charcot-Marie-Tooth (CMT) es uno de los trastornos neurológicos 
hereditarios más comunes que afecta a 17-40 de cada 100.000 personas según 
poblaciones; concretamente esta cifra se sitúa en 28 personas de cada 100.000 en 
España. La enfermedad recibe el nombre de los tres médicos que la identificaron por 
primera vez en 1886; Jean-Marie Charcot y Pierre Marie en París, Francia y Howard 
Henry Tooth en Cambridge, Inglaterra. La enfermedad de CMT, también conocida 
como neuropatía hereditaria motora y sensitiva o atrofia muscular del peroneo, abarca 
un grupo de trastornos que afectan los nervios periféricos.  
El fenotipo clásico incluye problemas en la marcha, déficit sensorial distal y atrofia 
distal inferior dando un aspecto de "jambes de coq" o botella de champagne invertida. 
Otras características completan el deterioro de patrón distal típico de CMT. Por 
ejemplo, disminución o ausencia de reflejos y equilibrio debido a la pérdida 
propioceptiva y deformidades esqueléticas como "pes cavus" y dedos en martillo. La 
escoliosis moderada puede formar parte de este fenotipo clínico. La severidad de la 
neuropatía puede evaluarse por un marcador de la neuropatía de CMT, un examen 
clínico de nueve ítems que mide síntomas sensoriales, síntomas motores, velocidades de 
conducción nerviosa y fuerza en brazos y piernas. 
De hecho, clínicamente, la examinación electrofisiológica es el primer paso importante 
de la división de CMT en subtipos. Los estudios de conducción nerviosa permiten una 
clasificación preliminar en formas desmielinizantes, axonales o intermedias. En la 
mayoría de los casos, la velocidad de conducción de los nervios motores (MNCV) y las 
amplitudes del potencial de acción compuesto del músculo (CMAP) en las extremidades 
superiores son necesarias ya que los nervios de la extremidades inferiores a menudo 
muestran ausencia de respuesta. Se diagnostica CMT1 o desmielinizante si esta 
velocidad de conducción motora es menor de 38 m/s. Si esta velocidad motora es 
normal (mayor de 45 m/s), se observa disminución de la amplitud de CMAP y 
disminución del potencial de acción del nervio sensitivo (SNAP), se diagnostica CMT2 
o axonal. CMT Intermedia (CMTI) se diagnostica si MNCV entra en el rango de 25 – 
45 m/s.  
Otra clasificación, según el tipo de herencia, también es posible. La variante de 
disfunción de la mielina -CMT1- y la variante axonal -CMT2- presentan herencia 
autosómico dominante (AD), mientras que CMTX es un desorden ligado al cromosoma 
X. En cambio, variantes con herencia autosómica recesiva (AR CMT) se clasifican 
como CMT4 si tienen características desmielinizantes y CMT2B o CMT2 AR si tienen 
resultados axonales (Tazir et al. 2014). 
 
Hasta la fecha, 80 genes causantes de CMT han sido identificados (Timmerman et al. 
2014). Algunos de ellos son causantes de diversos subtipos de CMT. Ya en el año 2002 
dos grupos asociaron un mismo gen -GDAP1 (MIM# 606598)-  a dos subtipos de CMT, 
desmielinizante autosómica recesiva (Baxter et al. 2002) y axonal autosómica recesiva 
(Cuesta et al. 2002).  
 
En la actualidad se sabe que GDAP1 (Ganglioside-induced Differentiation Associated 
Protein 1) causa tanto CMT4A (MIM# 214400) desmielinizante autosómica recesiva, 
AR-CMT2K (MIM# 607706) axonal autosómica recesiva, CMT2K (MIM# 607831) 
axonal autosómica dominante, como CMTRIA (MIM# 608340) intermedia autosómica 
recesiva (www.omim.org). Es importante remarcar que en el área Mediterránea gran 
parte de los casos de CMT son debidos a mutaciones en GDAP1 (Sivera et al. 2013).  
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GDAP1 se había identificado con anterioridad como uno de los 10 cDNAs expresados 
en una línea celular de neuroblastoma ratón diferenciada (Neuro2), en la que la 
diferenciación colinérgica había sido inducida por transfección de GD3 sintasa (a2,8-
sialiltransferasa). Este gen, con una longitud de 23,728 pares de bases (pb), contiene 
seis exones y cinco intrones. Dos variantes transcripcionales han sido descritas, siendo 
la isoforma "a" la más larga, con 358 aminoácidos. La isoforma "b" es exactamente 
igual que la "a" pero tiene 68 aminoácidos menos en la parte N-terminal, resultando en 
una proteína de 290 aminoácidos (Cassereau et al. 2011). 
GDAP1 pertenece a la familia de enzimas glutatión S-transferasas, presentando dos 
dominios de unión para GSH (de los aminoácidos 26 al 119 y del 210 al 287). La 
proteína presenta también dos hélices -α4 y α5- (entre los aminoácidos 152-164 y 169-
195), un único dominio transmembrana (TMD) en el extremo de la C-terminal y un 
dominio hidrófobo (HD) (Marco et al. 2004). A la misma familia pertenece su gen 
parálogo, GDAP1L1 (Marco et al. 2004), del que poco se ha estudiado. 
Estudios de expresión han detectado su mensajero predominantemente en sistema 
nervioso (Cuesta et al. 2002; Pedrola et al. 2005). La proteína ha sido detectada tanto en 
neuronas sensitivas y motoneuronas (Pedrola et al. 2008), como en células de Schwann 
(Pedrola et al. 2005; Niemann et al. 2005). A nivel celular, se localiza en la membrana 
mitocondrial externa (Pedrola et al. 2005; Niemann et al. 2005).  
La función de GDAP1 ha sido profundamente estudiada en modelos celulares. Aunque 
no se ha conseguido detectar actividad glutatión S-transferasa (Pedrola et al. 2005), 
algunos autores relacionan esta proteína con el estrés oxidativo (Noack et al. 2012). Lo 
que sí ha sido ampliamente demostrado es el rol de GDAP1 como regulador de la 
dinámica mitocondrial; actuando como factor de fisión mitocondrial independiente de 
FIS1 y DRP1 (Niemann et al. 2005; Niemann et al. 2009). Otros autores también 
relacionan a GDAP1 con el movimiento mitocondrial (Pla-Martín et al. 2013). Además, 
también ha sido relacionado con la fisión de lo peroxisomas (Huber et al. 2013) y la 
homeóstasis del calcio (Pla-Martín et al. 2013). 
 
 
Hipótesis y objetivos 
Basándonos  en estudios previos hechos en cultivo celular y en la patofisiología de los 
pacientes de CMT, nuestra hipótesis es que GDAP1 está implicado en el transporte 
mitocondrial  y en el posicionamiento de dicho orgánulo dentro de las neuronas y sus 
axones. Así, la patología de la enfermedad se debe a la disfunción en el transporte y/o 
localización de las mitocondrias, lo cual puede estar relacionado con la longitud del 
nervio.  
 
Así, el objetivo principal de esta tesis es investigar la función de GDAP1 y comprender 
su implicación en la enfermedad de CMT.  Para ello hemos generado un ratón nulo para 
el ortólogo murino de GDAP1 como herramienta para investigar cómo la falta de 
función del gen  causa la neuropatía. Avances en este tema pueden llegar a prevenir o 
reparar la axonopatía. 
 
Como primer punto de la tesis, es necesario caracterizar nuestro modelo de ratón y 
asegurarnos que es adecuado como modelo de CMT. Una vez este objetivo se ha 
conseguido, ya podremos utilizarlo como herramienta para entender en profundidad en 
proceso patogénico.  
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Resultados y Discusión 
El ratón nulo para Gdap1 (Gdap1-/-) se generó suprimiendo el exón 1 del Gdap1 murino 
mediante el sistema de recombinación Cre/loxP (genOway, Lyon, Francia; véase 
Materiales y Métodos para más detalles). Los ratones Gdap1 -/- se obtuvieron mediante 
cruces entre heterocigotos (Gdap1+/-). Los tres genotipos obtenidos en la descendencia 
cumplían las proporciones mendelianas y no se observaron diferencias en longevidad o 
fertilidad entre ellos. Los genotipos se comprobaron al tatuar los ratones, mediante 
biopsias de la cola que fueron utilizadas para obtener ADN genómico. Mediante 
diversas estrategias de PCR, y usando como molde el ADN genómico; se detectó la 
deleción del exón 1 en homocigosis en los ratones Gdap1-/- y en heterocigosis en los 
Gdap1 +/-. Los ratones Gdap1+/+ no presentaban alteración alguna en su genoma.  
La ausencia de expresión en los ratones Gdap1 -/- se comprobó mediante la detección de 
la proteína endógena en los controles (Gdap1+/+) y la carencia en los Gdap1 -/-. La falta 
de Gdap1 se comprobó también a nivel de mensajero, concluyéndose que la deleción 
del primero de los seis exones de Gdap1 es suficiente para abolir su expresión en el 
modelo de ratón. Además, comprobamos la expresión de su gen parálogo, GDAP1L1, 
(Marco et al. 2004); detectando el mensajero en solamente en sistema nervioso central 
(SNC). Este hecho contrasta con la hipótesis de que GDAP1L1 pueda asumir la función 
de GDAP1 cuando este último está mutado o delecionado (Niemann et al. 2014). 
Aprovechando el hecho de tener un anticuerpo para la detección de GDAP1, nos 
planteamos estudiar su expresión en todos los tejidos del ratón. La proteína GDAP1 fue 
detectada solo en tejido nervioso, corroborándose así los datos previos (Pedrola et al. 
2005; Pedrola et al. 2008).  
La ausencia de Gdap1 en el ratón provocó defectos en el caminar, como una posición 
anormalmente baja del cuerpo, y una pérdida de reflejos al ser sostenidos por la cola. 
Además, a partir de los 6 meses algunos ratones presentaban deformidades en las patas 
similares al pes cavus. Esto concuerda con el fenotipo clásico de los pacientes de CMT: 
andar equino y las deformidades en los pies conocidas como pes planus o cavus 
(Brennan et al. 2015). Estos defectos no se observaron en el modelo murino de 
Niemann et al. 2014. 
Datos más cuantitativos obtenidos mediante rota-rod test revelaron defectos en la 
actividad motora debidos a la pérdida de Gdap1 a partir de los 3 meses. Además, 
mediante el estudio de la pisada, se determinó que los ratones deficientes presentaban 
defectos en el posicionamiento de los dedos y en la forma de apoyar en pie, lo que les 
obliga a dar pasos más cortos. Estas alteraciones en la pisada concuerdan con mal 
funcionamiento de los pequeños músculos del pie inervados por el nervio ciático y la 
parálisis de los músculos flexores del tobillo (Wiethölter et al. 1990). A diferencia de 
los pacientes (Brennan et al. 2015), no se pudo detectar pérdida de masa muscular en los 
músculos de la pierna. 
La falta de Gdap1 en el ratón también provocaba defectos en las uniones 
neuromusculares (NMJ); encontrando desconexión entre el axón motor y la fibra 
muscular a los 12 meses de edad. No se observó la típica fragmentación de la 
degeneración Wallerian (Coleman & Freeman 2010); sin embargo sí se detectaron 
anomalías en la parte más distal del axón tipo lazos y engrosamientos. Este tipo de 
estructuras se han relacionado con axones en retraimiento (Bishop et al. 2004). Defectos 
en estas sinapsis producen debilidad o parálisis muscular (Tintignac et al. 2015).  
Para finalizar la caracterización del modelo, se observó también daño en la médula 
espinal de ratones Gdap1-/-. Produciéndose una pérdida progresiva de motoneuronas en 
el asta ventral. Por el contrario, no se observaron alteraciones en los ganglios de la raíz 
dorsal, al menos a nivel histológico.   
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GDAP1-CMT se ha relacionado con CMT  tanto axonal como desmielinizante, por ello 
también se estudió la Velocidad de Conducción Nerviosa (MNCV), rasgo diferencial 
entre ambos tipos de CMT. A los 5 meses de edad se observó un moderado descenso en 
la MNCV de los ratones Gdap1-/- en comparación con los controles; hecho que también 
ocurre en las neuropatías axonales (Sevilla et al. 2003). En las neuropatías 
desmielinizantes las reducciones son mayores (Tazir et al. 2014). Estudiando el 
Potencial de Acción Muscular Compuesto (CMAP), también observamos reducción de 
en área y en la amplitud; lo que puede reflejar pérdida de motoneuronas o un desorden 
de las uniones neuromusculares (Murray et al. 2014).  
Otra forma de clasificar CMT en axonal o desmielinizante es realizando una biopsia de 
algún nervio periférico, normalmente del sural (Sevilla et al. 2003). En nuestro modelo 
de ratón, nosotros optamos por el nervio ciático, al ser este el más largo (Krinke et al. 
2014). Los ratones Gdap1-/- presentaban una menor densidad de fibras nerviosas a los 5 
meses de manera similar a los pacientes (Sevilla et al. 2003). Por el contrario no se 
encontró alteración alguna en el g-ratio o presencia de los bulbos de cebolla 
característicos de los tipos desmielinizantes.  
 
Una vez caracterizado el modelo, nuestro objetivo era entender mejor la patofisiología a 
nivel celular de la enfermedad. Para ello hicimos uso del cultivo de neuronas sensitivas 
del ganglio dorsal (DRG) de ratones adultos (Valdés-Sánchez et al. 2010). Los cultivos 
de DRG ratones Gdap1-/- eran capaces de crecer; sin embargo, presentaron neuronas con 
somas más pequeños y neuritas más cortas en comparación con los controles. Además, 
se detectaron problemas en las modificaciones post-traduccionales que sufre el 
citoesqueleto de microtúbulos en ratones de 5 meses. El menor nivel de acetilación y 
mayor nivel de tirosinación encontrados, se corresponden con una desestabilización de 
los microtúbulos; pudiendo desencadenar problemas a nivel del trasporte de vesículas y 
mitocondrias  (Zala et al. 2013).  
 
Además del estudio de muestras fijadas de neuronas en cultivo de DRG de ratones 
adultos, se estudiaron las mitocondrias en movimiento mediante la microinyección de 
cultivos postnatales. La microinyección nos permitió seguir las mitocondrias dentro una 
neurita desde su zona más proximal hasta la más distal (Gilley et al. 2011). Estudios en 
cultivos de DRG revelaron defectos en el movimiento retrogrado (de la zona distal a la 
proximal) de  las mitocondrias. Concretamente se observó una tendencia al aumento del 
número de mitocondrias en movimiento y un aumento de su tamaño. Estos datos 
contrastaron con lo encontrado en cultivo de ganglio cervical superior (SCG), tejido no 
afectado en pacientes de CMT, donde se detectaron unas mitocondrias más lentas y con 
tendencia a más cortas; siendo las estáticas las que aumentaban su tamaño. 
El estudio se completó con el rescate de la neuronas nulas para Gdap1. En DRG se 
observó un descenso del número de mitocondrias en sentido retrógrado así como un 
descenso de la velocidad en sentido anterógrado debido a la expresión de GDAP1. En 
SCG solo se observó el descenso en el número de mitocondrias en sentido retrógrado. 
Aprovechando esta técnica, se analizó el efecto de las mutaciones más frecuentes de 
GDAP1 en los cultivos de DRG. Mutaciones dominantes no fueron capaces de alterar 
los parámetros estudiados en neuronas control. Sin embargo, mutaciones dominantes y 
recesivas, alteraron dichos parámetros en neuronas Gdap1-/-, siendo el efecto de la 
mutaciones en posición 157 y 161 más agresivo que el de las albergadas en posición 
120. Esta relación con el sitio mutado en vez de con el tipo de herencia contrasta con la 
patología en pacientes donde las formas recesivas de GDAP1-CMT suelen ser más 
agresivas (Sevilla et al. 2008).   
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Para finalizar, se estudiaron también estos parámetros de movilidad mitocondrial en el 
nervio ciático del ratón gracias al uso de explantes de ratones que poseían sus 
mitocondrias marcadas. Ratones nulos para Gdap1 de 1 mes de edad presentaron 
defectos en velocidad y tamaño de sus mitocondrias al compararlos con los controles. 
Concretamente, se observó un descenso en la velocidad anterógrada (del soma en la 
médula al terminal nervioso en el músculo) y un aumento del tamaño de las 
mitocondrias que se movían en sentido retrógrado (del terminal nervioso en el músculo 
al soma en la médula). Estos datos corroboran y explican más en profundidad las 
alteraciones en el movimiento mitocondrial descritas en líneas de neuroblastoma 
debidas a la interferencia de GDAP1 (Pla-Martín 2012).  
 
 
Si repasamos todos los defectos producidos por la falta de GDAP1 en el movimiento 
mitocondrial y en el crecimiento de las neuronas, las proteínas MIRO/MILTON vienen 
a nuestra mente. MIRO es una GTPasa pequeña asociada a la mitocondria que regula el 
transporte de mitocondrias y la organización en las prolongaciones celulares (Tang 
2015). De hecho, el ratón nulo para Miro1 exhibe reducción en la velocidad retrógrada 
(Nguyen et al. 2014). De manera similar a MIRO, GDAP1 también tiene proteínas a las 
que se une (Pla-Martín 2012) que pueden explicar con detalle las alteraciones 
observadas en el ratón nulo.  
La hipótesis es que GDAP1 interacciona con los transportadores SUMO4 e EIF2B5, 
entre otros. La pérdida de GDAP1 afecta a diversos procesos en los que estos 
transportadores están implicados. La ausencia de GDAP1 hace que, de alguna manera 
SUMO no pueda activar DRP1 (Ong et al. 2015). Como consecuencia la fisión se 
bloquea produciendo mitocondrias elongadas. 
Además, como GDAP1 no puede unirse a EIF2B5, EIF2 no puede tener la 
conformación apropiada y no puede bloquear Bcl-xL mediante CHOP (Iurlaro & 
Muñoz Pinedo 2015). Bcl-xL bloquea DRP1 (Saez-Atienzar et al. 2016)   y como 
consecuencia la fisión se bloquea de nuevo. Bcl-xL también bloquea la acetilación de la 
tubulina (Saez-Atienzar et al. 2016)  y, como consecuencia, el movimiento mitocondrial 
se ve afectado.  
Finalmente, como GDAP1 también interacciona con Caytaxina, el ratón nulo para 
Gdap1 presenta una velocidad anterógrada más lenta. 
Como consecuencia de la menor velocidad anterógrada, los axones distales se denervan 
a nivel de las NMJs. Mitocondrias más lentas también provocan la posición incorrecta 
de las mitocondrias en relación con el retículo endoplasmático, así como estrés de 
retículo. 
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Conclusiones 
1º: Gdap1 murino se expresa en el sistema nervioso central y en el periférico. Tejidos 
no neuronales no expresan GDAP1. 
 
2º: Otros miembros de la familia Gdap1, como Gdap1L1, también se expresan en el 
sistema nervioso central del ratón. 
 
3º: La eliminación del primer exón de Gdap1 es suficiente para generar un modelo de 
ratón para Charcot-Marie-Tooth (CMT) debido a mutaciones en GDAP1. La pérdida de 
expresión ubicua en el ratón no afecta a su viabilidad y fertilidad. Como modelo, el 
ratón Gdap1-/- presenta las principales características de la enfermedad: pie cavo, 
déficits motores, velocidad de conducción nerviosa ligeramente reducida y alteraciones 
en el potencial de acción compuesto. 
 
4º: El uso de este modelo nos ha permitido determinar que CMT debido a GDAP1 es 
una neuropatía de tipo axonal. 
 
5º: El nervio ciático, el cual tiene axones sensitivos y motores, está alterado en ratones 
de 5 meses de edad. Se ha detectado pérdida del número de fibras y un cambio en el 
tamaño de las mismas. No se observaron signos desmielinizantes. 
 
6º: En el músculo, la pérdida de Gdap1 produce denervación. Las placas 
neuromusculares no se encuentran totalmente ocupadas por los terminales nerviosos a 
los 12 meses de edad. Además, detectamos estructuras anormales en dichos terminales. 
Las uniones neuromusculares de ratones de 5 meses de edad, son indistinguibles entre 
controles y animales nulos para Gdap1. 
 
7º: En la parte ventral de la médula espinal, la pérdida de Gdap1 produce una pérdida 
progresiva de neuronas sanas. Señales de daño han sido detectadas en lisados de la 
médula espinal completa. 
 
8º: En los ganglios de la raíz dorsal (DRG), la ausencia de GDAP1 parece no alterar las 
neuronas sensitivas al menos a nivel histológico hasta los 12 meses de edad. 
 
9º: Cultivos de DRG de animales adultos se ven comprometidos por la pérdida de 
GDAP1. Se han observado somas más pequeños y neuritas más cortas. 
Desestabilización del citoesqueleto de microtúbulos puede explicar estos defectos.  
 
10º: La pérdida de GDAP1 afecta principalmente al transporte y la dinámica 
mitocondrial. Tejidos afectados en CMT de los ratones Gdap1-/- , como DRG en cultivo 
y nervio ciático, presentaron mitocondrias en movimiento retrógrado más largas. 
Además, la velocidad anterógrada estaba reducida. Tejidos no afectados en CMT, como 
ganglio superior cervical en cultivo, presentó mitocondrias más cortas y lentas en 
movimiento retrógrado.  
 
11º: Mutaciones en GDAP1 presentes en pacientes de CMT produjeron efectos diversos 
en neuronas sensitivas en cultivo. Esta variedad de efectos concuerda con al amplio 
rango de fenotipos presentado en los pacientes.  
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Material y Métodos 
Para llevar a cabo todo este estudio profundo del ratón nulo para Gdap1 se han utilizado 
técnicas frecuentemente realizadas en laboratorios de genética molecular. Otras son de 
uso rutinario en ámbitos donde se trabaja con el ratón como animal modelo. Sin 
embargo también se han puesto a punto algunas técnicas novedosas en nuestro 
laboratorio como el estudio de las uniones neuromusculares (NMJ).  
Para ello elegimos el Gastrocnemius (en la pantorrilla) como músculo de estudio por 
presentar unas sinapsis retrasadas (DeSyn, Delayed Synapsis), cuyo mantenimiento 
depende exclusivamente de los factores provenientes del nervio (Pun et al. 2002), y por 
ser un músculo grande de fácil acceso (Murray et al. 2014). La técnica de marcaje de las 
NMJ consistió en diseccionar el musculo y fijarlo en paraformaldehído. Posteriormente 
se marcó la parte muscular de la NMJ, el receptor de la Acetilcolina (AChR) con 
bungarotoxina conjugada con rodamina. Para marcar la parte del terminal nervioso se 
realizó una inmunohistoquímica normal con un anticuerpo primario frente a la Beta 
Tubulina III y un secundario conjugado con Alexa-488. Una vez realizado el marcaje, 
se procedió a cortar el músculo longitudinalmente para su posterior montaje en 
portaobjetos. Fue necesario el uso de un microscopio confocal potente para poder 
obtener imágenes confocales de series contiguas en z (cada 0.5µM). Con todas esas 
imágenes confocales ser realizó una reconstrucción en 3D con la que estudiar si las 
NMJ estaban correctamente inervadas. Una NMJ se contabilizó como completamente 
ocupada si había evidencia de una continuidad entre el terminal nervioso (Beta tubulina 
III) y la placa neuromuscular (AChR) (Wong et al. 2009). 
 
Otra técnica interesante fue el uso de microinyecciones para marcar mitocondrias 
selectivamente en un subconjunto de neuritas de neuronas sensitivas en cultivo (Gilley 
& Coleman 2010). Microinyectando un marcador mitocondrial (Milde et al. 2013) en 
50-60 neuronas de un total de 5000-6000 en cultivo, es relativamente fácil capturar 
videos de su movimiento en la parte más distal de sus neuritas. Para su posterior análisis 
existe también un software (Andrews et al. 2010) que nos facilita el seguimiento de las 
partículas en movimiento, en nuestro caso mitocondrias, calculando su velocidad y 
tamaño entre otros parámetros. 
 
Finalmente, más que una técnica, fuimos capaces de aprovecharnos de la gran variedad 
de ratones genéticamente modificados existentes hoy en día en el mercado. Cruzamos 
nuestros ratones nulos para Gdap1 con otros que presentaban sus mitocondrias 
marcadas (http://jaxmice.jax.org/strain/018397.html). La descendencia de estos cruces 
presentaba el alelo mutado para Gdap1 y las mitocondrias marcadas. La obtención de 
estos ratones hizo posible estudiar la mitocondrias en movimiento en el mismo nervio 
ciático de los animales; sin necesidad de disgregación, cultivo y marcaje.  
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1.- The disease of study: CMT        
1.1.-History and clinical features of CMT 
Hereditary peripheral neuropathies (HPN) include hereditary motor and sensory 
neuropathies (HMSN), hereditary motor neuropathies (HMN), hereditary sensory 
neuropathies (HSN) and hereditary sensory and autosomic neuropathies (HSAN). 
Despite this heterogeneity, HPN are a group of disorders that share characteristic 
clinical phenotypes that manifest as a peripheral neuropathy with a chronic progressive 
course. The most frequent entity, HMSN, also known by the eponym Charcot–Marie–
Tooth disease (CMT), is a heterogeneous group of disorders which can be classified on 
the basis of their clinical, neurophysiological, genetic and pathological features. 
Charcot–Marie–Tooth disease is one of the most common degenerative disorders of the 
peripheral nervous system (Tazir et al. 2014). Nowadays, the prevalence of CMT 
disease is 40 cases per 100000 population in the United States, 28 per 100000 in Spain, 
18 per 100000 in Italy and 11 per 100000 in Japan (Kedlaya 2014).  
Historically, it was in 1886 when Professor Jean Martin Charcot (1825-1893) and his 
student Pierre Marie (1853-1940) published in Paris the first description of distal 
muscle weakness and wasting beginning in the legs, calling it ‘peroneal muscular 
atrophy’. At the same time in Cambridge, Howard Henry Tooth (1856-1926) described 
the same disease in his PhD dissertation, calling the condition ‘peroneal progressive 
muscular atrophy’. Tooth was the first to attribute symptoms correctly to neuropathy 
rather than to myelopathy, as physicians previously had done (Kedlaya 2014). 
 
Currently, most cases of CMT are slowly progressive disorders that usually present in 
the second decade, although earlier or later initial presentations may occur depending on 
the underlying genetic abnormalities. The classical phenotype includes steppage gait, 
moderate distal sensory deficit, and distal lower amyotrophy giving an aspect of 
“jambes de coq” or an inverted champagne bottle. Other characteristical features such as 
decreased or absent deep tendon reflexes in distal symmetric pattern gait and balance 
impairment, because of proprioceptive loss and skeletal deformities that result in "pes 
cavus" and hammertoes, complete the typical CMT phenotype (figure I1). Moderate 
scoliosis may be part of this clinical phenotype. The severity of the neuropathy can be 
evaluated by a CMT neuropathy score, a nine-item clinical examination that measures 
sensory symptoms, motor symptoms, arm and leg strength and nerve conduction 
velocities. 
 
Figure I1. Common foot deformities in Charcot–Marie–Tooth disease and related disorders. (A) 
Claw toes, (B) pes cavus and (C) hind foot varus deformities of the feet (Rossor et al. 2015). 
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The electrophysiological examination is the first important step in separating 
myelinopathies from neuronopathies or axonopathies. Nerve conduction studies allow a 
preliminary subtype classification into demyelinating, axonal or intermediate CMT 
forms. In most cases, motor nerve conduction velocity (MNCV) and compound muscle 
action potential (CMAP) amplitudes in the upper extremities are required since the 
lower extremity nerves often demonstrate absent responses. When the median MNCV is 
<38 m/s, CMT1 (demyelinating form) is diagnosed, whereas if the median MNCV is 
>45 m/s with the finding of decreased CMAP amplitude, decreased or absent median 
sensory nerve action potential (SNAP) and in general absent sural and peroneal SNAPs, 
CMT2 (axonal form) is diagnosed. Intermediate CMT (CMTI) is diagnosed if the 
median MNCV falls in the range of 25–45 m/s within the family. In addition to MNCVs 
subtype classification is also based on the pattern of inheritance. The myelin 
dysfunction variant of CMT, CMT1, and the axonal variant, CMT2, are autosomal 
dominant (AD) disorders, whereas CMTX is an X-linked disorder. In contrast, 
autosomal recessive CMT variants (AR CMT) are classified as CMT4 if they have 
demyelinating features and CMT2B or AR CMT2 if they have axonal findings (Tazir et 
al. 2014). 
 
Autosomal dominant CMT are the most frequent forms of CMT in most European and 
North-American countries. AD CMT1 is the most common form, such that it accounts 
for more than 80% of patients with CMT attending an inherited neuropathy clinic. Most 
patients with AD CMT1 have the classical CMT phenotype. Neuropathological features 
include a significant reduction of myelinated axons and “onion bulbs” which are 
composed of several layers of basal lamina, connective tissue and Schwann cells 
(hypertrophic neuropathy) around thinly myelinated axons. Most of AD CMT1 patients 
have a mild to moderate disability although some of them have a marked handicap and 
end up in wheelchairs. Autosomal dominant axonal CMT (CMT2) is relatively frequent 
as it may represent about a third of all AD CMT cases. Most CMT2 patients have a 
classical CMT phenotype but with a wider range of age of onset. Moreover, sural nerve 
biopsy findings demonstrate axonal loss often with a cluster of regeneration(axonal 
sprouting), without pathological evidence of primary demyelination. Autosomal 
dominant intermediate CMT (DI CMT) is characterized by a classic, mild to moderately 
severe CMT phenotype, and median MNCVs overlapping those observed in CMT1 and 
CMT2, with a range from 25 to 50 m/s. 
 
Autosomal recessive CMT disorders were once considered to be extremely rare. 
However, clinical and molecular investigations of CMT families with AR inheritance, 
originating from countries around the Mediterranean basin, in the Middle-East and in 
Europe are increasing. Most autosomal recessive CMT cases are characterized by earlier 
onset and more rapid clinical progression that results in more marked distal limb 
deformities such as pes equino-varus, claw-like hands, and sometimes major spinal 
deformities. Nerve biopsy studies in AR CMT1 demonstrate prominent demyelinating 
lesions responsible for marked secondary axonal loss along with subtype-specific 
myelin abnormalities, whereas in AR CMT2 myelinated fibres are severely reduced in 
number without evidence of demyelination and remyelination or of active axonal 
regeneration. Otherwise, severe to late onset autosomal recessive intermediate CMT 
diseases have also been reported. 
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X-linked CMT should be suspected when male-to-male transmission is absent on 
pedigrees and when males are more impaired than females. Four dominant and 
recessive X-linked CMT subtypes have been described to date (Tazir et al. 2014). 
 
1.2.- Genes and molecular basis in CMT 
The first CMT locus was mapped in 1982, and 30 years of genetic research has not only 
allowed the successful identification of 80 disease-causing genes (figure I2), but also 
pioneered the discovery of novel genomic mechanisms. Loci and genes for CMT and 
related peripheral neuropathies were initially identified using genetic linkage studies, 
positional cloning, or candidate gene approaches (Timmerman et al. 2014). 
 
Figure I2. Genes and loci for Charcot-Marie-Tooth (CMT) and related inherited peripheral 
neuropathies. The figure shows 80 currently known genes (orange symbols) and their corresponding 
chromosomal loci (vertical bars). The corresponding phenotypes are indicated by blue symbols and are 
according to the disease nomenclature. Note that the disease names may not always correspond to 
information available in OMIM, GeneReviews, or in other publicly available databases. (Timmerman et 
al. 2014) 
 
At the present time, mutations or rearrangements in PMP22, GJB1, MPZ and MFN2 in 
the order of decreasing frequency account for about 90% of the molecular diagnoses in 
western populations (Sivera et al. 2013), while mutations in all other genes tested seem 
rare. Otherwise, most of the known CMT genes are strictly implicated either in axonal 
CMT or in demyelinating form, while some like GDAP1, NEFL and MPZ may be 
mutated in both forms. Some patients with Dejerine–Sottas syndrome (DSS) or 
congenital hypomyelination neuropathy (CHN) phenotypes may also share mutations in 
dominant or recessive genes such as MPZ, PMP22, EGR2, GDAP1, MTMR2 or PRX. 
Moreover, gene mutations are mainly of dominant inheritance and others are recessive, 
while some of them such as EGR2, P0, NEFL, MFN2, GDAP1, and HSPB1 mutations 
may be of both inheritance traits (Tazir et al. 2014). 
(Extended table in the Appendix with CMT types, gene and phenotype, table A1) 
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Genes encoding proteins expressed in Schwann cells and neurons are linked to CMT, 
proteins that are involved in a wide range of processes: myelin assembly, 
cytoskeleton/axonal transport, protein aggregation, endosomal sorting, mitochondrial 
functions, mRNA processing/transcription, and ion channel transport (figure I3). When 
these proteins are mutated, various cellular processes are disrupted, thus resulting in 
CMT (Jerath & Shy 2014). 
 
 
Figure I3. Known disease genes for CMT and related disorders, and their proposed 
pathomechanism. The figure shows all known genes and their involved cellular function, either in 
neuron or in Schwann cell (Rossor et al. 2015). 
 
Through this variety of genes and molecular processes, we can conclude that CMT 
disease pathophysiology of both the myelinopathy and axonopathy forms is the 
consequence of altered Schwann cell-axon communication; abnormal intercellular 
contact and signalling induce neurodegeneration and axonal loss, which ultimately 
produce muscular atrophy and weakness (Juárez & Palau 2012).  
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2.-The gene of study: GDAP1         
 
2.1.- GDAP1-related CMT 
Locus 8q13-q21 was linked to autosomal recessive CMT (CMT4A) with slow 
demyelinating presentation in four consanguineous Tunisian families in 1993 by the 
group of Dr Jeffery M. Vance. Several years later the same group identified the 
candidate gene, encoding ganglioside-induced differentiation-associated protein-1 
(GDAP1) (Baxter et al. 2002) and the group of Dr Francesc Palau also found an 
association of the Gdap1 gene with axonal recessive CMT (AR-CMT2K) (Cuesta et al. 
2002). This was the first time that same gene was linked with both demyelinating and 
axonal CMT (table I1).  
 
CMT Type Inheritance Clinical presentation Nerve/muscle pathology
CMT4A
RI-CMTA
AR-CMT2K
AR
Severe phenotype: early onset and 
rapid progression with proximal 
involvement, loss of ambulation; 
frequent vocal cord palsy
Axonal changes, secondary 
myelin abnormalities.            
No specific mitochondrial 
abnormalities found.
AD-CMT2K AD Variable onset, less severe course
Chronic axonal degeneration. 
Mitochondrial abnormalities 
reported.
Table I1. GDAP1 associated CMT types with clinical and neuropathologic phenotypes. Part of table 
3 (Genes involved in mitochondrial dynamics, associated CMT types with clinical and neuropathologic 
phenotypes), here showing only GDAP1 associated CMT (Pareyson et al. 2015).  
 
To date, 59 allelic variants has been already found in GDAP1 (LOVD v.2.0 Build 
36©2004-2014 Leiden University Medical Center) (see table A2 at the Appendix for 
details). 54 of these variants are pathogenic and link the gene with several types of 
CMT.  
 
It is important to note relevant changes in CMT genetic distribution (table I2). A clear 
example of this is the predominance of GDAP1 over MFN2 in Spanish clinical series 
(Sivera et al. 2013). Indeed, there is a high rate of CMT patients in Mediterranean basin 
that have mutations in GDAP1 in comparison with some other countries (Manganelli et 
al. 2014). 
Manganelli et 
al. n = 197
Sivera et al. 
n = 404*
Gess et al. 
n = 589†
Murphy et al. 
n = 471‡
Saporta et al. 
n = 787
Country Italy Spain Germany UK USA
PMP22 72.3 (107) 56.1 (186) 69.9 (237) 69.0 (205) 65.0 (343)
GJB1 9.5 (14) 16.9 (56) 13.8 (47) 15.4 (46) 15.1 (80)
GDAP1 5.4 (8) 12.7 (42) 0 0.6 (2) 1.1 (6)
MPZ 4.7 (7) 5.7 (19) 6.1 (21) 4.3 (13) 8.5 (45)
SH3TC2 2.0 (3) 0.6 (2) 0 1.6 (5) 0.6 (3)
MFN2 1.3 (2) 1.2 (4) 3.5 (12) 4 (12) 4 (21)
Genes
Frequency, % (number of patients)
 
Table I2. Comparison of genetic distribution in several series of patients depending on country. 
Percentages and numbers indicate the most common genes in series of Charcot-Marie-Tooth patients. 
*Caucasian cases only (excluded Gypsy cases). †Patients with sufficient nerve conduction studies. 
‡Patients attending inherited neuropathy clinic;. #PMP22 duplication, deletion, and point mutations. 
(Adapted from Manganelli et al. 2014).  
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2.2.-GDAP1 
GDAP1 was previously identified as one of 10 cDNAs expressed in a differentiated 
Neuro2a mouse neuroblastoma cell line, in which cholinergic differentiation with 
neurite sprouting was induced by transfection of GD3 synthase (a2,8sialyltransferase) 
cDNA.  
This gene, with a length of 23,728 base pairs (bp), contains six exons and five introns 
(figure I4). Two transcript variants of GDAP1 have been identified. Transcript variant 1, 
representing the longer variant, encodes the longer isoform, designated as isoform "a" 
(358 amino acids). Transcript variant 2, encoding isoform "b", contains an alternative 
in-frame exon, uses an alternative splice site in the 5′ coding region, and a downstream 
start codon, compared to transcript variant 1. Isoform "b" (290 amino acids) has a 
shorter N-terminal region compared to isoform "a" (Cassereau et al. 2011). 
 
Figure I4. Molecular analysis of GDAP1. Diagram showing exon–intron structure. Exons are indicated 
by black boxes; exon 6 coding sequence is in black and the noncoding sequence is in white (Cuesta et al. 
2002). 
 
It was detected two GST domains analyzing the secondary structure (figureI5). Amino-
acid residues 26–119 showed the βαβαββα topology of the glutathione (GSH) binding 
site, and amino-acid residues 210–287 (Cuesta et al. 2002). It has been also shown that 
GDAP1 has a single transmembrane domain (TMD) at the extremity of the C-terminal, 
and a hydrophobic domain (HD) in the flanking C-terminal region. Moreover, GDAP1 
has two additional regions between amino acids 152–164 and 169–195 which are 
predicted to represent two helices, α4 and α5 (figure I6), creating the α4–α5 loop 
(Marco et al. 2004). 
 
 
Figure I5. Schematic representation of the GDAP1 protein with predicted domains and the GDAP1 
genomic organization with the corresponding exons. The numbering above the GDAP1 protein 
indicates the amino acid positions of the structural domains. The numbering below the genomic 
organization corresponds to the amino acid boundaries of each exon (Cassereau et al. 2011).  
 
 
Figure I6. Predicted three-dimensional structure for human 
GDAP1 protein. The region presented as a backbone 
corresponds to part of the Zea mays GST used to model GDAP1 
structure. This region (alpha helices 4 and 5 and loop between 
them) cannot be properly analysed for GDAP1 because of lack 
of sequence similarity. The region shown in black would 
correspond to the position of the GDAP1 a4-a5 loop, in the case 
that helices 4 and 5 conserve the same structure that is in 
canonical GSTs. N indicates N-terminal end. (C) indicates 
approximate position of the C-terminal end. (Marco et al. 
2004). 
a4-a5 loop 
Introduction 29 
 
 
GDAP1 expression studies show that mRNA is expressed in almost all the human and 
mouse tissues analysed but is most abundant in nervous tissues (Cuesta et al. 2002; 
Pedrola et al. 2005). Protein studies show GDAP1 expression not just in dorsal root 
ganglia (DRG) sensory neurons and motor neurons from anterior horn of spinal cord, 
whose axons are the site of pathology, but also in large neurons in the brain (Pedrola et 
al. 2008). Others authors also observed expression in myelinating Schwann cells 
(Niemann et al. 2005). 
 
GDAP1 clearly appears to be localized in mitochondria, based on subcellular 
fractionation studies in human neuroblastoma cell line and overexpression experiments 
in fibroblasts. It has been also demonstrated that transmembrane domains are necessary 
for the correct localization of GDAP1 to mitochondria (Pedrola et al. 2005). Indeed, 
loss of GDAP1 signal after proteinase incubation and similar detection as porin after 
detergent treatment, demonstrate that GDAP1 is an outer mitochondrial integral 
membrane protein whose GST domains are exposed to cytoplasm (Niemann et al. 
2005).  
 
It has been clearly demonstrated that GDAP1 is a fission-inducing factor. Mouse 
neuroblastoma cell line experiments have revealed that overexpression of GDAP1 
promotes mitochondrial fragmentation without inducing cellular apoptosis, changes in 
mitochondrial transmembrane potential or interfering in mitochondrial fusion. 
Moreover, transfections with GDAP1-specific RNAi led to an increase in the number of 
cells with a tubular mitochondrial morphology compared with untransfected or control 
transfected cells (Niemann et al. 2005). Additional studies, in human neuroblastoma 
cells, proved that GDAP1 depletion induces a reduction in mitochondrial 
interconnectivity and an increase in organelle motility but without increasing tubular 
mitochondrial morphology (Pla-Martín et al. 2013). GDAP1 dominant mutations cause 
a loss or reduction of fission activity, or interfere with mitochondrial fusion. 
Recessively inherited mutant forms of GDAP1 display reduced fission activity 
compared to wild-type GDAP1 (Niemann et al. 2009). 
GDAP1-induced fission is dependent on Fis1 and Drp1. Unlike with other fission 
factors, GDAP1-induced fission does not increase the susceptibility of cells to undergo 
apoptosis (Niemann et al. 2009).  
 
The amino-acid sequence of GDAP1 shows strong similarity to glutathione S-
transferases (GSTs) (Cuesta et al. 2002). However, a measure of GST enzymatic 
activity using the model substrate 1-chloro-2,4-dinitrobenzene (CDNB), an electrophilic 
substrate used to study the kinetic properties of GSTs, did not confirm GST activity for 
GDAP1 without transmembrane domain. It remains possible that GST activity for 
GDAP1 requires a proper localization (Pedrola et al. 2005). 
Recent experiments determine that GDAP1 over-expression produced an increase of the 
total cellular GHS content and the mitochondrial membrane potential up to a level 
where it apparently limits mitochondrial respiration, leading to reduced mitochondrial 
Ca2+ uptake and superoxide production. The authors supported the hypothesis that the 
potential GST-GDAP1 is implicated in the control of the cellular GHS content and 
mitochondrial activity and the involvement of oxidative stress in the pathogenesis of 
GDAP1-related CMT (Noack et al. 2012).  
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In agreement, studies in human neuroblastoma cells proved that GDAP1 depletion 
increase ROS loads according to hypothesis that lack of GDAP1 causes oxidative stress. 
However, as these cells did not present alterations in mitochondrial electron transport 
chain complexes activity, it is unclear whether this oxidative stress has a mitochondrial 
origin (Bolinches Amorós 2014).  
However, GDAP1 dominants mutations lead to mitochondrial damage manifested in 
partial disturbance of the inner mitochondrial membrane potential (∆Ψm), increased 
reactive oxygen species (ROS) loads, and increased susceptibility to apoptotic stimuli. 
Recessively inherited mutant forms of GDAP1 do not induce this damage (Niemann et 
al. 2009). 
Experiments in skin fibroblasts from AD-CMT2K patients conclude that the lower 
respiration rate due to impaired complex I activity reduces ATP production without 
decreasing the efficiency of oxidative phosphorylation. Mitochondrial energetic 
metabolism of AD-CMT2K fibroblasts revealed a functional impairment of 
mitochondrial complex I activity. In AR-CMT2K fibroblasts, the rate of ATP synthesis 
driven by complex I was reduced by as much as 50%. However, the rate of ATP 
production per unit oxygen consumption (ATP/O ratio) was normal in AD-CMT2K 
fibroblasts, indicating that the efficiency of oxidative phosphorylation was unaffected 
(Cassereau et al. 2009). The authors hypothesize that lack of ATP due to a Complex I 
deficiency could reduce mitochondrial mobility (figure I7), particularly in the distal 
portion of neuronal axons. Insufficient mitochondrial motility in the long axons might 
explain, at least in part, why the distal portions of the peripheral nerves are principally 
affected in CMT disease involving GDAP1 mutations (Cassereau et al. 2011). 
 
 
Figure I7. Schematic hypotheses evoked to explain the mitochondrial dynamics and bioenergetics 
defect in CMT4A/2K (purple dotted arrows) and consequences of the complex I deficiency (in 
green). 1: The mutated GDAP1 increases the ROS level which has a deleterious effect on lipid 
peroxidation, and on protein oxidation of complex I. 2: GDAP1 plays a role in complex I regulation 
involving the phosphorylation and/or acetylation pathways. 3: The mutated GDAP1 is responsible for a 
mitochondrial dynamics defect, either directly or through an increase of the ROS level. A deficit of 
complex I leads to a decrease in the reduction of NADH, altered electron transfer to complex III, a 
reduction of the pumping of protons into the intermembrane space, an excessive production of ROS and, 
finally, a reduction of ATP synthesis (Cassereau et al. 2011). 
  
 
In addition, it has been suggested
movement within the cell. Human neuroblastoma cells experiments revealed that 
GDAP1 interacts with the trafficking
β-tubulin. These authors hypothesize that
mitochondria towards the ER and mitochondria
the cellular pathogenesis of 
 
Others authors affirm that mitochondrial fission factor
fission factor. Loss of GDAP1 results
fission capacity is decreased, whereas overexpression promotes
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2.3.-GDAP1 family: GDAP1L1 
Phylogenetic analysis demonstrate that GDAP1 belongs to a new group of GST-like 
proteins that is quite different from all other GST classes (GDAP1 class). Genes of this 
class, which includes human GDAP1 and GDAP1L1 (GDAP1like1) genes, are 
characterized by three main features. (1) Their distinctive sequences appear quite distant 
from all other GSTs in dendrograms (figure I9). (2) They have a characteristic 
additional amino acid region between predicted helices a4 and a5 (a4-a5 loop) that is 
absent in most GSTs. (3) They also have C-terminal extensions that may correspond to 
transmembrane domains. Those domains are absent in canonical GSTs, which, in 
general, are cytosolic enzymes. These studies also conclude that obvious orthologs of 
GDAP1 exist in many vertebrate species. GDAP1 paralogs, corresponding to the closely 
related GDAP1L1 human gene and its orthologs, also are found in different vertebrates 
(Marco et al. 2004). GDAP1 and GDAP1L1 are most closely related to the Zeta, Omega 
and Theta GST classes but are unlikely to catalyse reactions with compounds that are 
known substrates for other previously studied GSTs (figure I9) (Shield et al. 2006). 
 
 
 
Figure I9. Unrooted NJ tree for GSTs of model animals (Hs: Homo sapiens, Mm: Mus musculus, Dm: 
Drosophila melanogaster, Ag: Anopheles gambiae, and Ce: Caenorhabditis elegans). Numbers refer to 
NJ and MP bootstrap values (Marco et al. 2004). 
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The chromosomal locus of GDAP1L1 is 20q12. This gene, with a length of 33,818 base 
pairs, contains eight exons. Five to nine transcript variants of GDAP1L1 have been 
identified depending on database. The most strongly supported isoform has 367 amino 
acids but all this information is based in sequences and predictions (ID 78997 in 
www.ncbi.nlm.nih.gov; ENSG00000124194 in www.ensembl.org; 
OTTHUMG00000032530 in vega.sanger.ac.uk). GDAP1L1 has a 56% amino acid 
sequence identity and 70% similarity with GDAP1(figure I10) (Shield et al. 2006). 
 
 
 
 
 
 
Figure I10. Homology modelled structures of the 
amino terminal thioredoxin-like domains of GDAP1 
and GDAP1L1. The conserved active site serine 
positioned at the amino terminal end of helix 1 is shown 
in stick format (Shield et al. 2006). 
 
 
Little has been published about GDAP1L1. In 2014 it was established that the Gdap1l1 
mouse ortholog is expressed in the CNS, but not in the PNS (Niemann et al. 2014). In 
addition, even if the murine ortholog is a cytosolic protein, GDAP1L1 can be 
translocated to mitochondria under stress conditions with increased oxidized glutathione 
concentration (Niemann et al. 2014). According to that Niemann et al. (2014) proposed 
that loss of GDAP1 is compensated by the mitochondrial translocation of GDAP1L1 in 
CNS. 
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3.-Peripheral nervous system        
Peripheral neuropathy is a condition where damage resulting from mechanical or 
pathological mechanisms is inflicted on nerves within the peripheral nervous system 
(PNS). Damage can be located either on neuron's axons (axonopathy) or on Schwann 
cells surrounding its (myelopathy). In contrast to the central nervous system (CNS), the 
PNS possesses a unique ability to regenerate, recognized since the time of Camilo Golgi 
and Santiago Ramon y Cajal. However, despite the considerable capacity for regrowth 
upon injury, PNS regeneration is far from complete, especially in larger species such as 
humans, and functional recovery rarely returns to pre-injury levels (Richner et al. 2014).  
 
The peripheral nervous system includes sensory receptors, sensory neurons, and motor 
neurons. Sensory receptors are activated by a stimulus that is converted to an electric 
signal and transmitted to a sensory neuron. Sensory neurons connect sensory receptors 
to the CNS that processes the signal, and transmits a message back to an effector organ 
through a motor neuron. The PNS has two parts: the somatic nervous system and the 
autonomic nervous system. 
The somatic nervous system (voluntary) controls movements of skeletal muscles and 
enables humans to react consciously to environmental changes. It includes 31 pairs of 
spinal nerves and 12 pairs of cranial nerves (but not the optic nerve). Spinal nerves 
emerge from various segments of the spinal cord (figure I11) and it has a dorsal and a 
ventral root. The dorsal root contains afferent (sensory) fibres that transmit information 
to the spinal cord from the sensory receptors. Cell bodies of the afferent fibres reside in 
the Dorsal Root Ganglia (DRG). The ventral root contains efferent (motor) fibres that 
carry messages from the spinal cord to the effectors. Cell bodies of the efferent fibres 
reside in the spinal cord gray matter. These roots become nerves that innervate muscles 
and organs.  
The autonomic nervous system (involuntary) maintains homeostasis automatically and 
without voluntary input. Its parts include receptors within viscera (internal organs), the 
afferent nerves that relay the information to the CNS, and the efferent nerves that relay 
the action back to the effectors. The effectors in this system are smooth muscle, cardiac 
muscle and glands, all structures that function without conscious control. The efferent 
portion of the autonomic system is divided into sympathetic and parasympathetic 
systems (www.pennmedicine.org 2001).  
 
 
 
 
 
 
Figure I11. The 
spinal cord (CNS) 
and the peripheral 
nervous system 
(PNS). Peripheral 
nerve injury induces 
various changes in the 
PNS (peripheral nerve 
fibres and DRGs) but 
also in the central 
nervous system 
(CNS) (spinal cord) 
(Richner et al. 2014). 
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 3.1- DRG 
Dorsal Root Ganglia (DRG) neurons are primary afferent neurons responsible for 
transmitting sensory information from the periphery to the CNS. The DRGs are part of 
the PNS and are located in the neural foramen of the vertebrae, in close proximity to the 
CNS. For each cervical (C), thoracic (T), lumbar (L) and sacral (S) vertebra the DRGs 
are designated C, T, L or S and the corresponding number of the given vertebra in a 
rostro-caudal order (Richner et al. 2014). 
 
DRG cell bodies are pseudo unipolar, with a peripheral and a central branch. The DRG 
contain many functional classes of sensory neurons (Smith et al. 2012). Sensory neuron 
types can be delineated by the expression of neurotrophic factor receptors, tropomyosin 
receptor-kinase A (TrkA), TrkB, TrkC, which serve as receptors for the neurotrophins 
(figure I12) (Lallemend & Ernfors 2012). 
Nociceptive neurons are small, unmyelinated cells mediating pain sensation. They also 
express the TrkA receptor and respond to the neurotrophin NGF. Their central 
projections terminate largely in laminae I and II 
Tactile mechanosensitive sensory axons are larger than nociceptive axons and are well 
myelinated. Peripherally they project via cutaneous nerves to a variety of specialized 
receptors in skin. Their central terminations are restricted to the dorsal horn but in 
deeper laminae than nociceptive axons, and these projections are arranged 
topographically, reflecting the specific area of skin they innervate peripherally. Many of 
these neurons express TrkB and respond to the neurotrophin BDNF. 
The largest sensory neurons are proprioceptive, projecting peripherally via muscle 
nerves and supplying muscle spindles and Golgi tendon organs. They provide the CNS 
with information regarding body position and muscle length and tension. These neurons 
respond to the neurotrophin NT3 via TrkC receptors. Their central axons project to 
more ventral layers of the spinal cord than mechanoreceptors do, where they provide 
direct excitatory input to motoneurons (mediating the simple stretch reflex) as well as a 
variety of interneurons involved in locomotion (Smith et al. 2012). 
 
Figure I12. Central termination patterns of different classes of DRG neuron. The group Ia and some 
group II afferents that innervate muscle spindles (spindles) in the periphery project into the ventral spinal 
cord to connect motor neurons directly. Group Ib afferents (which innervate golgi tendon organs, GTO) 
as well as group II afferents, connect interneurons at the intermediate zone of the spinal cord. The C-, Aδ- 
and Aβ-low-threshold mechanoreceptors (LTMRs) project to the dorsal horn. Hence, C-LTMR endings 
terminate in lamina IIi and overlap with the Aδ-LTMR fibres that end partly within lamina II and mainly 
in lamina III. The Aβ-LTMR fibres terminate in laminae III through V. The Aδ myelinated fibres 
innervate laminae I and V and peptidergic and non-peptidergic neurons, laminae I and II. Nociceptive, 
thermoceptive and pruriceptive neurons are either unmyelinated (C-fibre) or lightly myelinated (Ad) 
sensory neurons. Peripherally, all types except types Ia, Ib and II afferents, innervate the skin and, unlike 
peptidergic neurons, non-peptidergic neurons terminate only in cutaneous fields and do not contribute to 
deep innervation of, for instance, viscera (Lallemend & Ernfors 2012). 
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 3.2- Motor neuron
The human body has more than 300 bilateral
million muscle fibres, which are innervated by
in the spinal cord alone (Kanning et al. 2010)
Lower MN cell bodies are located in specific nuclei in the brainstem as well as in the 
ventral horn of the spinal cord and therefore, like upper MNs, 
the CNS. The remarkable characteristic of lower MNs is their axonal extension 
connecting targets outside of the CNS. Lower MNs are cholinergic and receive inputs 
from upper MNs, sensory neurons (SNs) as well as from interneurons (INs). Paralysis i
a typical clinical symptom
alternative route to convey the information to the muscle targets in the periphery. Lower 
MNs are classified into three groups according to the type of target they innervate: (
branchial, (ii) visceral, and (iii) somatic MNs.
Somatic MNs are located in the Rexed lamina IX in the brainstem and the spinal cord 
and innervate skeletal muscles responsible for movements. MNs form coherent groups 
connecting to a unique muscle target 
single MN together with all 
Interestingly, motor units are 
type (figure I13).  
 
 
 
Figure I13. Schematic of 
illustrating the spinal cord (SC)
neuron (SN, blue) located in the DRG transmits a 
stretch stimulus sensed by the muscle spindle (MS, 
gray) to an interneuron (IN, purple) as well a
to motor neurons (MNs, dark and light green). In turn, 
MNs stimulate the contraction of extensor muscle 
(red) and ensure the concomitant relaxation of the 
antagonist flexor muscle located in the limb
2014). 
 
Somatic MNs can be divided into 3 groups: (i) alpha, (ii) beta, and (iii) gamma 
according to the muscle fibre
(figure I14) (Stifani 2014). 
Alpha motor neurons, the most abundant and biggest, innervate
muscle and drive muscle contraction.
Gamma motor or fusimotor neurons innervate intrafusal muscle
spindle and play complex roles in
Beta motor neurons, less well
fibres (Kanning et al. 2010)
 
 
 
 pairs of muscles containing more than 100
 more than 120,000 motor neurons (MN) 
. 
have their som
 of lower MN lesions since once damaged there is no 
 
defined as MN pools. A motor unit defines a 
its axonal branches and all the muscle fibres
homogeneous: a MN innervates muscle fibres
a myotatic reflex 
 circuitry. Sensory 
s directly 
 (Stifani 
 type they innervate to within a specific muscle target 
 
 extrafusal skeletal
 Most α-MNs receive direct Ia input. 
 fibres
 motor control.  
-defined population, innervates both intra
. 
Figure I14. Schematic
innervation. Longitudinal
muscle fibres showing 
innervates extrafusal muscle 
whereas γMN (green) connects to intrafusal
fibres within the muscle spindle surrounded 
by the capsule. Sensory neurons (blue) 
carry information from the intrafusal
to the central nervous system (Adapted 
from Purves et al. 2004)
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 Neuromuscular junction. 
The neuromuscular junction (NMJ) is a specialized synapse in the peripheral nervous 
system, which serves to achieve reliable transmission between the αMN and skeletal 
muscle fibres (Punga & Ruegg 2012). 
The NMJ is composed of three compartments (figure I15): 
(1) The presynaptic part – the motor nerve terminal – is responsible for synthesis, 
storage and release of the neurotransmitter acetylcholine (ACh). 
(2) The intrasynaptic part – the synaptic basal lamina – constitutes a structural and 
functional extracellular matrix and facilitates adhesion between synaptic membranes. 
(3) The postsynaptic part – the muscle membrane – contains a high density of 
acetylcholine receptors (AChRs) and other molecules important for the establishment 
and maintenance of the NMJ (Punga & Ruegg 2012). 
 
Figure I15. The mammalian neuromuscular junction (NMJ). (A) Schematic diagram illustrating cell 
types and organelles at the mammalian NMJ. The presynaptic motor nerve terminal are shown in green. 
Note the presence of large numbers of mitochondria. The post-synaptic muscle fibre is shown in yellow, 
with characteristic postsynaptic folds and clustering of acetylcholine receptors (AChRs; red). Terminal 
Schwann cells (TSC) are shown in blue and two NMJ-capping cells (kranocytes) are shown in magenta. 
(B) Schematic diagram illustrating the normal innervation pattern of three muscle fibres (yellow) in an 
adult mammalian muscle. Note how each muscle fibre is only innervated by a single axon (green; 
ensheathed by myelin shown in grey) at a single point of synaptic contact (red; AChRs). Also note how 
each presynaptic motor nerve terminal branches at the endplate resulting in a mirror image of the 
underlying AChRs (Murray et al. 2010). 
 
Notably, the NMJ goes through a unique series of maturation processes that differ from 
those of the central synapse. First, whereas maturation of the central synapse normally 
occurs within hours, the NMJ takes days to weeks to refine its molecular and structural 
organization to achieve its mature form, which exhibits efficient neurotransmission. 
Furthermore, the stability of the NMJ increases on maturation, and the synaptic 
structure, once mature, persists throughout most of postnatal life, thus enabling life-long 
effective motor performance (Shi et al. 2012). There is, however some loss of NMJ 
innervation and reinnervation by axonal sprouting in ageing animals. 
Due to the tight correlation between synaptic activity and NMJ morphology, a great 
deal of information can be gained about the functional status of motor neurons from 
analysis of NMJ morphology. As loss of NMJs frequently represents one of the first 
aspects of neuromuscular pathology, quantification at the level of innervation can give 
important information about the progression of pathology and the potential effect of a 
therapeutic intervention. Furthermore, as NMJ loss represents a significant step in 
pathological progression, the development of therapeutics that can stabilize connections 
and encourage regeneration may yield significant benefit (Murray et al. 2014). 
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4.- Mitochondrial dynamics in peripheral nerves     
Peripheral nerves require efficient energetic metabolism to maintain their complex 
machinery and the transport of many molecular and organelle cargoes along axons, 
which may be as long as one meter. The highly specialised Schwann cell with many 
myelin lamellae wrapping axons also has to be maintained. Proper mitochondrial 
functioning is therefore fundamental for axonal and myelin formation and maintenance 
(Pareyson et al. 2015). 
 
 4.1.- Mitochondria in neurons 
Mitochondria are organelles with an outer and an inner membrane (OMM, IMM). In the 
outer membrane porins forms large aqueous channels that make it permeable to 
molecules up to 5000 daltons, including small proteins. Such molecules can enter the 
intermembrane space which is chemically equivalent to the cytosol. 
The major working part of the mitochondrion is the matrix and the inner membrane that 
surrounds it (figure I16). The inner membrane is highly specialized, it is selectively 
permeable to those small molecules that are metabolized or required by the many 
mitochondrial enzymes concentrated in the matrix. The matrix enzymes include those 
that metabolize pyruvate and fatty acids to produce acetyl CoA and those that oxidize 
acetyl CoA in the citric acid cycle. The principal end-products of this oxidation are CO2, 
which is released from the cell as waste, and NADH, which is the main source of 
electrons for transport along the respiratory chain—the name given to the electron-
transport chain in mitochondria. The enzymes of the respiratory chain are embedded in 
the inner mitochondrial membrane, and they are essential to the process of oxidative 
phosphorylation, which generates most of the animal cell's ATP. The inner membrane is 
usually highly convoluted, forming a series of infoldings, known as cristae, that project 
into the matrix (Alberts et al. 2007). 
 
Figure I16. Mitochondrial function in normal cells. Under regular oxygen conditions, healthy cells 
primarily rely on mitochondrial OXPHOS for ATP production. 1) Ca2+ ions are taken up into a 
mitochondrion through VDACs and Ca2+-sensitive uniporter channels, and stimulate ATP generation. 2) 
Glucose is converted into pyruvate during glycolysis which is 3) imported into the mitochondrion for 
entry into the TCA cycle. 4) Reduced succinate and NADH molecules are used by the ETC complexes to 
power ATP generation. 5) ROS created along the ETC are balanced by antioxidants, such as superoxide 
dismutase (SOD), and 6) UCP channels. 7) Excess Ca2+ ions are expelled from the mitochondrion through 
the MPTP comprised of VDAC, ANT, and CypD (Carlson et al. 2013). 
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Mitochondria are essential organelles for the life and death of eukaryotic cells and 
participate in oxidative phosphorylation; biogenesis of iron-sulfur clusters, heme, 
certain lipids, amino acids (Otera et al. 2013) and it targets signalling molecules 
including hydrogen peroxide and nitric oxide. Further, owing to their large capacity to 
store Ca2+, mitochondria are crucial for Ca2+ buffering and are thus involved in 
numerous signalling pathways. However, mitochondrial Ca2+ overload can lead to 
neuronal apoptosis or necrosis (Sajic 2014). 
 
The biosynthesis of mitochondria requires contributions from two separate genetic 
systems. The majority of the proteins in mitochondria are encoded by special genes 
devoted to this purpose in nuclear DNA. These proteins are imported into the organelle 
from the cytosol after they have been synthesized on cytosolic ribosomes. Other 
organelle proteins are encoded by mitochondrial DNA (mtDNA), consisting in many 
copies of small circular DNA anchored to the IMM, and synthesized on ribosomes 
within the organelle. In mammalian cells, mtDNA makes up less than 1% of the total 
cellular DNA. The human mitochondrial genome contains about 16,500 nucleotides and 
encodes 2 ribosomal RNAs, 22 transfer RNAs and 13 different proteins. Those proteins 
are subunits of Citochrome oxidase, ATP synthase and NADH dehydrogenase  (Alberts 
et al. 2007). 
 
Mitochondria proliferate by growth and division, thus their fusion and fission are 
important for maintaining mitochondrial number and function (Otera et al. 2013). Post-
mitotic tissues such as components of the nervous system have the lowest capacity to 
maintain function following impairment of mitochondrial function, due to their limited 
capacity for self-renewal (Sajic 2014).  
 
Furthermore, neurons are spatially complex cells with long axons, which renders the 
distant parts more liable to experience mitochondrial insufficiency than the majority of 
spherical or columnar cells. In neurons, as well as the standard cellular requirements, 
ATP is necessary for impulse conduction, as maintenance and post-impulse restoration 
of the membrane potential is dependent on the removal of Na+ ions by the 
Na+/K+ATPase. These great variations in impulse activity over time, thus the relative 
metabolic demands of central and peripheral components of the same neuron are 
constantly changing. Clearly, delivering mitochondria to areas of high metabolic 
demand (the right place) at the right time is essential, but should not be done at the 
expense of neglecting the cell body. Therefore, the long-distance two-way transport 
system for mitochondria in neurons is necessarily complex, receiving signals from 
several regions and “trying” to provide a sufficient supply to all areas simultaneously, 
including sites remote from the cell body. Indeed, with some cell processes more than 
one metre long in human, clearly the potential difficulties are compounded in that the 
very process of delivering energy has evolved into a major energy-requiring system in 
its own right (Sajic 2014). 
 
  
40 GDAP1-related CMT mouse model
 
 4.2.- Mitochondrial fusion
Mitochondrial dynamics define the con
organelles, fundamental to regulate their shape, size and number, as well as the 
mitochondrial transport along axons, and the interactions with other organelles, such as 
the endoplasmic reticulum (ER) 
 
Fusion is the combination of two separate mitochondria into one and 
unify the mitochondrial compartment 
whereby first the OMMs fus
partner needs to be mobile and move towards the other fusing partner
that a mobile mitochondrion will get engaged in fusion with a stationary mitochondrion 
increases with the velocity 
at impact, the higher the chance that the colliding mitochondria will fuse 
Mitochondrial fusion (Figure I
the OMM, Mitofusin-1 (MFN1) and Mitofusin
Atrophy-1 (OPA1). MFN1 and MFN2 form homo
two mitochondria, determining their tethering in the fusion process. MFN1 interacts 
also with OPA1, important for the I
2015). 
 
Figure I17. Mitochondrial fusion.
come into contact and the mitofusins (MFN1 and MFN2) in the outer membranes (OM) of the two 
mitochondria tether them by forming homo
membranes (IM) begin the fusion process which is mediated by OPA1, lo
also with MFN1. After fusion of the membranes, the two mitochondria merge their whole content and at 
the end of the process one larger mitochondrion is obtained 
 
 
Fission generates morphologically and functionally distinct organelles
2013). Under basal physiological conditions, fusion is in equilibrium with fission in 
such a way that the distribution of mitochondrial sizes in cells is maintain
constant (Sajic 2014).  
Mitochondrial fission is regulated by other proteins
mitochondrial fission factor (MFF) and mitochondrial fission protein 1 (FIS1), acting in 
the OMM as ligands of a cytoplasmic multimeric GTPase, also related to dynamins, 
named DRP1 (dynamin-related protein
favouring the assembly of DRP1 
 
-fission 
tinuous process of fusion and fission of these 
(Pareyson et al. 2015). 
serves to mix and
(Cagalinec et al. 2013). It is a two
e, followed by fusion of the IMMs. At least one fusing 
.
of the moving partner. In other words, the greater the speed 
17) is regulated by dynamin-like GTPases located both in 
-2 (MFN2), and in the 
- and hetero-oligomers in O
MM fusion and cristae shaping 
 In the mitochondrial fusion, two mitochondria next to each other 
- and hetero-dimers. The two OM fuse and then the inner 
cated in the IM, which interacts 
(Pareyson et al. 2015). 
 
 (Figure I18
-1) in mammals. GDAP1 participates
(Pareyson et al. 2015). 
 
 
-step process 
 The probability 
(Sajic 2014). 
IMM, Optic 
MM of 
(Pareyson et al. 
 
(Cagalinec et al. 
ed relatively 
), including 
 possibly 
 Figure I18. Mitochondrial fission.
mitochondria in a process which is less known. 
with the cytoplasmic multimeric protein DRP1, an important effector of fissio
OM (Pareyson et al. 2015). 
 
The balance of these two processes determines org
critical for organelle distribution and bioenergetics. The latter is particularly important 
in neurons, which have a unique bioenergetic profile due to their dependence upon 
energy from mitochondria and their specialise
Beyond the control of morphology, the mitochondrial fusion
also critical in regulating cell death and mitophagy. Mitochondrial fission contributes to 
quality control by favouring removal of dam
facilitate apoptosis in conditions of cellular stress. Failure of mitochondrial fusion
fission dynamics has been linked to several diseases
neurodegenerative diseases 
 
Introduction
 Fission of one mitochondrion leads to the formation of two novel 
In the fission process, MFF and FIS1, in the OM
n. GDAP1 participates in
anelle shape, size and number and is 
d, compartmentalised energy needs. 
-fission cycle appears to be 
aged mitochondria via mitophagy and may 
 as CMT and other 
(Cagalinec et al. 2013). 
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 4.3.- Mitochondrial transport 
In motor and sensory neurons of the peripheral nervous system, mitochondria 
particularly concentrated in defined regions: the initial segment of the axon stemming 
from the perikaryon, close to
junctions (motor neurons) or to the sensory end terminals (sensory neurons
site of any lesion (Pareyson et al. 2015)
are in movement reflecting the acute need 
ATP among the microdomains inside 
continually over a long distance at a relatively constant speed, or
start again with a different speed or direction
 
The neuronal cytoskeleton, which is composed of microtubules, acti
neurofilaments, acts as a railway to transport
flow is termed anterograde
going backwards to the neuron's soma.
The majority of mitochondrial movement is microtubule
Two principal motor proteins 
cargoes from the cell body toward the terminal end (anterograde), whereas dynein is 
preferentially involved in retrograde flow
binding domain with two branches and an ATP
like movement; moreover, they use several adaptors and scaffolding proteins to 
recognize and bind cargoes 
The Miro-Milton complex is the best understood adaptor complex for the regulation of 
mitochondrial anterograde transport. The
a receptor with a transmembrane
membrane, and Miro binds to 
(KHC) (A in figure I19). 
The adaptor proteins for retrograde movement
that there is only one complex
directly via its largest subunit, p150. Dynactin may facilitate the
dynein motor or its cargo binding
 
Most of immobile mitochondria there are also 
regulated by syntaphilin (SNPH).
(Ni et al. 2015). 
Figure I19. Schematic representations of mitochondrial transport machineries
transported on microtubules by kinesin; 
miro. B) Mitochondria are transported
mitochondria stop once they bind to syntaphilin, while still
dynein light chain, LC8, has been sh
microtubule interactions. D) Mitochondria
verprolin homologous protein 1 (WAVE1) regulates actin polymerization
additional unidentified proteins on the outer mitochondrial membrane
 
in neurons 
 nodes of Ranvier, at distal sites close to the neuromuscular 
. Approximately 30–40% of total mitochondria 
for buffering Ca2+ influx and distribut
neurons. A mitochondrion can either
 pause sporadically and 
 (Lovas & Wang 2013). 
 mitochondria along neurons. 
 when directed toward the terminal end and retrograde
 
-based (A-C in
have been described. The kinesin family 
. Both protein families have a microtubule
-hydrolyzing activity allowing a step
(Pareyson et al. 2015). 
 current model suggests that Miro 
 domain integrated into the outer mitochondrial
Milton, which in turn binds to Kinesin
 of mitochondria are less clear;
, dynactin, which binds to dynein and microtubules
 processivity of the 
 (B in figure I19) (Lovas & Wang 2013)
bound to microtubules
 SNPH serves as a docking protein (
. A)
Milton acts as an adaptor linking Kinesin Heavy Ch
 on microtubules by dynein; Dynactin act as an adaptor. 
 being attached to motors and microtubules; 
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 are transported on actin filaments byMyo19;  WASP family 
. “Protein X” indic
 (Lovas & Wang 2013)
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Mitochondria are also transported along actin filaments (D in figure I19), a process that 
happens more frequently in dendritic spines, growth cones, and synaptic button where 
the actin cytoskeleton is enriched. This actin-based movement is relatively short-range, 
likely mediated by myosin motors, and important for local and acute translocation and 
docking of mitochondria in response to action potentials, Ca2+ influx, or neurotrophic 
stimulation. Actin-based transport can also coordinate, supplement, or even oppose 
microtubule-based transport. 
Although mitochondria are able to travel along actin, little is known of actin motors or 
their mitochondrial adaptors. As a motor, Myo19 has been described but it is still 
unknown if Myo19 binds to the mitochondrial membrane directly or via its binding 
partners. In addition, the WASP family verprolin homologous protein 1 (WAVE1) that 
regulates actin polymerization has been recently shown to control depolarization-
induced mitochondrial movement into spines and filopodia and regulate spine 
morphogenesis (Lovas & Wang 2013). 
 
The last component of neuron cytoskeleton, neurofilaments, are particularly abundant in 
axons and their main function is to control the axon diameter and thereby axonal 
conductance (Kevenaar & Hoogenraad 2015). Neurofilament network disruption can 
impair axonal architecture and axonal transport. Neurofilaments influence the dynamics 
of mitochondria too by regulating their arrest when detaching from molecular motors 
and microtubules, as stationary mitochondria appear to be bound to the “beams of the 
scaffold” NF-M and NF-H (C in figure I20) (Pareyson et al. 2015). 
 
Figure I20. Axonal transport. The figure shows the anterograde and retrograde transport taking 
place in the axon of a neuron. The cytoskeletal architecture with the polarized microtubules and the 
neurofilament scaffold is represented. (A) Anterograde transport toward the terminal end is mediated by 
kinesins and kinesin-1 is the main mediator of mitochondrial anterograde transport. It steps along 
microtubules in an ATP-consuming process with its leg-like heavy chains and, through the adaptor 
Miro1-Milton complex bound to MFN2, transports the entire mitochondrion. (B) The dynein complex 
moves in the opposite direction (retrograde axonal flow) in the same step-wise ATP-consuming fashion. 
It ties the mitochondrion through dynactin and its important p150glued subunit. (C) Mitochondria move 
along the cells and are particularly concentrated in regions of high energetic demand, such as at the node 
of Ranvier. Stationary mitochondria are bound to neurofilaments (NF-M, NF-H) (Pareyson et al. 2015). 
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 4.4.-Microtubules as railway of 
Microtubules are cylindrical
with a fast-growing plus-end
switches stochastically between polymerization
dynamic instability (Kevenaar & Hoogenraad 2015)
uniformly arrayed with all plus
to the cell body, whereas in a dendrite
& Wang 2013). Microtubules serve as tracks and different molecular complexes carry 
mitochondria along this rai
heterodimers confers a clear polarization, fundamental for properly directing axonal 
transport, as molecular motors preferentially move in a unique direction 
2015). Microtubules are uniformly arranged in
distally and minus ends are
The dynamics of microtubules are
microtubule-associated proteins
modifications and plus-end tracking
There are post-translational tubulin modifications that makes microtubules more stable
(figure I21). In migrating mammalian cells, 
the leading edge are more stable and enriched in acetylation
& Gaertig 2010). In agreement, acetylation and detyrosination occurs on polymerized 
microtubules; deacetylation 
preference of some kinesins for acetylated and detyrosinated
reported (Janke & Kneussel 2010)
Figure I21. Microtubule cytoskeleton
modification can regulate axonal transport 
proteins (MAPs) linking to microtubule
 
axonal transport 
 polymers built up from α- and β- tubulin het
 and a more stable minus-end. These tubulin
 and depolymerization, 
. In an axon, microtubules are 
-ends pointing to the axonal terminal and the minus
 their polarities are typically more mixed 
lway. Polymerization of alpha- and beta
 axons: their plus ends are oriented 
 directed toward the soma. 
 regulated by a large number of factors, including
 (MAPs), motor proteins, post-translational
 proteins (Kevenaar & Hoogenraad 2015)
subsets of microtubules that orient
 and detyrosination
and retyrosination on depolymerised ones. Moreover,
 microtubules
. 
 implications in axonal transport. Post-translational tubulin 
by modulating motor proteins and microtubule
s (Adapted from Janke & Kneussel 2010).  
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5.-Models to study CMT         
  
5.1.- Mouse as a model of CMT 
Owing to the rapid progress in animal genome engineering, mouse models of disease 
are experiencing tremendous development. There is a need for phenotypic 
characterization of the novel models including the morphologic approach. The small 
body size of this species requires specific technical solutions enabling the assessment of 
particular morphological features (Krinke et al. 2014). The characterization of mouse 
models of human disease is essential for understanding the underlying pathophysiology 
and developing new therapeutics. Many diseases are often associated with more than 
one model, and so there is a need to determine which model most closely represents the 
disease state or is most suited to the therapeutic approach under investigation. In the 
case of neurological disease, motor tests provide a good read-out of neurological 
function (Brooks & Dunnett 2009). 
 
 
Peripheral nervous system in mouse. 
PNS is guided by the same rules as in other species. In general, sensitivity is determined 
by the size of affected structures. Therefore, the sciatic nerve, the longest spinal nerve, 
is suitably represents the peripheral nerves. Axonal damage or “axonopathy” is “distally 
accentuated”, most prominent in the distal nerve branches; according to dying back 
theory, axons located distally from an injury undergo degeneration. Moreover, since the 
axons are maintained by axonal transport of materials supplied by the nerve cell body, 
and such transport to distal nerve branches needs to overcome long distances, the distal 
axonal portions most remote from the nerve cell body are most vulnerable. 
In order to assess whether damage to nerve fibres is distally accentuated, the sciatic 
nerve must be collected and examined at least at two levels: proximally (above the 
knee)and distally in one of the main branches , e.g. the tibial nerve (below the knee). It 
is important to remark that the mouse sciatic nerve originates mainly from the third (L4) 
and fourth (L5) lumbar spinal cord segments (figure I22). The number of lumbar 
vertebrae in mice is variable, e.g. mostly five vertebrae occur in DBA/2J, mostly six 
vertebrae in C57BL/6J and a mix in B6129PFZ/J (Krinke et al. 2014). 
 
 
 
 
 
 
 
 
 
 
Figure I22. Image representing spinal cord, 
DRG and sciatic nerve in rat. Diagram of the 
sciatic and saphenous nerves, their terminal 
branches and their dorsal root origins showing 
that the saphenous nerve (femoral nerve plexus, 
L3 DRG) has minimal overlap with the sciatic 
nerve plexus (L4, 5 and 6 DRGs) (Decosterd & 
Woolf 2000).  
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Relationship between sciatic nerve branches and footpad innervation has also been 
established (figure I23). The s
tibial and sural branches of 
respectively (Decosterd & Woolf 2000)
 
 
 
 
Figure I23. Different zones of the plantar surface of the rat pa
innervated by the sciatic terminal branches and the s
nerve. At the borders between the skin territories some
axonal terminals may occur (Decosterd & Woolf 2000)
 
Examination of the PNS reasonably includes samples of the skeletal muscle. In the 
mouse, the soleus muscle is type I
long digital extensor are type II (glycolytic)  predominant. L
gastrocnemius muscle is considered to contain nerve fibres especially susceptible to 
toxic neuropathies (Krinke et al. 2014)
 
Analyzing NMJs, skeletal muscles of mouse can be subdivided into two subtypes, 
designated Fast Synapsing
gastrocnemius), muscles (figure I24
synaptogenesis during embryonic development and in the maintenance of NMJs in the 
adult. In FaSyn muscles, a mature pattern is achieved within less than 1 day of 
development but, in DeSyn muscles, it req
timing and rate of synapse assembly appear to reflect muscle
independent programs of focal AChR clustering.
soleus), focal AChR clustering and maintenance depends crit
factors, whereas this dependence is much more limited in FaSyn muscles. NMJs on 
FaSyn and DeSyn muscles continue to differ for several months after birth. Thus, after 
birth and up to 3–5 months of age, AChR clusters and presynaptic 
DeSyn muscles are selectively vulnerable to the absence of nerve
et al. 2002).  
 
aphenous nerve innervates the medial footpad while 
the sciatic nerve innervate the central and lateral part
. 
w 
aphenous 
 overlap of 
. 
 (oxidative) predominant and quadriceps femoris or 
ike in other species, medial 
. 
 (FaSyn, like gluteus) and Delayed Synapsing
). These muscles differ in the rate of neuromuscular 
uires 4–5 days. These differences in the 
-intrinsic, nerve
 In a DeSyn muscle (such as the 
ically on nerve
nerve terminals in 
-evoked activity 
Figure I24. Distribution of FaSyn and 
DeSyn Muscles in the Hind
Mouse. DeSyn muscles are in blue, and 
FaSyn muscles are in green. The dotted 
lines indicate positions of the bones. SN: 
sciatic nerve (E). Lateral (D
thigh (D, and E) and calf (
views are subdivided into superficial (
and deep (E). Thigh muscle abbreviation
BF, biceps femoris; CF, caudo
GMax, gluteus maximus; GMed, gluteus 
medius; GMin, gluteus minimus; RF, 
rectus femoris; Std, 
dorsal; SM, semi-membranosus
vastus lateralis. C
abbreviations: EDL, extensor digitorum 
longus; LGC, lateral gastrocnemius; PB, 
peroneus brevis; PD4, peroneus 
digitiquarti; PD5, peroneus digitiquinti; 
PL, peroneus longus; 
tibialis anterior; (Pun et al. 2002)
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Mitochondria labelling in mice 
The co-evolution of optical in vivo imaging (or in vivo microscopy) and mouse genetics 
allows the investigation of neurological disease models in living animals at the level of 
single cells. Of particular importance was the generation of transgenic mice that express 
high levels of fluorescent proteins in their neurons. In these mice, neurons are labelled 
with different spectral variants of fluorescent proteins, which are expressed under the 
control of a modifiedThy1-promoter element (Misgeld & Kerschensteiner 2006).  
 
More specifically, mice engineering has made possible the generation of a fluorescence 
labels to selectively image mitochondrial dynamics in the mouse nervous system, in 
both live mice and acute explants (figure I25). In vivo imaging of mitochondria is very 
useful tool to analyse this essential organelle (Misgeld et al. 2007). 
 
 
 
 
 
 
 
 
Figure I25. In vivo imaging of mitochondrial transport. (c) 
Peripheral motor nerve fascicle in a Thy1-mitoCFP-S mouse. 
Mitochondria align inside motor axons (inset 1), and a high 
density of mitochondria fills the terminal branches of 
neuromuscular junctions (inset 2; acetylcholine receptors labelled 
with a-bungarotoxin; red). (d) Time-lapse series of mitochondria 
in the proximal part of an intercostal axon in a nerve-muscle 
explant. An averaged still frame of the imaged axon segment 
(top), and the filtered and intensity-inverted version of the image 
(middle) are shown (Misgeld et al. 2007).  
 
 
 
5.2.- Primary culture as a model of CMT 
Cell culture is used by researchers worldwide to elucidate metabolic pathways and to 
discover the mechanisms involved in cell signalling, regulation of gene expression and 
protein synthesis, cell proliferation, senescence, and cell death. However, it must be 
noted that cells in culture are different from those in vivo in many ways. The normal 
extracellular matrix (which has important influences on cell morphology and function) 
is absent, as are other cell types that normally surround the cells in question and 
communicate with them (Halliwell 2014). 
 
The formation of a complex nervous system requires microtubule-mediated processes 
that coordinate proliferation, migration, and differentiation of neuronal cells (figure 
I26). Therefore, it is not surprising that many neurodevelopmental problems and 
neurodegenerative disorders are caused by deficiencies in microtubule-related genes 
(Kapitein & Hoogenraad 2015). Use of primary culture allows us to study in depth 
several processes related with mitochondrial dysfunction: neurite initiation and 
outgrowth, axon elongation and regeneration, dendritic spine morphodynamics, synapse 
functioning and axonal transport. 
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Figure I26. Neuronal microtubule, and their
different functions of neuronal microtubules. Zooms show microtubule organization in dendritic spines 
(1), emerging neurites (2), and growth cones (3) of cultured rat hippoc
dendritic spines of neurons at DIV56 expressing the actin marker Lifeact (red) and the microtubule 
growth marker MT+TIP. For the MT+TIP, an overlay of 48 frames is shown to highlight the trajectories 
in the dendritic shaft, including spine entries. (2 and 3) Zooms of neurite formation (2) and a growth cone 
(3) from a cultured rat hippocampal neurons at DIV6, stained for tubulin (green) and actin (red). Arrows 
indicate overlap between the acti
 
 
Adult DRG primary culture
Dorsal Root Ganglia (DRG) 
mechanisms of PNS development,
addition, in peripheral neuropathies 
cells and study disease progression 
Evaluation of different parameters 
course enables us to study disease progression
DRG cultures often are used in neuron disease
dissect, dissociate and maintain in culture
 
Figure I27. Adult DRG primary culture 5div. 
months old mouse after 4 days "in vitro" (div). Note that neuron soma appears a
arrows)  while neurites come out from soma as a thin processes
arrows). B is a magnification of square drawn in A. 
 
 
 functions studied in cell culture. Cartoon illustrating the 
ampal neurons. (1) Zoom of 
n and microtubule cytoskeleton (Kapitein & Hoogenraad 2015)
. 
are a convenient source of neurons for studying the 
 growth, maintenance and disease
such as CMT, the possibility to 
can help to investigate the pathological mechanism.
in DRG neuron cultures throughout the disease time
.  
 models as they are relatively easy 
 (figure I27). 
Representative image of DRG primary culture from 2 
s a bright spheres
 becoming a neuronal net
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Postnatal SCG primary culture. 
The rodent superior cervical ganglion (SCG) is a useful and readily accessible source of 
neurons for studying the mechanisms of sympathetic nervous system (SNS) 
development and growth in vitro. The SNS of early postnatal animals undergoes a great 
deal of remodelling and development; thus, neurons taken from mice at this age are 
primed to re-grow and establish synaptic connections after in situ removal. The 
stereotypic location and size of the SCG make it ideal for rapid isolation and 
dissociation (Jackson & Tourtellotte 2014). 
Several techniques such as microinjection (figure I28) can be used to analyse 
mitochondrial movement in postnatal SCG culture (Gilley & Coleman 2010). To study 
mitochondrial movement there are many commercial markers. However, microinjection 
allows us to label only a few neurons in the dish and to know the orientation of 
individual axons. 
 
 
 
 
 
 
 
Figure I28. Postnatal SCG primary culture 
during microinjection. Representative image of 
SCG primary culture from P1 mouse after 4div. 
Note that neuron soma appears as a bright 
spheres while neurites come out from soma as a 
thin processes. Note also the shadow of 
microinjector pipette during microinjection of 
soma neurite.  
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Mutations in many genes cause Charcot-Marie-Tooth (CMT) neuropathy; and due to 
this a wide variety of subtypes and associated phenotypes has been described. 
Ganglioside-induced differentiation-associated protein-1 (GDAP1) is one of these 
genes causing CMT, which is the special interest in Mediterranean basin due to the 
elevated frequency of CMT patients with mutations in this gene. 
Despite previous studies in cell culture, the function of GDAP1 still unclear. It was 
initially described as a fission-inducing factor, but the molecular roles and pathogenic 
mechanisms in CMT disease remain undetermined. 
 
 
 
 
Hypothesis 
Based on cell culture studies and also the pathophysiology of CMT patients our 
hypothesis is that GDAP1 is implicated in mitochondrial transport and positioning 
within the neurons and axons. The disease pathology is due to impairment of transport 
and/or mislocalisation of mitochondria, which may be related to the nerve length.   
 
 
 
 
Objective 
The main objective of this thesis is to investigate the function of GDAP1 and 
understand its implications for CMT disease. For this purpose we have generated Gdap1 
null mice as a tool to investigate how the lack of gene function leads to neuropathy and 
to characterise the degeneration course.  
 
As a first aim of this thesis, it is necessary to characterize our mouse and assess its 
suitability as a model for GDAP1- related CMT. Once this first goal is reached, we can 
use it as a tool to better understand the pathogenic mechanisms. A good mouse model 
for a disease should allow us to investigate the molecular changes occurring in all 
mouse tissues because of the mutated gene, so we are not limited to cell culture. 
Discovering the function of GDAP1 and understanding its implications for neuropathy 
may help make it possible to prevent or repair axon loss in CMT patients. 
 
 
Thus, the main objective comprises 3 goals: 
  (1) Characterization of the Gdap1 null mice 
  (2) Consolidate Gdap1 null mice as a CMT model 
  (3) Determine the function of GDAP1 and understand its implications for CMT disease 
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1.- Mouse model characterization        
A knockout mouse for Gdap1 (Gdap1-/-) was generated by genOway (Lyon, France; see 
Materials&Methods for more details), deleting exon 1 of murine Gdap1. Briefly, 
embryonic 129sv stem cells were transfected with a FRT-recombinase plasmid which 
also contains a homologous region to the first of six exons of Gdap1 and a neomycin 
resistance gene. Recombined cells were then injected into blastocyts to create chimera 
mice. Chimeras were crossed with Flp recombinase-expressing C57BL/6J to remove the 
Neo resistance cassette and generate a line of Neo-excised floxed mice. Gdap1+/flox mice 
were crossed with ubiquitous Cre deleter mice to obtain constitutive Gdap1+/-strains 
(figure R0). 
 
Figure R0. Generation of Gdap1-/-mice. Schematic representation of Gdap1-/- targeting strategy. 
Diagram is not to scale. Hatched rectangles represent Gdap1 exons 1 to 6, solid line represents mouse 
chromosome 1. FRT sites are represented by double triangles and loxP sites are right-faced triangles. 
 
Gdap1+/+, Gdap1+/- and Gdap1-/- mice were born as offspring of Gdap1+/- breeding. All 
three genotypes were born at expected Mendelian ratios, had normal life span and were 
fertile. Knockout (Gdap1-/-) mice pathology was compared with that of CMT patients 
and wild type (Gdap1+/+) mice were used as controls. 
 
 
1.1- Genetic and protein characterization 
Genotyping was performed by PCR analysis of mouse genomic DNA obtained from tail 
biopsies. A PCR strategy allowed us to distinguish Gdap1+/+, Gdap1+/- and Gdap1-/- by 
identifying the deleted gene as a shorter amplified product( 
Figure R1). 
 
 
 
 
 
 
 
Figure R1. Gdap1 genotyping. PCR strategy 2 is able to 
differentiate Gdap1+/+ (2500pb), Gdap1-/- (550pb) and Gdap1+/- 
(both bands 2500 and 550pb). 
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Protein expression of GDAP1 was characterized in
(Figure R2). The expected band (3
medulla, spinal cord and dorsal root ganglia. 
enough to detect its expression in s
GDAP1 detection.  
Figure R2. GDAP1 expression in 
neuronal tissues: anterior brain, posterior brain, cerebellum, medulla, cervical spinal cord, thora
cord, lumbar spinal cord, dorsal 
heart, lungs, spleen, kidneys, liver, pancreas, small intestine, testis, uterus
housekeeping, ATP synthase as a mi
 
Loss of GDAP1 according 
non-neuronal tissue lysates from
R3). In these experiments we loaded more amount of protein so we could detect 
GDAP1 expression even in low
tissues were positive to GDAP1 expression and
Gdap1+/- when it was compar
 
 
 
 
 
 
Figure R3. GDAP1 expression 
genotype. Protein expression study in 
neuronal and non neuronal tissues from 
Gdap1+/+ (WT), Gdap1+/- 
littermates.  β-tubulin was use as a 
housekeeping and anti-GDAP1 from Abnova 
for GDAP1 detection. 
 
 
In order to confirm the absence of
different commercial antibodies against GDAP1
lack of GDAP1 in Gdap1-/-
to test protein expression 
neuroblastoma SH-SY5Y cell line 
antibody (from Abnova), for
267, this second one (from S
 
 
 
 adult wild-type mouse
7kDa) was only detected in brain, cerebellum, 
Total amount of loaded protein was not 
ciatic nerve. The other tissues tested were 
wild type adult mice. Protein expression study in neuronal and non 
root ganglia (DRG), sciatic nerve, quadriceps, soleus
&ovarius. Actin was use
tochondrial marker and anti-GDAP1 (Abnova) for GDAP1 detection.
on genotype was confirmed by western blot of neuronal and 
 Gdap1+/+, Gdap1+/- and Gdap1-/- littermates
-expression tissues such as sciatic nerve
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ed with Gdap1+/+. 
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and Gdap1-/- 
 protein expression in our mouse model we used three 
. Here we show another example of the 
mice (Figure R4). In this case, a different antibody was 
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(Pla-Martín et al. 2013). In contrast
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 tissue lysates 
negative to 
 
cic spinal 
&gastrocnemius, 
d as a 
 
 (Figure 
s.Neuronal 
 
used 
 to the previous 
158 to 
  
 
Gdap1l1expression. 
Gdap1l1is a paralogue gene 
58% of identity with GDAP1
(66%) just reaches 18% covered
assumes Gdap1 function (Niemann et al. 2014
also analysed Gdap1l1 expression 
 
No differences were observed between WT and 
expression at RNA level 
Gdap1l1 was expressed mainly in brain
used to confirm the expression of 
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Figure R5. Gdap1l1 and Gdap1
in Gdap1+/+ (WT) and Gdap1
design is described at Materials&
was used as housekeeping gene. 
 
Figure R4. GDAP1 expression 
Gdap1+/+ and Gdap1
Protein expression study in 
(WT) and Gdap1-
comparison with human neuroblas
SH-SY5Y control and G4 cell line
(Pla-Martín et al. 2013)
cell line is a GDAP1
model in SH-SY5Y cells
was used as a housekeeping and anti
GDAP1from Sigma for GDAP1 
detection. 
of Gdap1 (Marco et al. 2004). Murine GDAP1L1 
 (88% covered), although at nucleotide level
. However, there is still a possibility that the paralogue 
). To investigate these phenomena
in neuronal mice tissues from our mice model.
Gdap1-/- mice regarding
detected by RT-PCR (Figure R5). We determi
 but not in DRG. The same RNA samples were 
Gdap1 (Figure R5). Even though there was a w
-/-
, it is so poor after all PCR cycles.  
 expression by RT-PCR 
-/-
 mice tissues. Primers 
Methods section. Gapdh, 
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1.2- Phenotypic characterization of 
CMT-related hallmarks.
The clinical hallmarks of CMT include distal muscle wea
proprioception and pinprick sensation and a classical step
deformities, such as pes planus or cavus. The age of onset can vary from infancy to late 
adulthood with clinical severity ranging from mild to severe 
severe recessive form of GDAP1
weakness and wasting of the feet followed by involvement of the hands leading to 
pronounced disability. Patients are usually wheelchair bound starting from the second 
decade of life (Sevilla et al. 2008)
behaviour in Gdap1-/- and WT mice at the early adult age. 
 
We started with the observation of the mice in
low position during locomotion 
also noticed dragging tail in comparison with wild type animals (
images). Both hallmarks are indicat
1990). However, the penetrance was not complete and not all the knockout mice 
presented the same phenotype.
Furthermore, we observed abnormal hind
mice. When lifted by the tail, control mice 
limbs and body, but Gdap1
back limbs to their bodies (
attributed to motor deficits 
In addition, several 6 months
in one or both of their hind limbs 
 
Despite all these motor alterations, 
problems were detected in appearance
were not significant until 16 months
comparison with wild type 
 
Gdap1-/- mice 
 
kness and wasting, loss of 
page gait with foot 
(Brennan et al. 2015)
-related CMT starts early in infancy or childhood with 
. Based on that we decided to 
 
to the cage and we detected
in knockout mice (Figure R6, left upper images
Figure R
ors of distal muscles weakness (Wiethölter et al. 
 
-limb clasping reflex in 3 months
responded normally, by extending their hind 
-deficient mice flexed their legs to the trunk or tightened the 
Figure R6, left down images). This abnormal reflex 
(Rogers et al. 2001). 
-old and older Gdap1-/- mice presented pes planus 
(Figure R6, right image).  
 
Figure R6. Representative images of control and 
Gdap1-/- phenotype. In the left upper images we can 
compare the body position of both genotyp
they are walking; note that Gdap1 deficient mouse has a 
lower position of the body. In the left
can compare the mice behaviour when they are hold by 
the tail; note that control mice try to rely on so
structure with the hind limb while deficient mouse 
shrinks them. In the right image we can see a 8 months 
old Gdap1-/- that show a pes cavus like phenotype in the 
right hind limb 
 
Gdap1-/- mice had a normal lifespan
 and behaviour or breeding. Weight differences 
 when Gdap1-/- mice became overweight in 
(Figure R7).  
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Figure R7. Line chart representing weight of wild type (black squares) and Gdap1-/- (white 
triangles) mice. Average ± SEM are shown. Note that no differences were found since 2 to 16 months 
old mice (t Test value * < 0.05). 
 
 
Rota-rod analysis. 
Skeletal muscle weakness is the underlying cause of the majority of clinical problems in 
people suffering CMT disease. Nowadays we know that strength training may improve 
functional performance. In a comparative study, patients with CMT appeared to benefit 
significantly from a strengthening program, whereas patients with myotonic muscular 
dystrophy in the same study showed neither beneficial nor detrimental effects (El-
Abassi et al. 2014). 
The rota-rod test was specifically designed for making automated measurements of 
neurological deficits in rodents, and is one of the most commonly used tests to measure 
motor function in mice (Brooks & Dunnett 2009). To avoid learning results in Gdap1-/- 
mice, we decided to perform rota-rod test just once in a life time by animal. Doing this 
we obtained point-time results along age but we avoid the learning parameter after 
several trials. 
 
With the rota-rod test, we detected significantly reduced latency to fall in 3 months-old 
Gdap1-/- mice. The persistence of this motor behaviour was confirmed in older Gdap1 
lacking mice, from 4 to 7 months of age, but became more variable and thus non-
significant after 9 months of age (Figure R8). 
 
Figure R8. Column chart representing rota-rod scores for wild type (black) and Gdap1-/- (white) 
mice. Scores are represented as average ± SEM of time to fall off the accelerating rota-rod. (n>35,  t Test 
value*≤ 0.05; **≤0.01). 
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Due to the lack of total penetrance that we had observed in our colony, we realized that 
siblings from the same litter could present different phenotypes, so we chose a cohort of 
more affected Gdap1-/- mice as an example of a severe affection of CMT and studied 
their motor behaviour. In this case we followed the evolution at rota-rod performance 
from the same mice over time (Figure R9). When compared to control mice Gdap1-/-
animals always scored lower times of latency to fall, starting to be statistically 
significant at 5 months old and continuing this motor deficit up to 12 months.  
 
Figure R9. Line chart representing follow up  rota-rod scores for wild type (black) and Gdap1-/- 
(white) mice. Scores are represented as average ± SEM of time to fall off  the accelerating rota-rod. 
Animals used in this experiment performed rota-rod test monthly  (n=3 for wild type and n=6 for Gdap1-/- 
mice,  t Test value*≤ 0.05; **≤0.01). 
 
 
Balance beam and pole tests. 
Balance beam test assesses mice’s ability to maintain balance while traversing a narrow 
beam to reach a safe platform. It was originally designed to assess motor deficits in 
aged rats and has been proved to be equally useful in assessing motor coordination and 
balance in young, injured and genetically altered mice (Brooks & Dunnett 2009). Along 
the same lines pole test can be used to analyse proprioception defects.  
As our previous data showed that at 5 months old Gdap1-/-mice presented rota-rod 
deficits, we decided to perform these both tests at this time point (figure R10). We could 
not detect any difference between knockout and control mice.  
 
 
Figure R10. Column chart representing balance beam and pole test scores for wild type (black) and 
Gdap1-/- (white) 5 months old mice. Scores are represented as average ± SEM of time to cross, turn 
around or climb down. Animals used in this experiment only performed the test once in a life time, at 5 
months old (n≥5).  
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Balance beam test
Turn Around Climb Down
Pole test
 Gait and footprint analysis
A more detailed analysis of motor coordination and synchrony is provid
examining gait during normal walking 
characterize motor phenotype of 
age of 5 and 12 months (Figure R11
 
 
A detailed morphometric analysis of the gait (
points, Gdap1-/- mice had shorter stride length; 
narrower stride angle. Those facts agree with muscle weakness and steppage gait of 
CMT patients (Brennan et al. 2015)
We also detected an increase in stride width at 12 months; 
mice gain some weight with age we cannot correlate this p
impairment as it has been done in other studies 
is a positive correlation between str
 
Mean (SEM)
WT 2,68 (0,09)
Gdap1-/- 2,73 (0,09)
WT 7,49 (0,13)
Gdap1-/- 6,70 (0,30)
WT
Gdap1-/-
Gait-print
Stride Angle
Stride Width
Stride Length
Table R1. Summary table of gait
Gdap1-/- mice are shown. Measurements are in centimetres apart from Stride Angle that 
degrees. Student t test p values are
. 
(Brooks & Dunnett 2009). In order to better 
Gdap1-/- mice we analysed their gait behaviour at the 
). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R11. Representative 
walking track from a control (WT) and 
Gdap1-/-(KO) mice at different age (5 a
12 months old). Arrows illustrate the gait 
to better distinguish shorter steps of 
/-animals. Note also ink smears pattern due 
to dragged walking from CMT mice.
Table R1) revealed that at both time
and at 12 months we also detected 
.  
even though, as 
arameter with sensory 
(Wiethölter et al. 1990), as long as there 
ide width and weight. 
p value Mean (SEM) p value
0,682 2,77 (0,20)
3,43 (0,07)
0,043 7,25 (0,05)
6,41 (0,26)
130 (2) 0,196 132 (5)
127 (1) 112 (4)
5 months 12 months
-print analysis parameters. Mean ± SEM from 5 control and 
 also displayed.  
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As we observed everted paws in some mutant animals, we also analysed their footprints 
(Table R2). We detected a significant decrease of toe spreading values at 12 months in 
Gdap1-/- mice. As toe spreading correlates with the function of small foot muscles 
innervated by the sciatic nerve (Wiethölter et al. 1990), issues regarding sciatic nerve 
were revealed. 
 
We also detected an increase in plantar length in Gdap1-/- mice at 5 months old which 
was more evident in 12 months old mice. Plantar length increases due to paresis of the 
flexors of the ankle (Wiethölter et al. 1990), when animals walk on their calcaneal 
bones which normally do not touch the ground. 
 
Mean (SEM) p value Mean (SEM) p value
WT 1,27 (0,01) 0,029 1,20 (0,02) 0,000
Gdap1-/- 1,32 (0,01) 1,38 (0,02)
WT 0,90 (0,04) 0,254 0,94 (0,01) 0,014
Gdap1-/- 0,94 (0,04) 0,89 (0,01)
WT 0,53 (0,03) 0,269 0,52 (0,02) 0,977
Gdap1-/- 0,50 (0,02) 0,52 (0,03)
5 months 12 months
Plantar Length
Toe Spreading
Intermediate Toes
Footprint
 
Table R2. Summary table of footprint analysis parameters. Mean ± SEM from 5 control and 5 of 
Gdap1-/-  mice are shown. Measurements are in centimetres. Student t test p values are also displayed. 
  
 2.- Histological findings
 
2.1- Skeletal muscle histopathology
 
Muscle abnormalities. 
Effects of pathological and functional changes in 
neuropathies are related to the axonal length, so distal limb muscles are us
to be affected (Sevilla et al. 2008)
amyotrophy giving an aspect of “jambes de coq” or an inverted 
et al. 2014). 
Trying to find these human 
mice are quadruped animals instead of bipeds. Secondly, 
to 120cm, compared to the 
and weighed larger distal muscles (
CMT phenotype in our mouse model
mass (g) was calculated in order to 
 
Strikingly, skeletal muscle weight
muscle mass loss in soleus
there was an increased ratio in 
Maybe in mouse inverted champagne bottle appearance is due to an increase in 
quadriceps mass rather than a loss of gastrocnemius mass.
 
 
Figure R12. Column chart showing big distal muscles weight along age
Gdap1-/- (white). Average ratio of muscl
Asterisks represent Student t Test value
 
 
To better understand motor deficits previously described, 
muscles were studied microscop
paraffin-embedded muscle slices
age ( 
Figure R13). Presence of connective tissue in
knockout mice didn´t show evidences of muscle wasting.
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GDAP1 mutations causing CMT 
. The classical CMT phenotype includes distal lower 
champagne bottle 
hallmarks in mice presents several hindrances. First of all 
human nerves can measure up 
4 cm of the mice (Bala et al. 2014). Nevertheless, 
soleus&gastrocnemius and quadriceps) looking for 
. The ratio of muscle mass (mg) divided by 
control for the effect of mouse weight
 ratio of Gdap1-/- mice didn't show 
&gastrocnemius at any time point. Unlikely
Gdap1-/- mice at 9 and 15 months old
 
 
 of wild type (black) and 
e weight (mg) and animal weight (g) ± SEM 
*< 0.05; **≤0.01. 
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ically in more detail. Hematoxilyn&eosin 
 revealed inclusions of connective tissue 
 these muscles could explain why 
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Same images showed damaged muscle fibres with pyknotic nuclear clumps and atrophic 
rounded muscle fibres in Gdap1-/- mice while this was less frequent in wild type animals 
(Figure R13). 
 
 
Figure R13. Representative images of gastrocnemius muscle from Gdap1+/+ (WT) and Gdap1-/- mice 
at different age (5 and 12 months old). Hematoxilyn&Eosin staining of paraffined muscle sections. 
Scale bars represents 200µm. Arrow marks connective tissue inclusion. Note the shape and colour change 
in 12 months old Gdap1-/- muscle. 
 
 
NMJ occupancy. 
Distal skeletal muscle weakness is the underlying cause of the majority of clinical 
problems in CMT patients. The contractile activity of skeletal muscle is regulated by 
action potentials from motor neurons to muscle fibres. Transmission occurs at a highly 
specialized chemical synapse, the neuromuscular junction (NMJ) or motor endplate. 
Accordingly, impairment of NMJ function results in muscle weakness or paralysis 
(Tintignac et al. 2015). Due to the tight correlation between synaptic activity and NMJ 
morphology, a great deal of information can be gained about the functional status of 
motor neurons from analysis of NMJ morphology (Murray et al. 2014). Based on that 
we decided to study NMJ in Gdap1-/- and WT mice at adult age. 
  
 
We selected gastrocnemius
gastrocnemius is a ‘Delayed Synapsing’
critically on nerve-derived factors
and receptors in muscle fibres (
each genotype and age and no differences in 
between knockout and wild type mice either at 5 or 12 months old 
 
 
 
 
 
Figure R14. Bar chart showing
number of NMJ counted in wild 
type (black) and Gdap1-/- (white) 
mice along time. Average of
counted per animal ± SEM
represented (n=3). 
 
 
Labelled receptors in muscle fibres were similar in shape and distribution in 
and Gdap1-/- mice (Figure R
as a mark of muscular plate damage 
In contrast, irregular labelled axon terminals were found in knockout muscles. These 
atypical axon ends didn't take over the postsynaptic folds
order to quantify these abnormalities
occupied according to whether the 
the axon terminal or not (see Material
 
Figure R15. Representative confocal 3D rendering stack of images of NMJs from the gastrocnemius 
muscle of 12 months old mice. 
the postsynaptic acetyl-choline receptor was stained with rho
red). Denervated or non-occupied
doesn't take over the postsynaptic folds.
 as distal skeletal muscle because its NMJ characteristics. As 
 (DeSyn) muscle, NMJ maintenance depends 
 (Pun et al. 2002). NMJ were imaged labelling axons 
Figure R15). More than 100 NMJ were 
the total number of plates w
(Figure R
 
 NMJ 
 are 
15). Reduction in the complexity of the NMJ morphology 
(Murray et al. 2014) was not observed
 (asterisk in 
 we classified NMJ into occupied and 
muscular part of the plate was completely
s&Methods for more details).  
Axons were immunostained with anti-β-III tubulin (β
damine-coupled α-bungarotoxin (AC
 NMJ are marked with asterisks. Note that in non-occupied
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Occupancy study revealed 
completely occupied NMJ (99%±1%) as well as 
NMJs from 12 months old 
percentage of occupancy 
(p<0.001) (Figure R16).  
Typical fragmented appearance as seen during Wallerian degeneration upon nerve 
transection or crush (Coleman & Freeman 2010)
observed abnormal tangle-like structures and 
12 months knockout animals
feature, a swollen axonal segment with a protruding axonal process, was commonly 
seen in retreating axons (Bishop et al. 2004)
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no differences at 5 months old where control mice sh
Gdap1-/- mice (92%±6%). 
wild type mice were fully occupied 
in Gdap1-/- muscle was significantly reduced (70%±1%) 
 
 
 
 
 
 
Figure R16. Bar chart
percentage of occupied NMJ along mice age. 
Average percentage ± SEM for
showed in black and for Gdap1
Student t Test p value ***< 0.001)
 
 
 was not detected
focal swellings near to axon
; that were not present in control mice (Figure R
. 
 
 
 
Figure R17. Confocal stack images of NMJs 
from the gastrocnemius muscle of 12 months 
Gdap1-/- mice. Axons were immunostained with 
anti-β-III tubulin (β-III tub, green) and the 
postsynaptic acetyl-choline receptor was stained 
with rhodamine-coupled 
(AChR, red). Arrows mark abnormalities like a 
retraction bulb (left) and terminal tangle (right).
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2.2- Sciatic nerve studies 
 
Electrophysiology abnormalities. 
The observed defects in motor behaviour in mice lacking GDAP1 prompted us to 
further investigate their electrophysiological properties along the sciatic nerve. 
Therefore, we measured the motor nerve conduction velocity (MNCV) and compound 
motor action potential (CMAP).  
 
In line with the absence of detectable behavioural phenotype, we were not able to detect 
any electrophysiological differences between Gdap1-/- and WT mice at 2-months of age. 
At 5 months, a reduction of MNCV was found in GDAP1 lacking mice that showed a 
velocity of 37.5±0.8m/s in comparison with 40±0.7m/s of wild type ( 
Figure R18). Slight reductions in MNCV can be associated with axonal neuropathies 
(Sevilla et al. 2003) while more considerable reductions are associated with 
demyelinating neuropathies (Tazir et al. 2014). 
 
 
 
 
 
Figure R18. Motor Nerve Conduction 
Velocity measurement in wild type and 
Gdap1-/- mice at 2 and 5 months old. Average 
velocity (±SEM) from wild type mice are 
represented in black and Gdap1-/- in white (n≥4). 
Asterisks are indicative of the t test p-values 
(**p≤0.01 ). 
 
In addition, we also studied the CMAP. The CMAP is a summated voltage response 
from the individual muscle fibre action potentials. Several parameters were measured 
from CMAP responses: latency, duration, amplitude and area (Mallik & Weir 2005). 
Interestingly, 5-months Gdap1-/- mice revealed a significant reduction of CMAP 
amplitude and area obtained for distal (at the ankle) and proximal (at the hip) 
stimulation (Figure R19). Amplitude and area reflect the number and size of muscle 
fibres that ultimately fire. Lower values results from loss of motor axons or neurons; 
less often a NMJ disorder (Katirji et al. 2013). 
 
Figure R19. Compound Muscle Action Potential (CMAP) amplitude and are analysis in wild type 
and Gdap1-/- mice at 2 and 5 months old. Average amplitude and area (±SEM) from wild type mice are 
represented in black and Gdap1-/- in white (n≥4). Asterisks are indicative of the t test p-values  (*p<0.05; 
**p≤0.01).  
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Duration was also altered in 5 months Gdap1-/- mice. Proximal stimulated duration was 
significantly increased in comparison with wild type animals (figure R20). CMAP 
duration is primarily a measure of synchrony. Duration increases in conditions which 
result in selective slowing of some motor fibres (Katirji et al. 2013). 
 
 
 
 
 
Figure R20. Compound Muscle 
Action Potential (CMAP) duration 
analysis in wild type and Gdap1-/- mice 
at 2 and 5 months old. Average 
duration (±SEM) from wild type mice 
are represented in black and Gdap1-/- in 
white (n≥4). Asterisks are indicative of 
the t test p-values  (*p<0.05). 
 
Strikingly, 5 months old knockout animals also revealed a significant reduction of 
CMAP latency obtained for distal (at the ankle) and proximal (at the hip) stimulation 
(Figure R21). Latency includes three separate times: nerve conduction time from the 
stimulus site to the NMJ, the time delay across the NMJ and the depolarization time 
across the muscle fibres (Katirji et al. 2013). Opposing to our data, an increase in 
latencies reflects the nerve conduction slowing of the fastest fibres (Tankisi et al. 2012). 
 
 
 
 
Figure R21. Compound Muscle 
Action Potential (CMAP) 
latency analysis in wild type 
and Gdap1-/- mice at 2 and 5 
months old. Average latency 
(±SEM) from wild type mice are 
represented in black and Gdap1-/- 
in white (n≥4). Asterisks are 
indicative of the t test p-values  
(*p<0.05;**p<0.01). 
 
 
 
Morphometric analysis. 
Generally,  myelinated nerve fibres suffer from different degrees of atrophy with age. 
Analysis of the myelinated nerve fibres of the sciatic nerve pointed to the significant 
atrophy and loss of large myelinated nerve fibres with age. An increase in the number of 
small nerve fibres with a thinner myelin sheath might point to the regeneration of nerve 
fibres during the aging process (Ugrenović et al. 2015). Specifically, in CMT caused by 
mutations of GDAP1, sural nerve biopsy reveals axonal atrophy, absence of onion 
bulbs, axonal loss and absence of demyelinated fibres (Sevilla et al. 2003). To 
investigate if these features found in CMT patients were present in our mouse model 
sciatic nerve from 5 month old mice were dissected. 
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Semi-thin sections didn't reveal a
onion bulbs or other anomaly. Ultrathin sections were use
characterize axon population
Figure R22. Representative ultrathin sections of Wild type and 
old mice. Scale bars represented 20, 2 and 0.5 µm
 
Ultrathin sections images allowed us
and distal sciatic nerve. Density of myelinated fibre
sciatic nerve at 5 months old
CMT patients, axonal neuropathy is associated with loss of a
biopsies (Sevilla et al. 2008)
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Figure R23. Myelinated fibre density 
quantification from 5 month old mice.
Average density (±SEM) of wild type mice 
are represented in black and 
white. Values for proximal and distal part of 
sciatic nerve are represented. Asterisks are 
indicative of student t test values 
(**p<0.01). More than 1100 axons were 
counted for each condition (n=4).
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Lacking GDAP1 mice had not affected g-ratio, neither in proximal nor distal part of 
sciatic nerve (table R3). Measures for both part of the nerve were similar and close to 
the optimal value. 
 
 
Table R3. g-ratio quantification from 5 month old 
mice sciatic nerve fibres. Average g-ratio (±SEM) of 
wild type and Gdap1-/- mice are shown. Data for 
proximal and distal part of sciatic nerve are 
represented. Student's t test p-values are exposed (n=4). 
 
Studying myelinated fibres size revealed no differences in the average of axon diameter 
at 5 months old mice (Table R4). Average diameter was around 3µm for both genotypes 
either in proximal as in distal part of sciatic nerve. 
 
Table R4. Myelinated fibre axon diameter 
quantification from 5 month old mice. Average 
diameter (±SEM) of wild type and Gdap1-/- mice are 
shown. Data for proximal and distal part of sciatic 
nerve are represented. Student's t test p-values are 
exposed (n=4) 
 
Nevertheless, we analysed myelinated fibre size distribution and detected higher density 
of large axons in distal nerve from Gdap1-/- mice (Figure R24). Deficient GDAP1 mice 
also showed lower density of axons of 2µm diameter. No fibres larger than 9µm were 
found, yet both genotypes displayed a population of very small myelinated fibres (1-
3µm).  
 
Figure R24. Axon diameter distribution of myelinated fibre from 5 month old mice. Average density 
(±SEM) for each diameter is shown. Wild type is represented in black bars,  and Gdap1-/- mice density in 
white. Data for proximal and distal part of sciatic nerve are represented. Asterisks are indicative of 
Student's t test p-values (*p<0.01,**p<0.01, n=4). 
 
Since GDAP1 is a mitochondrial protein (Pedrola et al. 2005; Niemann et al. 2005)we 
were also interested to perform the characterization of this organelle inside sciatic nerve 
fibres. Shape, morphology and localization was similar between knockout and control 
mice at 5 months old (Figure R22).   
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Surprisingly, when we analysed the number of mitochondria at proximal and distal 
sections of sciatic nerve, a higher number of mitochondria were counted in knockout 
animals at 5 months old (Figure R25).Even so, with this parameter we cannot affirm a 
higher number of mitochondria. It could be possible that longer mitochondria in sciatic 
nerve axons cause a higher number of mitochondrial sections in electron microscopy 
slices. 
 
 
Figure R25. Number of 
mitochondria in myelinated 
fibres. Average number (±SEM) 
from wild type mice are 
represented in black and Gdap1-/- 
in white. Values for proximal and 
distal part of sciatic nerve are 
represented. Asterisks are 
indicative of Student's t test p-
values  (**p<0.01, ***p<0.001, 
n=4). 
 
 
 
Mitochondrial DNA content. 
To distinguish between the increment in number of mitochondria or the increase in their 
size, mtDNA/nuclear DNA ratio is used. Increased mitochondrial/nuclear DNA ratio is 
associated with increased mitochondrial biogenesis which could contribute to further 
oxidative stress leading to damaged mtDNA, mitochondrial dysfunction and oxidative 
damage (Malik & Czajka 2013).  
Similar mitochondrial DNA copy number -normalized dividing by nuclear DNA copy 
number- was found in sciatic nerve of both WT and Gdap1-/- mice ( 
 
 
Figure R26). Since no difference in mitochondrial biogenesis was observed we reasoned 
that increase of the number of mitochondria within Gdap1-/- mice axons represent 
elongated mitochondria (Figure R25).  
 
 
 
 
Figure R26. Quantification of mitochondrial 
DNA copy number by real-time PCR 
(16S/ANG1) in sciatic nerve samples from 5 
month old mice. Average ±SE of a mix of 3 
Sciatic nerve by genotype. Wild type data are 
shown in black bar and Gdap1-/-mice results in 
white. 
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2.3- Histopathology of Spinal Cord
 
Motor neuron. 
On account of the denervation
studying the soma of these motor neurons axons. The 
their axons to voluntary muscles have their soma 
horn of the spinal cord. Specifically, MNs that control legs muscles contraction have 
their soma in the ventral horn of lumbar spinal cord
In agreement with loss of properly occupied
in Redex lamina IX of ventral horn of lumbar spinal cord. A simple glance
stained paraffin embedded slices
wild type αMNs had a "healthy" appearance, 
visible nucleolus. Moreover, some neurons f
Figure R27. Representative images of lumbar spinal cord from 
different age (5 and 12 months old). 
represents 100µm and 20µm. 
 
With the aim of quantify this
Less number of "healthy" MNs 
However, while in control mice the number of healthy MNs per section underwent a 
progressive reduction over time (2
this process is enhanced in 
between 2 and 5-months (
equal between 5 and 12-months, which suggest t
first months of life in the Gdap1
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 observed at neuromuscular plates, we were
α motor neurons (MN) that send 
in the Redex lamina IX in the 
 (Stifani 2014). 
 NMJ, we found alterations in MNs located 
 (Figure R27), indicated abnormalities in 
Gdap1-/- αMNs were pyknotic, without 
rom 12 months CMT mice had
Gdap1+/+ (WT) and 
Nissl staining of paraffined spinal cord sections. Scale bars 
 abnormalities, healthy appearance MNs were counted. 
was found in Gdap1-/- mice at 5 and 12 months of age. 
-months vs 12-months WT animals, p
Gdap1-/- mice as indicated by the slopes of neuron loss 
Gdap1-/-: 0.71 versus WT: 0.333). By contrast, slopes were 
hat loss of neurons occurs early in the 
-null mice (Figure R28).  
 
 
 
 
 
Figure R28. Number of "healthy" 
MNs in anterior horn per section in 
lumbar spinal cord.
(±SEM) from wild type mice are 
represented in black and 
white. Asterisks are indicative of 
Student's t-test p
**p<0.01, ***p<0.001).
5 12
***
**
*
*
 
 interested in 
ventral 
 at Nissl 
αMNs. While 
 vacuoles. 
 
Gdap1-/- mice at 
-value<0.05), 
 Average number 
Gdap1-/- in 
-values (*p<0.05; 
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Due to the histopathological features found in spinal cord, we were interested in 
investigate possible altered pathways in order to explain MNs pyknosis and vacuoles. 
Morphologically, apoptotic cells are characterized by the following classical changes: 
cell shrinkage, pyknosis, karyorrhexis, and the formation of apoptotic bodies. As potent 
regulators of the intrinsic apoptotic machinery, Bcl-2 family members, such as anti-
apoptotic Bcl-2/Bcl-xL and pro-apoptotic Bax, can orchestrate the procedure of cell 
death (Wu et al. 2015). 
By western blot we checked expression of principal pro-apoptotic (Bax) and anti-
apoptotic (Bcl2) proteins in lumbar spinal cord lysates at three time points of both 
genotypes. (Figure R29). Surprisingly, Gdap1-/- mice presented increased of pro-
apoptotic Bax at younger age (2 and 5, only significant at 2 months old). By contrast, in 
older age, 12 months old, CMT mice showed increased anti-apoptotic Bcl2.  
 
Lack of GDAP1 has been related with increase of oxidative stress (Noack et al. 2012). 
In order to better understand oxidative stress we focused on determining catalase 
expression, the major hydrogen peroxide reducing enzyme.  
Westerns blot revealed an increased expression of catalase in younger Gdap1-/- animals 
(Figure R29). Western blot at 12 months couldn't be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R29. Oxidative-stress and apoptosis quantification in spinal cord along age. Quantification of 
western blot detection of Catalase, Bax and Bcl2. protein expression in wild type and Gdap1-/- (KO) 
spinal cord. Average ratio KO/WT is represented. Asterisks are indicative of Student's t-test p-values 
(*p<0.05, n≥3). 
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2.4- Histopathology of Dorsal Root Ganglia
 
Sensory neuron. 
Mild to severe sensory loss i
to proprioception, vibration
al. 2003). We chose Dorsal Root Ganglia 
mouse model. 
 
Paraffin-embedded sections of DRG
compared between wild type and 
tissues were found in CMT mouse model
and distribution of sensory neurons didn't 
Figure R30. Representative images of DRGs from 
(5 and 12 months old). Haematoxylin
100µm and 20µm. 
 
 
 
 
s observed in GDAP1-CMT patients; particularity affecting 
 and touch (Baxter et al. 2002; Cuesta et al. 2002; Sevilla et 
(DRG) to identify sensory defects in our 
s from 5 and 12 months old mice were 
Gdap1-/- mice. No abnormalities compared 
 even in old animals (figure R30
show any symptom of damage.
Gdap1+/+ (WT) and Gdap1-/- mice at different age 
-Eosin staining of paraffined DRG sections. Scale bars represents 
 
 
analysed and 
to control 
). Appearance 
 
 
 3.-Pathogenic mechanism
 
3.1- Adult Dorsal Root Ganglia (DRG) 
 
Mitochondria distribution inside neurites
As a neurodegenerative disease, we were interest
culture model in order to study several
Root Ganglia (DRG) primary culture has been widely used in 
easy dissection and maintenance. 
abnormality in our mouse model, sensory 
patients (Baxter et al. 2002; Cuesta et al. 2002; Sevilla et al. 2003)
cultures allows us to study 
 
As GDAP1 is a mitochondrial protein
first attempt consisted of 
reported previously in GDAP1
We tried different techniques
complex V of the respiratory chain and Tom20, and 
gave us the specificity for axonal neurites 
old mice DRG cultures are shown in 
after 5 days "in vitro" (div)
neurons from those mitochondria coming from
neurites from neighbouring
follow a single process.  
 
Figure R31. Neuron (βtubulinIII in red) and mitochondria (C
DRG culture from 5 and 7 month old mice. 
the DRG culture 5div. Red channel (
smaller images. Merge of both channels plus DAPI (in blue), for nuclei labelling,  is showed in 
images. 50µm are represented in all scale bars.
s      
primary cultures 
. 
ed in having an adult
 CMT hallmarks associated with 
neural diseases due to its 
Although histology of DRG somas did
loss has been observed in 
. D
the grown of their processes  in culture.  
 (Pedrola et al. 2005; Niemann et al. 2005)
detecting defects in mitochondrial size or pattern
 knock-down SH-SY5Y cell line (Pla-Martín et al. 2013)
 to label mitochondria (immunodetection of 
Mitotracker dye) but none of them 
we required. In adult mice (5 and 7 months 
figure R31) neurites formed a net between neurons
 and it was very difficult to distinguish mitochondria from 
 non-neuronal cells of the culture. 
 neurons build up a network which makes 
ytochrome C in green) labelling in 
Representative images for mitochondria characterization in 
βtubulinIII) and green channel (Cytochrome C) are showed in 
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Neuron morphology. 
While we were trying to characterize mitochondria in DRG neurons in culture we 
noticed that Gdap1-/- neurons seemed to have fewer neurites than the control ones. In 
order to test this hypothesis we performed this quantification counting the number of 
processes that were outgrowing from DRG somas from 5 and 7 months old mice 
cultures. However, no difference was found between wild type and Gdap1-/- cultures, 
either at 5 or 7 months old mice (Figure R32). 
 
 
 
 
 
 
Figure R32. Number of primary neurites 
quantification in DRG culture from 5 
and 7 month old mice. Average number 
(±SEM) of wild type mice cultures (5div) 
are represented in black and Gdap1-/- in 
white. 
 
 
 
Soma area. 
When we started to study DRG's cells in culture we also noticed that Gdap1-/- neurons 
seemed to be smaller than the control ones. As toxic effects can produce neurite 
retraction and soma atrophy (Zhu et al. 2007) we performed area quantification of soma 
in DRGs cultures from 5 and 7 months old mice. We could conclude that lack of Gdap1 
produce neurons with smaller soma (Figure R33).  
 
 
 
 
 
 
Figure R33. Soma area quantification 
in DRG culture from 5 and 7 month old 
mice. Average area (±SEM) of wild type 
mice cultures are represented in black and 
Gdap1-/- in white. Asterisks are 
representing the Student's t test p-values 
(*<0.05; **<0.01; ***<0.001). 
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Neurite length. 
As in 5div cultures we observed smaller soma in Gdap1-/- cultures, we were interested 
in measure neurite length in order to check whether this was reduced due to the lack of 
Gdap1. To analyse neurite length we worked with 1div cultures, so we could follow a 
single process. Measurements were performed in two ways, calculating the average 
length of the three longest neurites per neuron and also counting only the longest one.  
 
 
Shorter neurites were found in Gdap1-/- neurons in comparison with wild type ones 
using both methods (Figure R34). Growing defects or toxics effects can produce  
neurite retraction (Zhu et al. 2007). 
 
 
 
 
 
 
Figure R34. Neurite length 
quantification in DRG culture from 5 
month old mice. Average length (±SEM) 
of wild type mice cultures are represented 
in black and Gdap1-/- in white. Three 
longest neurites and only the longest one 
were measured. Asterisks are representing 
the Student's t test p values (*<0.05). 
 
 
 
Microtubule stability. 
Remodelling of the microtubule cytoskeleton is essential to successfully complete all 
the different stages of neuronal development. Microtubules can provide tracks for 
intracellular transport, set up local cues to position organelles, act as signalling devices 
or generate cellular forces (Kapitein & Hoogenraad 2015).  
Acetylation of α-tubulin or enzymatic removal of its C-terminal tyrosine residue 
(detyrosination) gradually occurs in the microtubule polymer and is therefore found in 
long-lived, stable microtubules, i.e., microtubules with a low turnover that undergo few 
catastrophic events (Witte et al. 2008). Moreover, mitochondria are mainly transported 
along microtubules consisting of polymerized tubulin. Therefore, we first decided to 
study acetylation of α-tubulin, as this process is considered to be a recognition signal for 
the anchoring of molecular motors and decreased levels of acetylated α-tubulin have 
been associated with neurodegenerative diseases (d’Ydewalle et al. 2011).  
 
Using DRG primary cultures at 1div from 5 months old mice we observed a decrease in 
the fluorescence of acetylated α-tubulin in neurons lacking Gdap1 (Figure R35), which 
was confirmed by fluorescence quantification of the 3 longest and the longest neurite 
(Figure R36).  
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Figure R35. Representative images
animals. Acetylated α-tubulin (in green) and III 
culture 1 DIV. Green and red channel
DAPI (in blue), for nuclei labelling,  is also showed. 
 
In addition, we also studied tyrosinated 
differences between wild type and 
tubulin (Figure R38) but there was a trend towards an increase 
for 3 longest and the longest neuron) in 
tubulin in microtubules that has not yet undergone detyrosination
assembly, that is, tyrosinated 
turnover (Witte et al. 2008)
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β-tubulin (as neuron marker in red) labelling in DRG 
s are shown independently. In addition, merge of both channels plus 
Scale bars represents 50µm. 
 
 
 
Figure R36. Acetylated 
quantification in DRG culture from 5 
month old mice.
fluorescence/ length (±SEM) of wild 
type mice cultures are represented in 
black and Gdap1-/-
longest neurites and only the longest one 
were measured. 
representing the Student's t test p values
(*<0.05; **<0.01; ***<0.001).
 
 
α-tubulin (Figure R37). N
Gdap1-/- neurons were observed in tyrosinated 
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 Figure R37. Representative images
animals. Tyrosinated α-tubulin (in green) and III 
culture 1 DIV. Green and red channels are shown independently. 
DAPI (in blue), for nuclei labelling,  is also showed. 
 
 
 
 
Figure R38. Tyrosinated α-
quantification in DRG culture from 5 
month old mice. Average of 
fluorescence/ length (±SEM) of wild 
type mice cultures are represented in 
black and Gdap1-/- in white. Three 
longest neurites and only the longest 
one were measured. Asterisks are 
representing the Student's t test p values
(*<0.05; **<0.01; ***<0.001). 
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3.2- Postnatal DRG and SCG primary cultures
Working with postnatal cultures allows
(Gilley & Coleman 2010)
Microinjection of mitochondrial markers in several neurons allowed us to label all 
mitochondria along neurites only in 
R39). This technique avoids labelling 
follow a single neurite to its end without hav
mitochondria during a period of time 
organelle or velocity of movement 
R40). 
 
All this work was done under Dr Coleman
(Cambridge, UK) were microinjection and 
& Coleman 2010). We compare 
sensitive, affected in CMT) and SCG (sympathetic, non
used in the Coleman group because of their suitability for microinjection
culture of both tissues were obtain
these experiments. Microinjection of DRG was done at 4div and SCG at 6div. In both 
cases, imaging was done the day after microinjection. 
Gdap1-/- rescued cultures are presente
 
 
 
 
Figure R40. Representation of 
mitochondrial movement study in
cultured sensory neurons
Representative images of WT and 
Gdap1-/- microinjected DRG neurons
(a) Representative straightened 
neurite (b) kymograph (time-distance 
graph) of mitochondria transport
static organelles appears as vertical 
bars while moving velocities 
correspond to horizontal bars slopes
(c) Moving mitochondria from this 
kymograph identified using ImageJ 
plugin ‘Difference tracker’ (Andrews 
et al. 2010) were slopes are 
calculated. Soma reference is draw on 
top. 
 
 
 us to use new techniques, such as microinjection
, in order to better understand GDAP1 function
selected neurons from total cultur
non-neuronal mitochondria and
ing a complicated net. Studying labelled 
give useful parameters as percentage of moving 
(Andrews et al. 2010; Gilley et al. 2012)
’s supervision in The Babraham Institute 
imaging of SCG were already set up 
two distinct types of neurons: DRG (peripheral, 
-affected in CMT
ed from same animals and maintained in culture for 
Data from wild type, 
d below.  
 
 
 
Figure R39
of mitochondrial markers in 
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Mitochondrial movement. 
First we analysed the percentage of moving mitochondria in both cultures. DRG 
neurites presented a trend but non-significant (p-value 0.08) towards and increased 
percentage of moving mitochondria (figure R41, left graph). There was no changes in 
mitochondrial moving inside neurites from SCG cultures (Figure R41, right graph).  
 
Figure R41. Percentage of total moving mitochondria in both DRG (left graph) and SCG cultures 
(right graph). The percentage was obtain by counting the number of moving mitochondria divide by the 
total number of mitochondria (static + moving).  Average percentage (±SEM) of wild type cultures are 
represented in black and Gdap1-/-  data in white. 
 
 
Other parameter to take into account was the number of moving mitochondria in 100µm 
in one second. This parameter is different from the percentage; the mitochondria that 
were moving were counted but not the stationary ones (Andrews et al. 2010). 
 
When we studied the number of mitochondria that moved in 100µm in one second, we 
observed a statistically non-significant trend (p-value 0.06) to increased retrogradely 
moving mitochondria in DRG cultures of Gdap1-/- animals (Figure R42, left graph).  No 
differences were found in SCG neurons (Figure R42, right graph).  
In addition,  we could observe what happens when we rescued Gdap1-/- cultures by 
microinjection with a plasmid containing wild type Gdap1 (Pedrola et al. 2008). When 
we rescued the deficient culture with GDAP1, we found a decrease in the retrograde 
moving mitochondria in both, DRG and SCG neurites that was not observed in the 
anterograde movement (Figure R42, grey bar). 
 
Figure R42. Number of moving mitochondria in 100µm per second in both DRG (left graph) and 
SCG cultures (right graph). Wild type data are represented in black, Gdap1-/- in white and rescued 
(microinjection of GDAP1-Wild type plasmid in Gdap1-/- neurons) in grey. Asterisks are representing the 
p-values of proper statistic test (*<0.05; **<0.01; ***<0.001).  
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With the same cultures, we were interested to investigate in detail velocities of moving 
mitochondria. We studied two parameters, average velocity and maximum velocity 
(Andrews et al. 2010). 
 
Lack of GDAP1 did not affect to DRG neurons but produced slower mitochondria in 
null mice SCG cultures when we analysed average speed (Figure R43). In contrast, the 
rescue by reinsertion of GDAP1 in null mice neurons increased the velocity in DRG 
cultures but not in SCG. This increase was only in anterograde direction (Figure R43, 
gray bar). 
 
Figure R43.Average speed in both DRG (left graph) and SCG cultures (right graph). Wild type data 
are represented in black, Gdap1-/- in white and rescued (microinjection of GDAP1-wild type plasmid in 
Gdap1-/- neurons) in grey. Asterisks are representing the p-values of proper statistic test (*<0.05; 
**<0.01; ***<0.001). 
 
 
In agreement, DRG neurons did not seem to be affected while SCG neurons from 
Gdap1-/-cultures had a decreased maximum speed in comparison with wild type cultures 
(Figure R44). Also in concordance, rescued neurons by GDAP1 expression increased 
the mitochondrial maximum velocity in DRG cultures in anterograde direction while the 
rescue has no effect in SCG cells (Figure R44, gray bar). 
 
Figure R44. Maximum speed in both DRG (left graph) and SCG cultures (right graph). Wild type 
data are represented in black, Gdap1-/- in white and rescued (microinjection of GDAP1-wild type plasmid 
in Gdap1-/- neurons) in grey. Asterisks are representing the p-values of proper statistic test (*<0.05; 
**<0.01; ***<0.001). 
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Mitochondrial size. 
As GDAP1 has been linked with mitochondria fusion and fission events (Niemann et al. 
2005; Pedrola et al. 2008; Burté et al. 2014), size of moving mitochondria was also an 
interesting parameter to study. The images from mitochondrial movement experiments 
in postnatal DRG and SCG cultures were also used to characterize moving and static 
mitochondria size. 
 
Retrogradely moving mitochondria from Gdap1-/-  DRG cultures were longer than wild 
type ones (Figure R45, left graph). Interestingly, rescue of deficient cultures with 
GDAP1 caused shorter mitochondria moving in both, retrograde and anterograde 
direction (Figure R45, left graph, gray bar).  
In contrast, SCG's moving mitochondria showed a statistically non-significant trend to 
be shorter in  Gdap1-/- neurons (p value 0.07). Expressing GDAP1 in SCG cultures 
produced no effect in the size of these moving mitochondria (Figure R45, right graph). 
 
Figure R45. Moving mitochondria size in both DRG (left graph) and SCG cultures (right graph). 
Wild type data are represented in black, Gdap1-/- in white and rescued microinjection of GDAP1-wild 
type plasmid in Gdap1-/- neurons) in grey. Asterisks are representing the p-values of proper statistic test 
(*<0.05; **<0.01; ***<0.001). 
 
 
In addition, we have also studied size of static mitochondria. DRG cultures did not 
reveal any difference between wild type and deficient mice cultures (Figure R46, left 
graph). On the other hand, in SCG cultured neurons, static mitochondria were longer in 
deficient mice cultures that in wild type (Figure R46, right graph). 
 
Figure R46. Static mitochondria size in both DRG (left graph) and SCG cultures (right graph). 
Wild type data are represented in black and Gdap1-/- in white.  Asterisks are representing the p-values of 
proper statistic test (*<0.05; **<0.01; ***<0.001).  
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Effect of GDAP1 mutation
As we had already studied 
(previous data), we were also interested in studying effects of 
mutations in similar cultures
mutations (Figure R47) we used
our laboratory (Pedrola et al. 2008; Pla
was also used in order to study
in wild type neurons) and rescue 
cultures) in comparison with mutation effects
Institute (Cambridge, UK) 
microinjection to confirm the
 
 
 
Figure R47. GDAP1 missense mutations studie
work. Used GDAP1 dominant and recessive missense 
mutations and its localization along the protein
Estela et al. 2011). 
 
Next, we show results of
postnatal DRG cultures: numbe
and moving mitochondria size.
 
The first parameter, number of moving mitochondria in 100µm per o
significantly altered by overexpression of 
dominant or recessive, in wild type neurons
In contrast, in Gdap1-/- DRG 
effect was GDAP1 pR120Q
GDAP1-wildtype (+GDAP1 in graph, gray bar
altered the number of moving mi
retrogradely moving mitochondr
A decrease was also caused by introducing 
pT157P expression (purple bar
directions while pR161H (
Finally, an increase in anterograde
expressed GDAP1 pR120W
Figure R48. Number of moving mitochondria in 100µm per second in both Wild Type (left graph) 
and Gdap1-/- DRG cultures (right graph)
Each column colour represents microinjection of wil
wild type (WT) or Gdap1-/- (KO)  neurons.
representing the p-values of proper statistic test  (*<0.05; **<0.01; ***<0.001).
0,0
0,2
0,4
0,6
0,8
1,0
1,2
retrograde anterograde
m
o
vi
n
g
 m
it
o
ch
o
n
d
ri
a
 i
n
 1
0
0
 u
m
moving mitochondria in WT neurons
 
s in DRG primary cultures. 
effects of the lack of Gdap1 in postnatal 
GDAP1
. To investigate the effect of several GDAP1
 site-directed mutated cDNAs previously developed in 
-Martín et al. 2013). Wild type (cDNA) 
 the effect of overexpression (when it was microinjected 
(when it was microinjected in 
. All plasmids were sent to 
where maxiprep and sequencing were
 point mutations.  
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To investigate mitochondrial velocity we only show maximum speed although as we 
observed the same behaviour on average speed. In wild type neurons (Figure R49, left 
graph) maximum speed was only affected by GDAP1 overexpression (squared black-
gray bar), increased values were found in retrograde movement. Missense constructs did 
not induce any effect. 
 
By contrast, rescued Gdap1-/-neurons presented an increase in anterograde mitochondria 
velocity (Figure R49, right graph, gray bar). In addition, GDAP1 pR161H (orange bar) 
mutation induced a change, decreasing retrograde velocity in Gdap1-/- cultures. The rest 
of mutations didn't have any effect on maximum speed of moving mitochondria.
 
Figure R49. Maximum speed in both Wild Type (left) and Gdap1-/- DRG cultures (right) when 
several GDAP1 mutations were expressed. Each column colour represents microinjection of wild type 
or missense construct according to labels in wild type (WT) or Gdap1-/- (KO)  neurons. Black lines are 
marking control wild type values. Asterisks are representing the p-values of proper statistic test  (*<0.05; 
**<0.01; ***<0.001). 
 
Similarly to previous parameters, moving mitochondria size was not affected by 
expression of missense mutations neither by overexpression of GDAP1 (squared black-
gray bar, Figure R50, left graph). 
 
Rescued Gdap1-/-  neurons showed shorter moving mitochondria than deficient neurons 
in both directions (gray bar, Figure R50, right graph). The values of rescued neurons 
were close to wild type values (black line). In addition, missense recessive mutation 
GDAP1 p.R161H (orange bar) caused shorter moving mitochondria in both directions, 
similar to recued neurons. Dominant mutation GDAP1 p.R120W (blue bar) led also to 
shorter moving mitochondria but only in anterograde direction. Nevertheless, recessive 
mutation GDAP1 p.R120Q (red bar) caused shorter moving mitochondria only in 
retrograde direction. On the other hand, expression of GDAP1 p.T157P (purple bar) had 
no effect on  moving mitochondria size.  
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Figure R50. Moving mitochondria size in both Wild Type (left graph) and Gdap1-/- DRG cultures 
(right graph) when several GDAP1 mutations were expressed. Each column colour represents 
microinjection of wild type or missense construct according to labels in wild type (WT) or Gdap1-/- (KO)  
neurons. Black lines are marking control wild type values. Asterisks are representing the p-values of 
proper statistic test  (*<0.05; **<0.01; ***<0.001). 
 
 
Taking together all the parameters we detected different profiles depending on DRG 
genotype (Gdap1+/+ or  Gdap1-/-) and also on mutation. 
In wild type neurons, GDAP1 mutations had no effect on mitochondria in motion, 
velocity and mitochondria size (table R5). Neither dominants mutations. 
In contrast, overdose of GDAP1 caused a trend (p value 0.082) to decrease moving 
mitochondria (wt on the table R5). Excess of GDAP1 also increased retrograde velocity 
and decreased anterograde size of those mitochondria in motion (wt on the table R5). 
Our results agree with previous data (Niemann et al. 2005; Pedrola et al. 2008).  
 
WT neurons: +GDAP1 +GDAP1 pR120W
+GDAP1 
pR120Q
+GDAP1 
pT157P
+GDAP1 
pR161H
microinjected/WT 64%
p_value 0,082
microinjected/WT
p_value
microinjected/WT 146%
p_value 0,019
microinjected/WT
p_value
microinjected/WT
p_value
microinjected/WT 65%
p_value 0,072
Anterograde Size moving mitochondria 
n.s.n.s. n.s. n.s.
Retrograde Size moving mitochondria 
n.s. n.s. n.s.n.s. n.s.
Anterograde Maximum speed
n.s. n.s. n.s. n.s.n.s.
Retrograde Maximum speed
n.s. n.s. n.s. n.s.
Anterograde Moving mitochondria in 100µm
n.s. n.s. n.s.n.s. n.s.
Retrograde Moving mitochondria in 100µm
n.s. n.s. n.s. n.s.
 
Table R5. Moving mitochondria parameters in wild type mice DRG cultures when different GDAP1 
mutations are microinjected. Percentage to wild type data has been calculated for each microinjection, 
either GDAP1 or mutated GDAP1.  p-values appear below percentage; n.s. means no significant value. 
This table is a summary of figures R48, R49, R50.  
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In Gdap1-/- DRG neurons all the GDAP1-mutations altered one or several parameters. In 
order to classify the mutations that caused same effects, percentages to null neurons and 
also to wild type neurons data were calculated for each microinjection (table R6). Null 
mice parameters are also show in the first column (blue).  
Those mutations that corrected the defects produced by lack of GDAP1 in null mice are 
showed in green. Of course, GDAP1 was able to restore them: it decreased the higher 
number of mitochondria moving retrogadely and decreased the size of mitochondria that 
were longer in null mice. In addition, GDAP1 increased anterograde speed (yellow). 
Also in green, GDAP1 pR120Q and pR161H restored only the mitochondrial size. 
 
The mutation that had the same effect that loss of protein is highlighted in blue. GDAP1 
pR120W increased number and size of mitochondria moving in a retrograde direction. 
Additionally, pR120W mutation increased anterograde moving mitochondria and 
decreased size of these mitochondria  in comparison with lack of protein.  
 
Gain of function is labelled in red. GDAP1 pT157P abolished the mitochondrial 
movement in an aggressive way (compared to wild type also) without modifying 
velocity or size of mitochondria.  
 
Finally, a rare phenomenon is highlighted in purple. GDAP1 pR161H decreased 
retrograde speed despite this was no altered in null mice. Moreover, pR161H mutation 
also abolished mitochondria in retrograde motion and, unexpectedly, mitochondria in 
motion size. 
 
KO neurons: KO +GDAP1 +GDAP1 pR120W
+GDAP1 
pR120Q
+GDAP1 
pT157P
+GDAP1 
pR161H
microinjected/KO - 55% n.s. n.s. 22% 20%
microinjected/WT 166% n.s. 250% n.s. 36% 33%
microinjected/KO - n.s. 226% n.s. 14% n.s.
microinjected/WT n.s. n.s. n.s. n.s. 11% n.s.
microinjection/KO - n.s. n.s. n.s. n.s. 53%
microinjected/WT n.s. n.s. n.s. n.s. n.s. 54%
microinjected/KO - 162% n.s. n.s. n.s. n.s.
microinjected/WT n.s. 138% n.s. n.s. n.s. n.s.
microinjected/KO - 68% n.s. 65% n.s. 53%
microinjected/WT 149% n.s. 140% n.s. n.s. n.s.
microinjected/KO - 56% 68% 65% n.s. 58%
microinjected/WT n.s. n.s. n.s. n.s. n.s. n.s.
Retrograde Moving mitochondria in 100µm
Anterograde Size moving mitochondria 
Retrograde Size moving mitochondria 
Anterograde Maximum speed
Retrograde Maximum speed
Anterograde Moving mitochondria in 100µm
 
Table R6. . Moving mitochondria parameters in null mice DRG cultures when different GDAP1 
mutations are microinjected. Percentages to null neurons and also to wild type neurons data has been 
calculated for each microinjection. First column refers KO/WT (without any microinjection) percentage 
in order to compare the effect of mutations with the completely lack of protein. Colour data groups are 
explained on the text. n.s. means no significant differences. This table is a summary of figures R48, R49, 
R50.  
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3.3- Sciatic nerve explants
 
Mitochondrial movement
Inference from primary cultures 
eliminates tissue properties
cultures and short axons. That 
mechanisms in the context of a live nerve
To investigate the same mitochondrial parameters
Dendra2 mice strain. All 
fluorescence localized specifically 
(http://jaxmice.jax.org/strain/018397.html)
allowed us to assay axonal transport 
dissociation or culturing 
Material&Methods). 
 
For this experiment we excised sciatic nerve carefully from 
old mice in order to avoid thick myelin sheet. Excised nerve 
under the microscope, for no more than 1 hour,
study. Imaging was carried out in the mid region of the excised nerve to
effects of calcium influx through
Figure R51. Representative images of sciatic nerve from WT/
mice. Mitochondria are fluorescent, easy to 
straightened from each time lapse (see next image).
 
Time lapse images from "ex vivo" mitochondria in sciatic nerve (
to analyse the same parameters 
study (Andrews et al. 2010; Gilley et al. 2012)
 
 
 
 
 
Figure R52. Representative images 
of sciatic nerve from 
WT/mitodendra and Gdap1
/mitodendra mice. (a) Representative 
straightened axon (b) kymograph 
(time-distance graph) of mitochondria 
transport (c) Moving mitochondria 
from this kymograph identified using 
ImageJ plugin ‘Difference tracker’ 
(Andrews et al. 2010). Soma reference 
is draw on top 
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.  
 as above, we took advantage 
tissues isolated from these animals exhibit b
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The number of mitochondria in movement inside peripheral axons of Gdap1-/- mice was 
similar to wild type. The percentage of moving mitochondria (moving 
mitochondria/total mitochondria) was equal between wild type and Gdap1-/-mice 
(Figure R53, left graph). Moreover, there was no difference between genotypes in the 
number of moving mitochondria in 100 µm per second (Figure R53, right graph). 
 
Figure R53. Percentage of total moving mitochondria (left graph) and number of moving 
mitochondria in 100µm per second (right graph) in sciatic nerve from 1 month old mice. The 
percentage was obtained by counting the number of moving mitochondria and dividing this number by 
the total number of mitochondria (static + moving).  Average data (±SEM) of wild type mice are 
represented in black and Gdap1-/- in white. 
 
 
These results were in agreement with previous data obtained in SCG cultures (table R7). 
However, they contrasted with those from DRG cultures (table R7) where we detected 
increased mitochondria in motion as well as increased retrograde moving mitochondria 
in 100µm.  
 
 
Table R7. Moving mitochondria 
parameters in Gdap1-/- SCG and 
DRG cultures and sciatic nerve. 
Percentage Gdap1-/-/Gdap1+/+ and 
Rescued/Gdap1-/- has been calculated 
for cultured neurites and axons inside 
nerve. p-values are shown besides 
percentage; n.s. means no significant 
value. This table is a summary of 
figures R41, R42, R53. 
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SCG DRG Sciatic nerve
Percentage of moving mitochondria 
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When we analysed average (total displacement of a particle / time tracked) and 
maximum (furthest displacement of each tracked particle between two frames) 
mitochondria velocities, we detected slower mitochondria in Gdap1-/- animals. 
However, the decrease is only detected in anterograde direction (Figure R54). 
 
Figure R54. Average speed (left graph) and maximum speed (right graph) in sciatic nerve from 1 
month old mice. Mean of average and maximum speed (±SEM) of wild type mice are represented in 
black and Gdap1-/- data in white. Asterisks are representing the p-values of proper statistic test (*<0.05; 
**<0.01; ***<0.001). 
 
 
These results were in agreement with previous data obtained in SCG and DRG cultures 
(table R8). Retrograde velocities were in agreement with SCG data while anterograde 
velocities were similar to DRG neurons. 
 
 
 
 
 
 
 
Table R8. Moving mitochondria 
velocities in Gdap1-/- SCG and DRG 
cultures and sciatic nerve. 
Percentage Gdap1-/-/Gdap1+/+ and 
Rescued/Gdap1-/- has been calculated 
for cultured neurites and axons inside 
nerve. p-values are shown besides 
percentage; n.s. means no significant 
value. This table is a summary of 
figures R43, R44, R54 
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maximum speed
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KO/WT 69% 0,002
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KO/WT 61% 0,001 92% 0,005
Rescued/KO 176% 0,004
KO/WT 68% 0,000 n.s.
Rescued/KO
KO/WT 67% 0,001 91% 0,003
Rescued/KO 162% 0,006
Sciatic nerve
n.s.
n.s. n.s.
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Anterograde Average speed
Retrograde Average speed
Anterograde Maximum speed
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n.s.
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Mitochondrial size. 
In addition, we examined the size of moving mitochondria. Gdap1 deficient mice 
showed longer mitochondria in the retrograde direction in their sciatic nerves than wild 
type animals (Figure R55, left graph). In contrast, such an increase in mitochondria size 
was not detected in static mitochondria (Figure R55, right graph). 
 
Figure R55. Moving mitochondria size (left graph) and static mitochondria size (right graph) in 
sciatic nerves from 1 month old animals. Wild type data are represented in black and Gdap1-/- in white.  
Asterisks are representing the p-values of proper statistic test (*<0.05; **<0.01). 
 
 
These results were in agreement with previous data obtained in DRG cultures (table R9) 
where longer mitochondria were found in null mice neurons. However, in SCG cultures 
from Gdap1-/- mice we observed shorter ones. 
 
 
 
Table R9. Mitochondria size in 
Gdap1-/- SCG and DRG cultures and 
sciatic nerve. Percentage Gdap1-/-
/Gdap1+/+ and Rescued/Gdap1-/-has 
been calculated for cultured neurites 
and axons inside nerve. p-values are 
shown besides percentage; n.s. means 
no significant value. This table is a 
summary of figures R45, R46, R55. 
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1.- Mouse model suitable for GDAP1-CMT disease 
There are few animal models for the GDAP1 form of CMT. Several fly models have 
been developed by Dr Galindo group (Del Amo et al. 2015), demonstrating that specific 
overexpression and knockdown of Gdap1 in retinal cells induce neuronal loss in an age-
dependent fashion.  
 
Regarding mouse specifically, apart from our Gdap1 null model there is just one other 
developed by Dr Suter group and reported during the course of this project (Niemann et 
al. 2014). In contrast to our null mouse model, which was generated by deleting the first 
of six exons of Gdap1 in order to ablate the expression, Niemann et al. generated a 
mouse deleting the fifth exon. This led to a truncated protein that was unstable. Both 
Gdap1-/- mouse models are fertile, with no disability and healthy offspring. This 
contrasts with mice lacking other mitochondrial fusion-fission proteins, such as Drp1 
(Wakabayashi et al. 2009), Opa1(Alavi & Fuhrmann 2013) and Mfn1 or Mfn2 (Chen et 
al. 2003) null mice models, which have embryonic lethality. 
 
 
To be useful as a model, it is important that animals mimic disease hallmarks although 
we know that sometimes this is particularly difficult in mouse models of neuropathies. 
GDAP1-CMT patients suffer a chronically progressive motor neuropathy beginning in 
early childhood and resulting in severe disability at the end of their first decade (Baxter 
et al. 2002; Cuesta et al. 2002; Sevilla et al. 2003). Our Gdap1 null mouse presents 
motor deficits in an age-dependent trend and those deficits are easily quantifiable by 
rota-rod test (figures R8, R9) and walking track analysis (figure R11, tables R1, R2). In 
addition, our mouse model also shows the "pes cavus" phenotype (figure R6). However, 
muscle wasting is not present at 12 months old (figure R12) whereas damaged muscle 
fibres have been detected (figure R13). 
The Niemann mouse model showed no signs of peripheral neuropathies. In 13 month 
old mice, same motor studies, which allowed us to detect the locomotion disability, 
revealed no significant differences between mutant and control animals (Niemann et al. 
2014). 
 
In addition to motor disability, mild to severe sensory loss is observed in GDAP1-CMT 
patients; particularly affecting proprioception, vibration and touch (Baxter et al. 2002; 
Cuesta et al. 2002; Sevilla et al. 2003). Looking for these impairments in our mouse 
model we studied the histology of DRG where the soma of neurons that innervate skin 
and muscle spindles are located (Lallemend & Ernfors 2012). DRGs were studied by 
histology and no abnormalities have been found even in old mice (figure R30). 
However, the molecular and cellular environment is disrupted when DRG cells are 
disaggregated and cultured and cultures are maintained for a limited duration with much 
shorter axons than in vivo (discussed below in points 5 to 8). So far, no sensory tests 
were studied in our mouse model. However, Dra Satrustegui's group is doing sensory 
test to our mouse model and they have found disabilities of Gdap1-/-. 
In 13 month old mice of the Niemann model, sensory studies revealed no significant 
differences between mutant and control animals (Niemann et al. 2014). 
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 Niemann_2014 Present work 
Mouse Generation: 
- exon deleted Exon 5 Exon 1 
- expected product Transpliced mRNA No mRNA 
Phenotype: 
- motor behaviour No phenotype at 13 mo Rota-rod defects at 3mo 
- NCV 75% at 19 mo 94% at 5mo 
- CMAP proximal stimulation 66% Amplitude at 19mo 76% Amplitude at 5mo 
Duration not affected 115% Duration at 5mo 
- CMAP distal stimulation No alteration in amplitude 63% Amplitude at 5mo 
Table D1. Gdap1 mice models comparison. Principal features in mouse generation and phenotype of 
both Gdap1 mice already published. Percentages represent null mice data divided by control mice data.  
 
 
 
2.-GDAP1-/- mice model the axonal form of CMT 
As in patients studies (Cuesta et al. 2002) Gdap1 null mice present slightly slower 
MNCV at 5 months old (a decrease of 6%, figure R18) and reduction in CMAP 
amplitude and area (figure R19). In addition, lower density of fibres was found (figure 
R23) in agreement with axonal CMT forms (Cuesta et al. 2002; Sevilla et al. 2003). 
Other CMT2 models corroborate these findings. As an example, HSPB1S135F and 
HSPB1P182L neuron expressing mice also present a significant decrease in the number of 
axons in distal parts of the sciatic nerve at 10 months old (d’Ydewalle et al. 2011). 
 
In contrast, onion blubs were not observed in electron microscopy images of sciatic 
nerve (figure R22) and g-ratio was equal to controls (table R3) at 5 months old, 
discarding demyelinating form (Tazir et al. 2014). 
 
 
 
3.-Gdap1 family genes are expressed in mouse 
GDAP1 is expressed in neuronal mouse tissues (figure R2) in agreement with previous 
studies (Niemann et al. 2005). No protein expression was detected in skeletal muscles 
(figure R2).  
 
Deletion of first of six exons of Gdap1 (figure R1) is enough to ablate its expression. 
Even short transcript couldn't be detected in null mouse model (figure R5). In contrast, 
deletion of fifth exon in Niemann model results in a transcript form with a transplicing 
form exon 4 to exon 6 (Niemann et al. 2014). 
 
Protein expression is dependent on genetic charge, heterozygous animals presents less 
protein amount that wilt types (figure R3). 
 
Gdap1 family member Gdap1L1 is also expressed mainly in CNS (figure R5). Although 
we didn´t check protein expression, reverse transcriptase analysis agree with similar 
studies that don't find expression in PNS (Niemann et al. 2014).  
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4.- Lack of Gdap1 produces axonopathy 
Motor defects already discussed in the first point need to be due to problems in long 
distal peripheral nerves as GDAP1 is not expressed in muscles (figure R2). In mice, 
sciatic nerve is the longest nerve (Krinke et al. 2014) that innervates hind limb muscles.  
 
Detailed electrophysiological analysis of Gdap1-/- sciatic nerve revealed alterations in 
MNCV and CMAP parameters (figures R18, R19, R20, R21). As discussed above, a 
slight reduction of MNCV as we find here, together with reduced CMAP amplitude and 
area are signs of an axonal form of CMT. In addition, longer durations reflect selective 
slowing of some motor fibres (Katirji et al. 2013). Shorter latencies are more difficult to 
explain, as normally an increase in latencies reflects the nerve conduction slowing of the 
fastest fibres (Tankisi et al. 2012). 
It's important to remark that all these alterations were found in 5 months old mice but 
not in 2 month old. This indicates that the neurodegenerative part of the axonopathy is 
progressive, again similar to the phenotype in patients. 
 
Alterations in electrophysiological outcomes can be explained by loss of fibre density in 
sciatic nerve (figure R23). In addition, asynchrony reflected by increasing CMAP 
duration may be explained by the change in the fibre size distribution found in CMT 
mice (figure R24). Although average axon size is no statistically different between 
control and CMT mice (table R4), we found  a slightly loss of small fibres and gain in 
bigger ones when we studied deeply (figure R24). This fact could also explain why 
smaller CMAP latencies were found in null animals.  
Interestingly opposite findings have been reported for another fusion related protein 
mouse model. MFN2 p.R94Q mice, which develop locomotor impairments and gait 
defects at 5 months old, presents an age-related shift in the size of myelinated axons 
leading to an over-representation of axons smaller than 3.5 um (Cartoni et al. 2010). 
No other axonal extrinsic abnormalities as demyelination (table R3 and figure R22) 
were found in our CMT mouse model. However, when we studied axons in more depth, 
intrinsic alterations were found. Mitochondria inside Gdap1-/- mouse sciatic nerve axons 
were longer that the controls (figures R25, R26, R55). This fact will be discussed more 
extensively in point 5. 
 
Both proximal and distal ends of sciatic nerve axons were also studied in detail. In the 
distal part, terminal ends of axons start to die back leading to denervation in the 
gastrocnemius muscle at some point between 5 and 12 months. Although the total 
number of NMJ endplates was not altered (figure R14), their occupation by axonal 
terminals was lower (figures R15, R16).It is well established that the synaptic 
connections between motor axons and muscle are shaped by nerve activity; impaired 
post-synaptic activity at neuromuscular synapses delays the withdrawal of presynaptic 
terminals and synapse elimination (Bloch-Gallego 2015). In addition, abnormalities 
such as retraction bulbs in the most distal part of the nerve, near to NMJ, were found 
only in old CMT mice (figure R18). 
Interestingly, denervation of NMJ was also observed in adult zebra fish expressing 
MFN2 pL285X mutant, along with clear alterations in swimming (Chapman et al. 
2013). 
Denervation of leg muscles is consistent with the increase of plantar length (PL) and 
decrease of toe spreading (TS) observed in footprint records (figure R11 and table R2) 
(Wiethölter et al. 1990). The absence of more severe findings in muscles could be 
explained by the short length of mouse leg nerves relative to humans. 
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At the proximal end of the axon, the somas of motor neurons located in ventral horn of 
lumbar spinal horn are also affected as suggested the pyknotic aspects of neuronal 
somas in Gdap1-/- animals (figure R27). Loss of "healthy" MNs (figure R28) can be 
attributed to increased catalase and Bax expression (figure R29). However, western blot 
experiments were done with the whole lumbar spinal cord protein extracts, so it is 
difficult to correlate apoptosis and oxidative stress, revealed by Bax and catalase 
increase, with pyknotic motor neurons.  
In addition, new roles for Bcl2 family have been described linking those proteins with 
mitochondrial dynamics (Saez-Atienzar et al. 2016). Apoptosis and mitochondrial 
dynamics are related: 1) BAX interacts with components of the mitochondrial 
fission/fusion machinery; 2) deficiencies in mediators of mitochondrial fission/fusion 
and cristae remodelling influence the kinetics of apoptosis; mitophagy is related to 
mitochondrial dynamics: (a) since a fragmented mitochondrial network is necessary 
(though not sufficient) for efficient mitophagy, DRP1 and MFN1/2 indirectly regulate 
mitophagy, both positively and negatively; (b) PINK1/Parkin targets MFN1 and 2 for 
degradation to promote mitochondrial fission. At the same time, mitophagy is related to 
apoptosis (Li & Dewson 2015).  
An alternative explanation for increased catalase and Bax will be discussed in point 9. 
 
 
 
5.- GDAP1 is implicated in mitochondrial dynamics 
It has been demonstrated that GDAP1 is a fission-inducing factor which promotes 
mitochondrial fragmentation without inducing cell apoptosis, changes in mitochondrial 
transmembrane potential or interfering in mitochondrial fusion. Moreover, transfections 
with GDAP1-specific RNAi led to an increase of cells with a tubular mitochondrial 
morphology compared with untransfected or control transfected cells (Niemann et al. 
2005; Pedrola et al. 2008; Niemann et al. 2009). Also fly models confirmed that 
overexpression of Gdap1 caused small mitochondria and interference of DmGdap1 
produced longer mitochondria (Del Amo et al. 2015). 
 
To test if lack of Gdap1 also alters mitochondrial dynamics in our mouse model we 
performed experiments to check mitochondrial morphology in different tissues. As 
already mentioned in point 4, the sciatic nerve ultrastructure analysis by electron 
microscopy showed a higher number of mitochondria per section in null mice axons 
(figure R25). As there was no increase of mitochondrial biogenesis in sciatic nerve 
extracts we concluded that the increase of  mitochondria number per section is due to 
elongated mitochondria that could be sectioned several times(figure R26). In addition, 
confirmation of the presence of longer mitochondria due to deficiency of Gdap1 in 
sciatic nerve axons was performed in sciatic nerve explants using mice with 
fluorescently-labelled mitochondria. Gdap1-/-mice presented longer mitochondria 
moving back to soma -in retrograde direction- (increase of 13%, figures R52, R55 and 
table R9). Static mitochondria were not different form controls.  
We also observed longer mitochondria in retrograde motion in DRG cultures from null 
animals relative to wild type (increase of 49%, figures R40, R45, R46 and table R9). In 
addition, when we rescued those sensory neurons by microinjecting Gdap1 
mitochondria became shorter than in non-rescued null cultures (KO), travelling in both 
directions (decrease of 32% in retrograde way and 44% anterogradely, (figure R45 and 
table R9). Again, static mitochondria were not different form controls. 
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Interestingly, when we studied moving mitochondria in SCG cultures we found the 
opposite. Shorter mitochondria were moving in a retrograde direction in null neurons 
(decrease of 23%, trend in figure R45 and table R9) and longer ones were found to be 
increased in the static pool (increase of 17%, figure R46 and table R9). The relevance to 
pathogenesis is that SCG are not affected in CMT. In addition, SCG belongs to 
sympathetic nervous system (SNS) (Jackson & Tourtellotte 2014). Impairments in 
mitochondrial dynamics affect different cell types in different individuals in a different 
way depending on the individual’s unique profile of intracellular and extracellular stress 
factors (Alavi & Fuhrmann 2013). It maybe that SCGs have a mechanism to avoid the 
formation of longer mitochondria and this is why these neurons are not affected in the 
same way. Smaller mitochondria moving in a retrograde direction could represent a 
mitophagy marker. 
In agreement with our results, opposite findings has been described for fusion related 
proteins. As an example, DRG cultures from MFN2R94Q/R94Q mice presents shorter 
mitochondria than control ones (Misko et al. 2010). 
Mitochondrial fission and fusion occupies a central position in mitochondrial quality 
control and it processes different intracellular and extracellular parameters in order to 
accommodate cell homeostasis and cell fate by several measures: a) Mitochondrial 
network morphology changes to either a more filamentous or more fragmented state to 
adapt mitochondrial function to actual energetic and metabolic demands of the host cell. 
b) Fusion of dysfunctional mitochondria to functional mitochondria can attenuate 
damage to mitochondrial proteins, lipids, and mtDNA. c) Inhibition of mitochondrial 
fusion targets single dysfunctional mitochondria to the mitochondrial autophagy 
pathway. d) Mitochondrial fragmentation, mitochondrial outer membrane 
permeabilization, and cytochrome c release signals severely impaired host cells to 
undergo cell death. According to this, mitochondrial fusion maintains mitochondria by 
attenuating mitochondrial damage as well as by protecting from mitochondrial 
autophagy. Moreover mitochondrial fusion antagonizes cell death signalling (Alavi & 
Fuhrmann 2013). 
 
 
 
6.- GDAP1 is implicated in mitochondrial transport 
GDAP1 has been also linked with mitochondrial motility. Depletion in human 
neuroblastoma cells induced the increase of organelle motility but without increase of 
tubular mitochondrial morphology (Pla-Martín et al. 2013). 
 
Similar results were obtained when we studied mitochondria motility in DRG cultures. 
An increased percentage of moving organelles were found in null neurons (30% more, 
trend in figure R41 and table R7). In detail, the increase was due to a higher number of 
mitochondria moving retrogadely in Gdap1-/- cultures in comparison to wild type ones 
(increase of 66%, trend in figure R42 and table R7). This data is supported by the 
opposite effect found when we rescue Gdap1-/- neurons. Microinjection of Gdap1 into 
null neurons decreased the number of mitochondria that were moving in retrograde 
direction (decrease of 45%, figure R42 and table R7).  
 
In contrast, no alteration in motile mitochondria was found either in sciatic nerve 
explants (figure R53 and table R7) or in SCG cultures from null mice (figure R41, R42 
and table R7). However, a decreased number of moving mitochondria in both directions 
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was found in rescued SGC cultures in comparison with null not rescued ones (decrease 
of 54% retrogadely and a trend of 47% anterogradely, figure R42 and table R7). 
 
In agreement with our results, opposite findings has been described for fusion related 
proteins. DRG neurons derived from MFN2 knockout mice transfected with 
MFN2R94Q/R94Qhad disrupted both anterograde and retrograde mitochondrial transport 
(Misko et al. 2010). In MFN2L285X/L285X zebra fish neurons only retrograde transport 
was selectively impaired (Chapman et al. 2013). 
 
 
In addition to studying motile mitochondria, we were also interested to determine 
moving velocities in our mouse model at diverse levels. Sciatic nerve explants from  
Gdap1null mice showed lower velocities than controls, average (decrease of 8%, figure 
R54 and table R8) and maximum (decrease of 9%, figure R54 and table R8), in 
anterograde direction.  
Despite SCG not being affected in CMT patients, same findings were replicated in 
sympathetic ganglion cultures from null mice. Reduction of around 31-39% in average 
and maximum velocities was observed in retrograde and anterograde direction (figure 
R43, R44 and table R8). However, those alterations were not detected in Gdap1-/- DRG 
cultures but rescued cultures presented opposite values; showing a increase in 
anterograde velocities, average (increase of 76%, figure R43 and table D5) and 
maximum (increase of 62%, figure R44 and table R8). 
 
Interestingly, similar findings have been described for fusion related proteins. DRG 
neurons derived from MFN2 knockout mice transfected with MFN2R94Q/R94Qmoved at 
slower velocities in the anterograde and retrograde directions (Misko et al. 2010). In 
MFN2L285X/L285X zebra fish neurons only retrograde speed was reduced (Chapman et al. 
2013). 
 
Mitofusins has been described as adaptor of Miro (Tang 2015). In Drosophila, the 
Milton/Miro complex mediates the binding of microtubule-based motors to 
mitochondria. Miro associates with the outer mitochondrial membrane via a 
transmembrane domain and recruits Milton, which binds directly to KHC (kinesin 
heavy chain). Recently, the mammalian homologs of Milton, TRAK1 and TRAK2, 
were shown to associate with the retrograde motor complex via dynactin. Interestingly, 
N-terminal TRAK binds to both dynactin and KHC, and this potentially mediates 
bidirectional transport of mitochondria. By contrast, depletion of TRAKs results in 
arrest of the anterograde and retrograde moving pools of mitochondria in both axons 
and dendrites, suggesting that TRAKs mediate processive transport in a regulated 
manner that remains to be elucidated fully (Fu & Holzbaur 2014). NDE1 and GSK3β 
associate with TRAK1. NDE1 promotes retrograde axonal mitochondrial movement 
and GSK3β promotes anterograde mitochondrial transport (Ogawa et al. 2016). 
As defective fusion -MNF2- and fission -GDAP1- produce slower mitochondria in 
retrograde and anterograde direction respectively; it is no absurd thinking that both 
proteins are involve in transport mitochondria along axons apart from its role 
mitochondrial dynamics. GDAP1 knock-down clones (with 40% and 80% protein 
reduction) of the human neuroblastoma SH-SY5Y cell line have problems to 
differentiate due to lack of GSK3β phosphorylation (Pla-Martín 2012). Perhaps GDAP1 
interacts and/or activates GSK3β by interaction with TRAK in a similar way to 
mitofusins. This idea will be discussed in point 9.  
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7.-GDAP1 mutations affect to mitochondrial dynamics and transport 
A high number of mutations has been found along GDAP1 gene; some of them has been 
reported as CMT causing mutations and some as a non pathogenic (table A2 and A3).  
 
With the aim of better understanding the pathogenic effect of mutated GDAP1 in CMT 
patients, we investigated the effect of several GDAP1 missense mutations (Figure R47) 
(Pedrola et al. 2008; Pla-Martín et al. 2013) on mitochondrial parameters depending on 
neurons genotype.  
 
When we express mutations of GDAP1 in wild type DRG cultures (table R5) only 
overexpression of GDAP1 alters the parameters decreasing number of mitochondria in 
retrograde way (trend with a p value of 0.082). In addition, GDAP1 increases retrograde 
velocity and decreases anterograde size of those mitochondria that are moving. It is 
interesting how the overdose of non-mutated protein also causes alterations. 
A increase in fragmented mitochondria were found in similar experiments on COS-7 
cells which doesn't express GDAP1 (Niemann et al. 2005; Pedrola et al. 2008).  
 
The absence of effect by dominant mutations pR120W and pT157P was unexpected. 
However, it is possible that the presence of wild type GDAP1 in neurons avoid any 
effect of microinjected mutation.  
 
 
When we express mutations of GDAP1 in Gdap1-/- DRG there are more parameters 
altered. There are mutations that correct the defects produces by lack of GDAP1 in null 
mice (green highlighted on table R6) . Of course, GDAP1 is able to restore all of them: 
it decreases the higher number of mitochondria moving retrogradely and decreases the 
size of mitochondria that were longer in null mice. In addition, non mutated protein also 
increases anterograde speed although speed is not reduce in DRG cultures of Gdap1-/- 
mice (green highlighted on table R6). 
Surprisingly, GDAP1 pR120Q expression in null neurons also is able correct one defect 
due to lack of GDAP1. This mutated protein reduce the increased size of retrograde 
moving mitochondria (green highlighted on table R6) as well as also reduce the size of 
anterograde moving mitochondria that were not altered in knockout cultures.  
These data contrast with the early and severe form of CMT that develop patients 
harbouring this recessive mutation (Boerkoel et al. 2003). 
 
We also decide to study another mutation at the same position but with dominant 
inheritance, pR120W. CMT patients harbouring this mutation have a mild phenotype 
(Claramunt et al. 2005) and even are asymptomatic (Zimon et al. 2012).  
Although mild phenotype, GDAP1 pR120W seems to doesn't restore any defect on 
mitochondrial movement when it is express in DRG cultures of Gdap1-/- mice. Its data 
are quite similar to lack of protein (blue highlighted on table R6) but also increases 
velocity and reduces size of anterograde mitochondria in motion. 
 
Dominant mutation pT157P has a "arresting" effect on mitochondria. This mutation 
decreases so abruptly the increased retrograde moving mitochondria in null neurons and 
also anterograde moving that were not altered. The decrease is so strong that there is a 
lower percentage of mitochondria in motion even if we compare with control mice 
neurons (red highlighted on table R6). However no effect on velocity or size was found. 
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That "arresting" effect on mitochondria could explain the severe phenotype presented in 
GDAP1 pT157P patients (Claramunt et al. 2005). 
 
Another severe form of GDAP1 related CMT is caused by the recessive inherited  
mutation pR161H (Baxter et al. 2002). The expression of mutated protein in null 
neurons also stops retrograde moving mitochondria in a similar way to pT157H 
mutation. In addition, pR161H decreases retrograde speed and also it is able to restore 
mitochondria in motion size.  
 
 
8.- GDAP1 is implicated in microtubule cytoskeleton stabilization 
Loss of GDAP1 produces cytoskeleton instability due to interfering to correct PMTs.  
Decreased acetylation (figures R35, R36) and increased tyrosination state (trend, figures 
R37, R38) may be the reason because DRG cultured neurons are not able to grow 
properly, presenting smaller soma (figure R33) and shorter neurites (figure R34) than 
the controls. Even so, this instability doesn't affect to neurites output (figure R32).  
Other CMT mouse models, CMT2F HSPB1S135F and HSPB1P182L neuron expressing 
mice as CMT2F model, also show a marked decrease in acetylated α-tubulin abundance 
in peripheral nerves (d’Ydewalle et al. 2011). 
Interestingly, an increase of a-tubulin acetylation induced by pharmacological inhibition 
of histone deacetylase 6 (HDAC6) corrected the axonal transport defects caused by 
HSPB1 mutations and rescued the CMT phenotype (d’Ydewalle et al. 2011). 
Lysine acetylation is a key post-translational modification known to regulate gene 
transcription, signal transduction, cellular transport and metabolism. Lysine 
deacetylases (KDACs) superfamily in mammals  currently holds eighteen members. A 
core division based on homology with yeast KDACs separates ‘classical HDACs’ (zinc-
dependent, Rpd3/Hda1 homologues) from ‘sirtuins’ (NAD+-dependent, Sir2 
homologues) (Matsushima & Sadoshima 2015).  
Cytosolic HDAC6 deacetylates tubulin, cortactin and HSP90, regulating axonal 
trafficking, cell motility and degradation of misfolded proteins. SIRT2 shares α-tubulin 
deacetylase activity with HDAC6, and has been suggested as the main microtubule 
deacetylase in mature neurons. SIRT1 deacetylates and activates the transcriptional co-
activator PGC-1α, a master regulator of mitochondrial biogenesis (Guedes-Dias & 
Oliveira 2013). 
A mouse model of another neurodegenerative disease, Amyotrophic lateral sclerosis, 
also presents a reduction in neurite length as well as mitochondrial fragmentation and 
impairment of mitochondrial transport. In this model, SIRT3 and PGC-1α protect 
against mitochondrial fragmentation and neuronal cell death by mutant SOD1G93A (Song 
et al. 2013). 
SIRT3 is the main deacetylase in the mitochondria, where it regulates oxidative 
phosphorylation, protein synthesis and multiple metabolic pathways (Guedes-Dias & 
Oliveira 2013). Effects of Sirt3 are mediated by the activation of FoxO3-dependent 
transcription of catalase and MnSOD, suppression of ROS-induced Ras activity, 
MAPK/ERF, and Akt/PI3Ksignalling (Matsushima & Sadoshima 2015). 
 
It would be interesting testing Sirt3 activation in Gdap1-/- mice. Activation of Sirt3 
could explain why motor neurons in spinal cord are nor dying (figure R29). Activation 
of Bcl-xL could blocks the increased Bax (figure R) and deacetylation of FoxO3a would 
increase catalase (figure R29).  
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9.- Role of GDAP1 in mitochondrial transport, homeostasis and 
pathology in neurons 
As GDAP1 was identified in a Neuro2a mouse neuroblastoma cell line differentiated by 
transfection of GD3 synthase (a2,8sialyltransferase) cDNA (Cassereau et al. 2011), 
there is another mouse model to take into account for comparisons with Gdap1 null 
mice. Complex ganglioside knockout mouse (GalNAcT-/-) was engineered to lack a key 
enzyme in complex ganglioside biosynthesis (GM2/GD2 synthase) and express only the 
simple ganglioside molecular species GM3 and GD3. GalNAcT-/-mice develop 
significant and progressive behavioural neuropathies, including deficits in reflexes, 
strength, gait, coordination and balance (Chiavegatto et al. 2000). GalNAcT-/-mice also 
display decreased myelination, axonal degeneration in both the central and peripheral 
nervous systems (Ma et al. 2003; Sheikh et al. 1999). 
 
 GalNAcT-/-mouse model Gdap1-/- mouse model 
Phenotype: 
- motor behaviour Limb clasping at 8mo Limb clasping at 3mo 
 Rota-rod defects at 8mo Rota-rod defects at 3mo 
- walking defects Reduced Stride Length at 8mo Reduced Stride Length at 5mo 
 Increased Plantar Length at 8mo Increased Plantar Length at 5mo 
- MNCV Slightly reduced at 3mo Slightly reduced at 5mo 
Electron microscopy 
- CNS: Degenerating fibres 
Increased unmyelinated fibres 
and axon size (3mo) 
 
- PNS Degenerating fibres 
Decreasing neurofilament 
spacing (3mo) 
Loss of myelinated fibres. 
Shift in axon sizes 
(5mo) 
Table D2. Mice models comparison. Principal features in phenotype of both Complex ganglioside 
knockout mouse (GalNAcT-/-) and Ganglioside-induced differentiation-associated protein-1 knockout 
mouse (Gdap1-/-)   
 
Early studies on isolated neurons indicated an enrichment of gangliosides in terminal 
axons and synaptic endings, suggesting a role in formation, development and 
maintenance of the nervous system. The importance of gangliosides in normal 
functioning and integrity of the nervous system and in neurodevelopment and neural 
regeneration has since been demonstrated. 
At the cellular level, the ability of exogenously applied gangliosides to potentiate 
neurite outgrowth in primary neurons, sensory ganglia and neuroblastoma cell lines, and 
axonal sprouting in regenerating axons has long been established. The ganglioside 9-O-
acetyl GD3 has been implicated in glial-guided neuronal migration and neurite 
outgrowth in both the developing and adult rat nervous system, and in facilitation of 
axonal growth and Schwann cell-induced myelination during both development and 
regeneration of mouse peripheral nerve. Additionally, gangliosides can enhance or 
regulate cell survival. They have been shown to be neuroprotective against toxic insult, 
anti-apoptotic during neural cell differentiation, and pro-apoptotic during neural cell 
proliferation (Palmano et al. 2015). 
 
Human neuroblastoma GDAP1 knock-down clones has also problems to differentiate 
properly (Pla-Martín 2012). Maybe GDAP1 is necessary to orchestrate all this change in 
cell morphology.  
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If we look for one studied protein that could orchestrate big changes in cell morphology, 
mitochondria distribution and dynamics the proteins Miro/Milton come to our mind. 
Indeed, Miro1 KO axons exhibit a reduction in overall retrograde velocity compared 
with WT (Nguyen et al. 2014). 
 
The evolutionarily-conserved mitochondrial Rho (MIRO) small GTPase which is 
specifically associated with the mitochondria and via a hydrophobic transmembrane 
domain. At the mitochondria, MIRO regulates mitochondrial homeostasis and turnover. 
In metazoans, MIRO regulates mitochondrial transport and organization at cellular 
extensions, such as axons, and, in some cases, intercellular transport of the organelle 
through tunnelling nanotubes. Recent findings have revealed a myriad of molecules that 
are associated with MIRO, particularly the kinesin adaptor Milton/TRAK, mitofusin, 
PINK1 and Parkin, as well as the  endoplasmic reticulum-mitochondria encounter 
structure (ERMES) complex. The mechanistic aspects of the roles of MIRO and its 
interactors in mitochondrial homeostasis and transport are gradually being revealed. On 
the other hand, MIRO is also increasingly associated with neurodegenerative diseases 
that have roots in mitochondrial dysfunction (Tang 2015). 
The next table (table D3) summarizes all known partners of MIRO involved in different 
functions: anterograde and retrograde motors o adaptors, mitochondrial fusion (MFN),  
mitosis segregation, neural development and signalling pathways, stress response and 
protein degradation. 
 
Interacting protein Nature of  partner Function/remarks
Milton (Dm)
TRAK1 and 2 
Kinesin 1/KIF5 Kinesin family, microtubule-based motor protein Microtubule-based transport (anterograde)
Dynein Microtubule-based motor protein Microtubule-based transport (retrograde)
Mitofusin 1 and 2 Dynamin-like GTPases Mitochondrial fusion
Cenp-F Centromeric protein Kinetochore function and chromosome 
segregation in mitosis
DISC1 Multifunctional scaffold protein
Neural development and multiple signaling 
pathways, such as Wnt and mTOR; 
associated with schizophrenia & depression
HUMMR Hypoxia-inducible protein Axonal mitochondrial transport, particularly in response to hypoxia
PINK1 Ser/Thr protein kinase that phosphorylates ubiquitin
Regulator of mitochondrial stress response 
and mitophagy
Parkin E3 ubiquitin ligase
Important component of the ubiquitin-
proteasome system of protein degradation; 
MIRO is a substrate of Parkin
Mitochondrial kinesin motor 
adaptors
Microtubule-based mitochondrial transport
Table D3. Summary of known MIRO interacting partners and their functions. Adapted from Tang 
2015). 
 
Similar with MIRO, GDAP1 also have potential partners (tableD4) with a wide range of 
functions which could explained all the alterations found in Gdap1-/-. 
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Interacting protein Nature of partner Function/remarks clons
Caytaxin Kinesin binding apoptosis, mitochondrial distribution 3
RAB6B GTPase activiy retrograde transport endosome to Golgi and Golgi to ER 5
PIKFYVE2 ATP binding retrograde transport endosome to Golgi 3
TUBB GTPase activiy. Ubiquitin protein ligase binding microtubule-based process 1
WASP actin binding actin cytoskeleton organization 1
INA neurofilament neurofilament cytoskeleton 
organization, development 1
CEP250 protein kinase binding centriole-centriole cohesion 3
CCDC123 cetrosomal protein organelle organization 2
MESDC2 chaperone Wnt signalling pathway 4
BMPR2 ATP-binding; metal-binding BMP pathway, brain development 1
ADCY8 membrane-bound Ca2+-stimulable adenylyl cyclase 2
GABBR1 receptor activity synaptic transmission 2
ARX cromatin binding axon guiance 2
Plexin semaphorin receptor axon guiance 1
NFASC cell adhesion, ankyrin-binding axonal guidance, neurite extension 1
BAI3 GTPase activator dendrite morphogenesis, synapse 
assembly 1
CENTB2 GTPase activator cellular response to nerve growth factor stimulus 1
msrA oxidoreductase protein repair; response to 
oxidative stress 2
EIF2B5 translation iniciation factor ER stress, astrocite diferenciation 1
ANKS4B ankyrin repeat response to ER stress 1
IL8 Cytokine ER stress,calcium singalling, 1
GABARAP beta-tubulin binding; Ubiquitin protein ligase binding
synapatic transmission, 
mitophagy, extrinsec apoptosis 13
ARRDC3 beta-3 adrenergic receptor binding
regulator of ubiquitin-protein 
transferase activity 2
SUMO4 ubiquitin-like protein protein sumoylation 1
ASB11 ankyrin repeat protein ubiquitination 1
Ubiquitin-proteasome
Cellullar stress
Signalling pathways and neuronal development
Microtubule-based transport (anterograde)
Microtubule-based transport (retrograde)
Actin-based organization
Neurofilament-based organization
Segregation in mitosis
Table D4.  Summary main GDAP1 partners. Two hybrid data from  Pla-Martín 2012. 
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The idea is that GDAP1 interacts with wide range of proteins in a similar way to 
Figure D1. GDAP1 interacting proteins in relation with mitochondrial transport. 
pictures of GDAP1 and its interacting proteins 
microtubule and actin cytoskeleton 
 
 
As GDAP1 interact with microtubule transport proteins
EIF2B5, among others ones, l
D2). 
Absence of GDAP1 causes in some way that  SUMO4 does
al. 2015). As a consequence fission is blocked producing elongated mitochondria.
In addition, as GDAP1 cannot bind to EIF2B5,  EIF2 has a not properly conformation
and cannot block Bcl-xL by CHOP 
DRP1 (Saez-Atienzar et al. 2016)
xL also blocks tubulin acety
mitochondrial movement is impaired.
Finally, as GDAP1 also interact with Caytaxin
anterograde mitochondria in motion.
 
Figure D2. Workflow of GDAP1
arrows. Red arrows showed inactivation or blocking action
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As a consequence of slower anterograde velocity, distal axons denervate at NMJ level. 
Slower velocity also causes no correct position of mitochondria near to ER, so ER stress 
proteins that interact with GDAP1 cannot interact. 
Longer mitochondria in retrograde direction are caused by DRP1 impairment to fission 
defective mitochondria, as well as, ubiquitin binding proteins cannot interact with 
GDAP1.  
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1º: Murine Gdap1 is expressed in central nerve system as well as in peripheral nerve 
system. Non neuronal tissues do not express GDAP1.  
 
2º: Other member of Gdap1 family, GDAP1L1, is also expressed in mice neuronal 
tissues, mainly in central nervous system. 
 
3º: Eliminating exon 1 of Gdap1 in mice is enough to generate a mouse model for 
GDAP1 related Charcot-Marie-Tooth (CMT). Mice lacking Gdap1 ubiquitously are 
viable and fertile. As a model, Gdap1-/- mice mimics the principal hallmarks of the 
disease: "pes cavus", motor defects, decreased motor nerve conduction velocity and 
alterations in compound muscle action potential. 
 
4º: Use of this mouse model allowed us to determinate GDAP1 related CMT as an 
axonal neuropathy rather than demyelinating. 
 
5º: The sciatic nerve, which has motor and sensory axons, is altered in 5 months old 
Gdap1-/- mice. Loss of fibre density as well as a switch in axon size has been detected. 
Demyelinating signs have not been observed.  
 
6º: In the muscle, loss of Gdap1 produces a dennervating process. Neuromuscular 
junctions are not fully occupied by nerve ends in 12 months old mice. In addition, we 
have detected abnormal structures in this axon terminals. Neuromuscular plates from 5 
months old mice are indistinguishable between control and null animals. 
 
7º: In the ventral horn of the spinal cord, lack of Gdap1 produces a progressive loss of 
healthy motor neurons. Signs of damage have been also found in protein lysates form 
the whole spinal cord. 
 
8º: In the dorsal root ganglia, the absence of GDAP1 seems to does not alter sensory 
neurons at least at histological level until 12 months old.  
 
9º: Adult dorsal root ganglia cultures are compromised by the lack of GDAP1. Smaller 
soma and shorter neurites has been observed in sensory neurons from Gdap1-/- mice. 
Microtubule cytoskeleton destabilization may explain this defects.  
 
10º: Mitochondrial transport and dynamics are the main processes disrupted by the loss 
of GDAP1. CMT affected tissues from Gdap1-/- mice, as dorsal root ganglia and sciatic 
nerve, have longer retrograde moving mitochondria. In addition, anterograde speed was 
reduced on this tissues. Non affected tissues, as superior cervical ganglia, presented 
shorter retrograde moving mitochondria and reduced retrograde speed. 
 
11º: GDAP1 missense mutations harboured in CMT patients have different effects on 
mitochondrial transport in cultured sensory neurons. These wide variety of effects can 
be correlated with the wide range of phenotypes presented in patients. 
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 Genetic characterization experiments
Generation of Gdap1-/-mice.
Gdap1heterozigous knock-
With this propose, targeting vector containing two loxP sites flanking
exons of Gdap1gene, a neomycin positive selection cassette, and a diphtheria toxin A 
(DTA)negative selection was used. This 
cassette was introduced into the mouse genome by homologous recombination in 129Sv 
embryonic stem (ES) cells. The targeting vector was integrated into the ES cell genome 
and the neomycin cassette located between exons 1 and 2 of the 
selection of ES cells that had successfully integrated the vector by the appropriate 
homologous recombination. The negative selection DTA cassette located outside the 
region of homology to the gene ensured that the ES cells in which random integration 
died. The DNA from the targeted ES cells was then 
Correctly targeted ES cells were microinjected into C57BL/6J blastocysts and 
transferred to the pseudopregnant CD1 females. Pregnant mice were carrying pups to 
term and born chimaeras were identified by agouti coat colour contribution 
(characteristic of 129Sv mice). Fo
crossed with C57Bl/6J mice to obtain F1 mice carrying the recombined allele 
containing the floxedGdap1
with Flp recombinase-expressing C57Bl/6J Flp mic
cassette and generate a line of Neo
Figure M1. null mice generation with genOway
mice ES cells where homologous recombinati
into a blastocyst which is transferred into a pseudopregnant foster mother and chimeras get born. C)To 
germ-line transmission chimera are crossed with C57BL mice and successfully some offspring wi
heretrozogous for DNA change. Crossing 
 
Chimera heterozygous offspring (
analysis and tested by PCR for the presence of the targeted allele. C
excision was performed in vivo by cross
promoter (CMV) driven Cre transgene resulting in the genomic deletion of 
1 from the floxed allele during the early stages of embryonic development. Th
heterozygous Gdap1-deficient founder mice (
Gdap1+/+, Gdap1+/- and Gdap1
 
All the breeding from heterozygous Gdap1
Instituto de Biomedicina de Valencia (IBV) with the a
of the Consejo Superior de Investigaciones
accordance with the Real Decreto 1201/2005. 
a 12 h light/dark cycle with food and water 
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out mouse model was created by genOway (Lyon, France). 
loxP-exon 1 Gdap1-FRT-PGK-
Gdap1gene allowed for 
analysed by Southern blot analysis. 
r the germ-line transmission, chimera
 allele and Neo selection cassette. These mice were mated 
e to remove the Neo resistance 
-excised floxed mice. 
 technology.  A)Target vector is electroporated into 
on takes place. B) Correctly targeted ES cells 
heterozygous mice, the three possible genotypes are obtained.
Gdap1+/floxed) were confirmed by Southern blot 
-breeding mice harbouring a cytomegalovirus 
Gdap1+/-) were further crossed to obtain 
-/-
 mice.  
-deficient founder mice were done in 
pproval of Bioethics Committee 
 Científicas (CSIC) and carried out in 
All mice were maintained at 21 ± 2°C on 
ad libitum. 
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Genotyping. 
Mice genotyping was performed on tail tip DNA extracted with Maxwell® 16 mouse 
Tail DNA purification kit (Promega) in a Maxwell® 16 Magnetic Particle Processor 
(MX3031. Promega) according to the manufacturer’s instructions.  
Polymerase chain reaction (PCR) was performed using Expand High Fidelity PCR 
System (Roche) a two different approaches were designed. Primers with melting 
temperatures are shown in table M1.  
PCR strategy 1 allowed to distinguish floxedGdap1 (with loxP sequences around 
deleting sequence), endogenous gene (without loxP sequences) and deleted gene 
(Gdap1-/-). Endogenous gene amplified a product of  379pb,  floxedGdap1 a 490pb 
product  and deleted gene  produced no amplification. 
PCR strategy 2 allowed to distinguishGdap1+/+ andGdap1+/-when presence of 
endogenous Gdap1 in detected previously. Wild type gene amplified single product of 
2700pb and exon 1 deleted gene amplified a 600pb product. So Gdap1+/+mice presented 
one longer band (2500pb), Gdap1-/-animals a shorter one (550pb) and Gdap1+/-mice 
both of them (2500 and 550pb). 
 
 
RT-PCR for Gdap1 and Gdap1L1 expression. 
Gdap1 and Gdap1L1 expression was studied using reverse transcriptase polymerase 
chain reaction (RT-PCR). RNA from tissues was extracted using TRI Reagent (Sigma) 
according to the manufacturer’s instructions. One microgram of RNA was treated with 
Dnase I (Sigma) to eliminate DNA contaminations and transformed into cDNA using 
M-MLV reverse transcriptase enzyme (Sigma) and random hexamer primers. With this 
product a normal PCR with Taq polymerase (Netzyme, Fermentas) was performed to 
study Gdap1and Gdap1L1 expression. Gapdh was used as a housekeeping gene. 
Primers with melting temperatures are shown in table M1.  
All PCR's products obtained after 35 cycles were load in an agarose gel and stained with 
ethidium bromide in order to detect DNA bands. 
Gene direction sequence Tm
Forward 5'-TCATGCGAAATGGCTCGGAGG-3'
Reverse  5’-GGAACCCCTTCTCTCACTTTCCAGG-3 ’
Forward 5’-CCTTGTTTCTCATCTACTCCTATTATCCGTAGG-3’ 
Reverse  5’-GGAACCCCTTCTCTCACTTTCCAGG-3 ’
Forward 5’- ATGCGCTTGAACTCAGCTGG -3’
Reverse 5’- GCCAGTGTAAAGGATTCTCC -3’
Forward 5’-ATGCGGCTCAACCTGGGTGAGG-3'
Reverse 5’-GGCAAAGCGTCTCTGGACCCTC-3’
Forward 5’-ATGGTGAAGGTCGGTGG AAC-3’
Reverse 5’-GCGGAGATGATGACCCTTTTGG-3’
Reverse Transcription
 PCR1
PCR2
Gdap1 mice genotyping
58ºC
65ºC
67ºC
68ºC
60ºC
Gdap1
Gdap1L1
Gapdh
 
Table M1. Primers used in Gdap1 null mice genetic characterization. Primers sequences and melting 
conditions are shown for Gdap1 genotyping by PCR and for Gdap1 and Gdap1L1 expression by RT.  
 
 
Real Time PCR for mitochondrial DNA copy number. 
This work was done in Genomics and Translational Genetics service of Centro de 
Investigación Principe Felipe (CIPF) in collaboration with Laura Ramírez.  
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Briefly, mitochondrial DNA copy number analysis by 16S gene and genomic DNA of a 
nuclear housekeeping gene ANG1 (Assay Applied Biosystems: Mm00833184_s1) were 
quantified using the same amount of DNA input (Perier et al. 2013).  
 
 
Western blotting. 
Tissues were snap frozen on dry ice and homogenized in lysis buffer (50mM TrisHCl 
pH 7.4, 1.5mM MgCl2, 5mM EDTA, 1% Triton X-100, 50mM NaF, 1mM Na2VO3) 
containing protease inhibitors (Roche). Tissue lysates were quantified by Bradford 
reaction (Bio-Rad) and 50µg were use to the westerns blots. When it was necessary 
Amicon® Ultra-0.5 Centrifugal Filter Devices (Millipore) were use in order to 
concentrate lysates, mainly for sciatic nerve extracts. 
Denatured protein extracts were resolved sodium docecylsulfate polyacrylamide gels 
(SDS-PAGE) in a Mini-PROTEAN® Electrophoresis System(Bio-Rad).  
After electrophoresis, proteins were transferred onto a PVDF membrane (BioTrace 
PVDF, Pall Corporation) using Mini Trans-Blot® Cell (Bio-Rad) in a transfer buffer 
consisting in 25mM Tris, 192mM Glycine and 20% methanol at 4ºC. 
After transferring, membranes were stained with Ponceau Red (Ponceau S 0,1%, 5% 
acetic acid) to visualize transference.  
Subsequent to several washes in water and one hour on blocking solution (5% dry milk 
in T-TBS) incubation at room temperature, primary antibodies were also added.  
Latter than several washes in T-TBS (20mM TrisHCl pH 7,5; 150mM NaCl and 0,1% 
Tween-20, a final incubation with the appropriate secondary antibodies was done. 
Finally, protein bands were detected using a Fujifilm Las-3000 after incubation with the 
ECL Plus Western Blotting Detection System (GE Healthcare).  
 
The following antibodies were used to study GDAP1 expression in mouse tissues: actin 
(Sigma); β-tubulin (Invitrogen), ATP synthase (Invitrogen), GDAP1 (Abnova) and 
GDAP1 (Sigma). To study spinal cord damage catalase (Sigma) for oxidation; and Bax 
(Santa Cruz) andBcl2 (Cell Signalling) for apoptosis were used in combination with 
actin (Sigma) as load charge control. All antibodies references and dilutions are shown 
in table M2 
 
Density of the bands was quantified by Multi Gauge V2.1 software using. 
Normalization using actin band quantification was done for each protein quantification. 
At list 3mice per condition were used to calculate the mean value and do comparisons 
between wild type and Gdap1-/-mice.  
 
name comercial reference dilution
GDAP1 Abnova H00054332-A01 1/1000
GDAP1 Sigma HPA014266 1/1000
ATPsynthase Invitrogen 459240 1/500
Actin Sigma A2066 1/4000
β-tubulin Invitrogen 32-2600 1/500
catalase Sigma C0979 1/500
Bax Santa Cruz N-20 sc-493 1/500
Bcl2 Cell Signaling 50E3 1/1000
 
Table M2. Antibodies used in western blotting experiments. References and dilutions are shown. 
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Phenotypic characterization experiments 
Rota-rod test. 
Motor performance and balance were tested using an accelerating rotarod (UGO Basile 
Accelerating Rotarod). Each mouse underwent for 4 days the same procedure. The first 
2 days were used to train the mice (five sessions of 1 min each, walking at 4 r.p.m.). 
The test sessions were run on day 3 and 4. Each test day, 2 series of 3 trials with a 2 
hours rest period between the 2 series and a 15 min rest period between consecutive 
trials was performed. During the test the speed of the rotarod was accelerated from 4 to 
40 r.p.m. over a 5 min period. A different group of animals was used for each time point 
of the study. At list 35 mice were use for each experiment.  
Two small group of littermates (6 null mice and 3 controls) passed the test monthly in 
order to better characterize the heterogeneity and the progression of the disease. This 
rota-rod test was named follow-up. 
Time to animal fall each trial was measured. Average by animal (or animal each time 
point in follow up experiments) was calculated for genotype comparisons.  
 
 
Balance beam test. 
The beam apparatus consists of 1 meter beams with a flat surface or round surface of 12 
mm or 5 mm width  resting 50 cm above the table top on two poles. A black box is 
placed at the end of the beam as the finish point. Nesting material from home cages is 
placed in the black box to attract the mouse to the finish point. The time to cross 80 cm 
is measured  
On training days, each mouse has to cross the flat beam 3 times, then 12 mm beam 3 
times and then the 5 mm beam 3 times. On the test day, times to cross each beam are 
recorded. Two successful trials in which the mouse did not stall on the beam are 
averaged (Luong et al. 2011). 
Mean by animal (n=5) was calculated for genotype comparisons. 
 
 
Pole test. 
For performing this test the mouse is placed on a vertical wooden pole with its head 
facing upwards. A normal mouse will grip the pole before turning through 180° and 
slowly climbing down to the base of the pole, latencies to turn to descend once turned 
and to complete the task are primary measured (Brooks & Dunnett 2009). 
Mean by animal (n=5) was calculated for genotype comparisons. 
 
 
Gait and footprint analysis. 
Footprint analysis was modified from that described for rats by De Medinaceli et al. 
(1982). This test allows assessing limb coordination and body weight support (rotation, 
stride length, base of support. Mice crossed an illuminated alley, 70 cm length, 9 cm 
width, and 6 cm height, before entering a dark box at the end. Their hindpaws were 
coated with nontoxic water-soluble ink and the alley floor was covered with sheets of 
white paper. To obtain clearly visible footprints, at least 3 trials were conducted 
(Wiethölter et al. 1990; Klapdor et al. 1997). The footprints were then scanned and 
analysed with ImageJ software version 1.48a (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2015). 
 
For the morphometric gait analysis 
centimetres or degrees: 
 
 
Stride Length (SL): 
were drawn, yieldi
Stride Length was measured as distance between the third toe from 
one print and the same position i
Stride Angle (SA). 
in one step side were drawn, yielding the stride trajectory. The 
Stride Angle was the angle formed in between two consecutive 
connecting lines. 
Stride 
were drawn, yielding the stride trajectory
The perpendicular dist
Stride Width.
 
 
 
Figure M
months old mice. 
shown: Stride Length (
 
 
For the morphometric footprint analysis 
centimetres: 
Plantar or Print length (PL).
the most proximal part of the foot visible on the paper (cuneiform or cuboid bone)
(Wiethölter et al. 1990). 
Toe spreading (TS).This is the distance between the prints of t
(Wiethölter et al. 1990).  
Intermediate Toes (TS). This is the distance between the prints of the second and the 
forth toe (Klapdor et al. 1997)
 
 
 
 
Figure M3. Representative footprint from a WT 12 months old mice
left  hind paw is displayed. Footprint parameters are shown: Plantar Length 
(PL), Toe Spreading (TS) and Intermediate Toes (IT).  
 
The average from four (two from left and two from right paw
measurements (three for each side step
Average were calculated for each group of 5 mice
Materials & Methods
the following parameters were measured in 
The line connecting the footpads of each side 
ng the stride trajectory (Wiethölter et al. 1990)
n the next step of the same paw. 
The line connecting the first toe of opposite paws 
 
Width (SW). The lines connecting the footpads of each side 
 (Wiethölter et al. 1990)
ance of the opposite footpad to that line is the 
 
2. Representative scanned walking track from a W
Only hind paws are displayed. Gait print parameters are 
SL), Stride Angle (SA) and Stride Width (SW).  
the following parameters were measured in 
This is the distance between the print of the third toe and 
he first and the fifth toe 
.  
. Only 
 
, for the footprint
, for gait print) were obtain f
 to do comparisons.  
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Histological procedures 
Tissue fixation and sections obtaining. 
Mice were sacrificed by gentle cervical dislocation. Distal big muscles (Soleus& 
Gastrocnemius and Quadriceps), lumbar spinal cord and DRG were dissected and 
immediately fixed in 4% paraformaldehyde (PFA) in PBS. For muscles and lumbar 
spinal cord, fixation on PFA was done over night at room temperature, for DRG only 
20min were necessary. 
After fixation, a 70% ethanol step was added prior to mount tissues in cassettes and 
introducing them in the tissue processor (Spin Tissue Processor STP 12, Myr) where 
tissues were included in paraffin. Tissue processor protocol was: 1h in 70% ethanol, 3h 
in 96% ethanol, 90 min in a new container with 96% ethanol, 2 h in 100% ethanol, 6 h 
more in a new 100% ethanol, 90 min in xylene, 150 min in xylene again, 150 min in 
liquid paraffin (60ºC) and 2 h more in new paraffin. 
Afterwards, tissues were embedded in paraffin blocks (Modular Tissue Embedding 
Center 350, Myr). 
Microtome (Rotary microtome HM 340 E, Microm) was used to slice paraffin blocks in 
10µm-thick sections for muscles and spinal cord, and 4µm-thick sections for DRGs. 
Slices were collected from a 40ºC water bath and mounted in a microscope slide.  
 
Haematoxylin&Eosin and Nissl staining. 
Haematoxylin has a deep blue-purple colour and stains nucleic acids by a complex, 
incompletely understood reaction. Eosin is pink and stains proteins non specifically. In 
a typical tissue, nuclei are stained blue, whereas the cytoplasm and extracellular matrix 
have varying degrees of pink staining (Fischer et al. 2008). 
 
The Nissl-staining method is based on the interaction of basic dyes such as cresyl violet, 
with the nucleic acid content of cells. These dye can bind to the DNA content of the cell 
nuclei, but also to the RNA that is highly concentrated in rough endoplasmic reticulum 
and ribosomes (Nissl substance) in the cytoplasm. Since neurons are very active protein 
synthesizing cells, the cytoplasm of these cells contain high concentration of rough 
endoplasmic reticulum. Nissl staining can specifically stain the cytoplasm of neurons 
without recognizing the perikarya of other cellular elements in the brain (Kádar et al. 
2009). 
 
 
Microscope slides containing paraffin sections were placed in a slide metal holder. For 
deparaffinise slices, holder was kept at 64ºC for 1h, 10min in xylene and 10min more in 
a new xylene container. 
For rehydrate sections several steps of percentage descending ethanol were done (100%, 
100%, 96%, 70% and 50%) to finally keep them 2min in distilled water. 
For haematoxylin staining, slices were immersed in Harris haematoxylin for 10min and 
then rinsed under tap water for 5min.  
For eosin staining, slices were immersed in eosin for 30s and fixed in re-used 96% 
ethanol for 1min.  
A last dehydrating step was done passing sections through an increasing ethanol 
percentage container (50%, 70%, 96%, 100%, 100%). Finally, holder was kept in 
xylene for 10min (2 times).  
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For Nissl staining, same protocol that for Haematoxylin& Eosin was used only 
changing the staining part. This time slices were immersed in 1% w/v Cresyl Violet 
(Sigma) plus 1% v/v Glacial Acetic Acid for 2min and then rinsed under tap water for 
5min.  
 
Slides were dry and mounted with DPX mounting medium and observed under research 
microscope (Leica DMRXA2 microscope plus Leica DFC300FX colour camera). 
 
 
MN counting in Spinal cord. 
The lumbar region of the spinal cord (L1–L5) was processed for paraffin embedding. 
300 serial cross sections (10µm thickness) of the lumbar spinal cords were made 
(3000µm or 3mm total length), among which every fifth section (50 sections examined 
per animal) was processed and Nissl stained. 
 
The anterior horn (either left of right) of stained sections were analysed microscopically 
(Leica DMRXA2 microscope, Leica DFC300FX colour camera, 40x 0.75NA) 
All cells were counted within the ventral horn below an arbitrary horizontal line drawn 
from the central canal. Morphological criteria were also employed, so that only large 
polygonal neurons in which the nucleolus was clearly visible at high magnification were 
included in the counts. 
At list 3 mice per condition were used to calculate the mean and do comparisons 
between wild type and Gdap1-/-mice. 
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Neuromuscular Junctions occupancy in distal large muscles 
Muscle election. 
First of all, it's important to remark that when analyzing neuromuscular junction (NMJ) 
morphology, muscle choice is of great importance. Some of the primary considerations 
might include muscle fibre type, body position, and comparative analysis to human 
conditions.  
We selected gastrocnemius because is a Delayed Synapsing (DeSyn) muscles. In a 
DeSyn muscle, focal AChR clustering and maintenance depends critically on nerve-
derived factors, whereas this dependence is much more limited in Fast Synapsing 
(FaSyn) muscles (Pun et al. 2002).  
Often, however, muscle choice is influenced by ease of dissection. Consequently, NMJ 
analysis is often performed exclusively on large appendicular muscles such as 
Gastrocnemius. To obtain good NMJ staining in such muscles, sectioning or mechanical 
disruption of muscle fibres is often required. As a result, the innervation pattern may 
become disrupted and a comprehensive and high quality analysis of innervation 
patterns, sprouting and dennervation is often compromised (Murray et al. 2014). When 
using such muscles a technical expertise is required to dissect them without damage. 
 
 
NMJ's labelling in the whole muscle. 
Gastrocnemius (containing also soleus) dissection was done after mice were sacrificed 
by cervical dislocation. The muscle was carefully cut apart and immediately covered 
with 4% paraformaldehyde (PFA) for an incubation of 20 minutes at room temperature.  
After washing three times in PBS for 10 minutes, acetylcholine receptor from the 
postsynaptic part of the neuromuscular junction was stained with α-Bungarotoxin-
tetrametylrhodamine (Sigma) in PBS for 20 minutes at room temperature.  
Subsequently, the muscles were washed again (three times in PBS for 10 minutes) and 
penetrated with ice-cold methanol for 5 minutes at −20 °C.  
After a new washing, a blocking solution containing 2% bovine serum albumin (BSA, 
Sigma), 0.2% Triton X-100 and 0.1% Sodium Azide was applied for 1 hour at room 
temperature.  
Spent this time, the presynaptic part of neuromuscular junction was label with a rabbit 
polyclonal antibody against III-β tubulin (Sigma); the antibody was applied in blocking 
solution over night at room temperature. All antibodies references and dilutions are 
shown in table M3. 
After washed over again, a secondary  Alexa 488-conjugated polyclonal antibody 
(1:100, Invitrogen) was diluted in the blocking solution and applied for 5 h at room 
temperature. Prior chopping the muscles, a last washing step was done.  
 
Finally, the whole gastrocnemius was manipulate under the dissection microscope to 
chop it in a sagital plane. Slices were cut manually with a scalpel and mounted with a 
Fluoromont-G Solution (SouthernBiotech) on a microscope slide. It's important to 
remark that all the process was done in a rotatory shaker at room temperature apart from 
postfixation step with methanol that was done statically at -20ºC.  
 
name comercial reference dilution
BTX Sigma T0195 10µg/ml
β-tubulin III Sigma T 2200 1/500
 
Table M3. Antibodies used in Neuromuscular Junction labelling. References and dilutions are shown. 
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NMJ's imaging and quantification. 
The whole gastrocnemius (with the soleus) was divided in 10 pieces that were analysed 
with a Leica True Confocal Scanning SP8 imaging system (DMI6000 microscope, 40x 
1.3NA apochromat oil immersion objective). 
Scoring of endplate occupancy was done at low power (40× objectives) magnification 
by digital stitching of contiguous z-series (each 0.5µm) obtained using the confocal 
microscope. An endplate was scored as occupied if there was evidence of contact by an 
overlying III-β-Tubulin nerve terminal with the α-Bungarotoxin-tetrametylrhodamine 
AChRs stained motor endplate area. If the AChR cluster was not fully filled by the 
presynaptic axon  the endplate was scored as not occupied (Wong et al. 2009). All NMJ 
counted were positive to neuronal and muscle markers in order to avoid aneural AChR 
clusters  (Wu et al. 2010). 
 
 
Data analysis for NMJ occupancy. 
For the morphological analysis of the neuromuscular endplates three control and three 
Gdap1 -/-  mice for each age were studied. More than 100 NMJ were studied for each 
group.  
Experiments were done in parallel with WT and KO samples to reduce variability 
between experiments. Occupied NMJ percentage of total counted number was 
calculated for each animal, mean was obtained for each genotype and age (n=3) 
(Krieger et al. 2013). 
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Electrophysiology 
Gdap1-/-and wild type mice of 2 and 5 months old (n
Lausanne where motor nerve conduction studies were done in collaboration with Dr 
Roman Chrast from Department
Lausanne, Switzerland. Special thanks to Dr. Jennifer Zenker for performing and 
helping to analyse the electrophysiological experiments.
Briefly (adapted from Mallik & Weir 2005; Katirji et al. 2013)
performed by electrical stimulation of a nerve and recording the compound muscle 
action potential (CMAP) from surface electrodes overlying a muscle supplied by that 
nerve. The recording electrodes are performed using adhesive conductive pads
onto the skin overlying the target muscle. The active electrode is placed over the muscle 
belly and the reference over an electrically inactive site (usually the muscle tendon). A 
ground electrode is also placed somewhere between the stimulating an
electrodes providing a zero voltage reference point. The sciatic nerve motor study might 
involve stimulation at the ankle and the hip
 
The CMAP is a summated voltage response from the individual mus
potentials (figure M5). In the CAMP response we can measure several parameters: 
amplitude, area, duration and latency.
The CMAP amplitude 
neurophysiological convention is that negative voltage is demonstrated by an upward 
deflection) and measured in millivolts (mV). CMAP amplitude reflects the num
size of muscle fibres that ultimately fire.
The CMAP area is conventionally measured between the baseline and negative peak. 
CMAP also reflects the number of muscle fibres in the CMAP. CMAP area is measured 
in mv/ms. Differences between distal and 
significance in the determination of conduction block from a demyelinating lesion. 
The CMAP duration is usually measured from the initial deflection to terminal 
deflection back to baseline (total duration). CMAP d
(i.e., the extent to which each of the individual muscle fibres fire at the same time). 
Duration measurements are usually in milliseconds (ms).
The latency of the CMAP is the time from stimulus to the initial CAMP deflecti
baseline. It is the time from stimulus artefact to onset of the response and is a biphasic 
response with an initial upward deflection followed by a smaller downward deflection. 
Latency includes three separate times: (1) nerve conduction time from t
to the NMJ, (2) the time delay across the NMJ and (3) the depolarization time across the 
muscle fibres. Latency measurements are usually in milliseconds (ms).
 
 
≥4) were send from Valencia to 
 of Medical Genetics, University of Lausanne, 
 
, mot
 (figure M4). 
 
 
 
 
 
 
 
Figure M4. Representative image of motor nerve conduction 
study in mice. Proximal (st1, hip) and distal stimulation (st2, ankle) 
are represented. 
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In the normal state stimulating the sciatic nerve at the ankle and the hip resu
CMAPs of similar shape and amplitude (
innervate the muscle fibres making up the response. However, the latency will be 
greater for hip (proximal) stimulation compared with ankle (distal) stimulation becaus
of the longer distance between the stimulating and recording electrodes. 
 
Figure M5. Representative CMAP response.
amplitude, area, duration and latency. Right image shows 
(DL: distal latency; PL: proximal latency). Lower right image shows a motor axon connecting with the 
muscle fibre; distal and proximal stimulation sites are represented (A: the nerve conduction time from the 
distal stimulation site to NMJ; B: the NMJ transmission time; C: the muscle depolarization time; D: the 
nerve conduction time between proximal and distal stimulation sites). If distal latency (A+B+C) is 
subtracted from proximal latency (A+B+C+D), only the ne
proximal stimulation sites (D) remains. Measuring the distance between these two sites we are able to 
calculate MNCV: distance (mm)/D(ms).
 
 
Motor Conduction Velocity
axons, which is calculated by dividing the distance travelled by the nerve conduction 
time. However, motor conduction velocity cannot be calculated by performing a single 
stimulation. Motor latencies include nerve conduction time, NMJ transmiss
muscle depolarization time. Thus, to calculate a motor conduction velocity, without 
including NMJ transmission and muscle depolarization times, two stimulation sites 
must be used: one distal and one proximal. When the distal latency is subtracted f
the proximal latency, then only the nerve conduction time between the proximal and the 
distal stimulations remains. The distance between these two sites can then be 
approximated by measuring the surface distance in millimetres. Thus, conduction 
velocity is usually measured in meters per second (m/s):
MNCV (m/s) =	


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figure M5) because the same motor axons 
 Left image shows detailed all the CMAP parameters: 
CMAP response to distal and proximal stimulus 
rve conduction time between the distal and 
 
 is a measure of the speed of the fastest condu
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Morphometric analysis of Sciatic nerve 
Sciatic nerve dissection, fixation and imaging. 
Same animals of 5 month old that were use to analysed nerve conduction velocity were 
use to study sciatic nerve ultrastructure (n=4). Dissection and fixation of sciatic nerves 
were done in collaboration with the laboratory of Dr. Roman Chrast (University of 
Lausanne). Dra. Jennifer Zenker was helping us directly by receiving and taking care of 
animals.  
Quickly, sciatic nerves were dissected and fixed by immersion in 2,5% glutaraldehyde 
for 2 h at 4°C, washed in 0.1 M cacodylate buffer (pH 7.3), and osmicated for 4 h in 1% 
OsO4 (Fluka). Nerves were rinsed in water, dehydrated, and embedded in Epon 812 
resin (Fluka). Half-micrometer sections were stained with 1% toluidine blue and 
examined by light microscopy.  
 
For electron microscopy analysis, ultrathin sections and imaging were done in 
collaboration with Instituto Valenciano de Patología, particularly with the laboratory of 
Dr. Jerónimo Forteza. Mario Soriano (biologist and technician) was helping us directly.  
Briefly, sciatic nerves were post fixed with 2 % osmium and 2 % uranyl acetate, rinsed, 
dehydrated and embedded in epoxi resin (Durcupan). Then, resin embedded sciatic 
nerves were cut, collected on coated single slot grids, and stained with lead citrate. 
Finally, photomicrographs were obtained under a transmission electron microscope FEI 
Tecnai G2 Spirit (FEI Europe) using a digital camera Morada (Olympus Soft Image 
Solutions GmbH).  
 
 
Number of mitochondria, myelinated fibre density and size. 
To morphometric analysis, 10 non-overlapping images were photographed at 2,550 
magnification for each sciatic nerve slice. The analysis was performed with ImageJ 
software version 1.48a (Rasband, W.S., ImageJ, U. S. National Institutes of Health, 
USA, http://imagej.nih.gov/ij/, 1997-2015). Images were binarized and all myelinated 
axons were count. Data from 4 mice (around 1200 axons) were counted for each 
condition. "Analyse Particle" tool was use to measure all axons and "Cell Counter" 
plugin was use to count all mitochondria inside axons.  
 
 
g-ratio. 
Rushton (1951) was the first to present the relationship between axonal diameter and the 
thickness of its myelin sheath as a g-ratio (g-ratio = axonal diameter/outer diameter of 
the whole nerve fibre) (Ugrenović et al. 2015; Paus & Toro 2009). 
 
 
 
 
Figure M6. g-ratio representation. Drawing of g-ratio calculation in 
myelinated axons. 
 
To analyse g-ratio, same images than previous experiment were used. g-ratio was 
obtained using "g-ratio" plugin from ImageJ (version 1.48a, National Institutes of 
Health, USA, http://imagej.nih.gov/ij/, 1997-2015) by manually tracing myelin and 
axons on micrographs. Computed values from 3 mice (450 randomly selected 
myelinated axons) were counted for each condition.   
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Adult Dorsal Root Ganglia (DRG) cultures experiments 
Animals for adult DRG cultures. 
All these experiments were done in Instituto de Biomedicina de Valencia (IBV) with the 
approval of Bioethics Committee of the Consejo Superior de Investigaciones Científicas 
(CSIC) and carried out in accordance with the Real Decreto 1201/2005.  
 
 
Adult DRG cultures. 
Adult mice aged 5-7 months were humanely killed by cervical dislocation. DRGs were 
dissected and kept in L15 medium (Gibco) over night.  
Dissected DRGs were washed in F12-medium (Gibco) prior to starting the dissociation 
protocol. Washed DRGs were incubated with 0.2% collagenase type I for 30 min at 4°C 
and for 1 h at 37°C. Next incubation was done in 0.05% trypsin (Gibco) for 30 min at 
37°C. Finally, 1% DNase (Sigma) was add for 5 min at RT.  
After a last wash in F-12 medium, DRGs were diluted in F-12 medium supplemented 
with 2 mM glutamine (Gibco), 62.5 ng/ml progesterone (Sigma), 16 µg/ml putrescine 
(Sigma), 400 ng/ml L-thyroxine (Sigma), 337 ng/ml triiodothyronine (Sigma), 38 ng/ml 
sodium selenite (Sigma), 0.35% Albumax II (Gibco),  0.6% antibiotic-antimycotic 
(mixture of penicillin, streptomycin and amphotericin B  from Gibco). DRGs were then 
gently dissociated using a Sigmacote (Sigma) treated Pasteur pipette.  
Finally, dissociated DRG were plated on a precoated 13mm glass coverslips. Coating 
state was done incubating coverslips with 0.05% poly-DL-ornitine (Sigma) overnight at 
room temperature followed by washing and incubation with 20 µg/ml laminin (Sigma) 
for at list 4 hours at 37ºC. Adult DRG cultures were maintained at 37°C in a humidified 
incubator under 5% CO2 at a density of 2000 cells per plate.  
A mixture of neurotrophins (NT3, βNGF and BDNF all from Peprotech, at 10ng/ml 
each one)  were added to the medium at 2 and 5 div in order to favour the neuronal 
growth (Valdés-Sánchez et al. 2010). 
 
 
Immunostaining of DRG cultures for characterization. 
For neuronal gross morphology and mitochondria characterization, 5 div DRG cultures 
were fixed with 4% paraformaldehyde in PBS for 20 min. After 3 rinses in PBS, 
permeabilization and blocking was done by incubating with 3% horse serum and 0.2% 
Triton X-100 in PBS for 30 min at room temperature.  
 
Neuronal cells were stained using monoclonal rabbit anti-β-tubulin III (Sigma) for 
discriminate neurons and monoclonal mouse anti-Cytochrome c (Invitrogen) to 
mitochondria labelling. After 4ºC overnight staining in blocking solution and several 
washes in PBS, neurons were incubated for 1 h at room temperature, with 
fluorochrome- labelled secondary antibody alexa-488 and TexasRed (1:400; Sigma), 
also in blocking buffer.  
A last staining was done with DAPI for nuclei visualization. Finally, neuronal cultures 
were washed again and mounted in fluoromount G. 
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For microtubules stability quantitative analyses, 1 div DRG cells were cultured without 
neurotrophins. To assess acetylated, tyrosinated, and total tubulin integrated in 
microtubules without unpolymerized tubulin subunits, cells were simultaneously fixed 
and permeabilized 24 hours after plating in PHEM buffer (60 mM Pipes, 25 mM Hepes, 
5 mM EGTA, and 1 mM MgCl2) containing 0.25% glutaraldehyde, 4% 
paraformaldehyde, 4% sucrose, and 0.1% Triton X-100 for 15 min at RT. Later than 
washing in PBS and quenching in 50 mM ammonium chloride for 5 min, cells were 
blocked for 45 min at RT. The blocking solution consisted of 10% foetal bovine serum 
(Gibco) and 0.1% Triton X-100 in PBS  (adapted from Witte et al. 2008).  
 
Double-staining was done. For microtubule acetylation experiments, 4ºC overnight 
incubation with mouse anti-acetylated α-tubulin (Sigma) and rabbit anti-β-tubulin III 
(Sigma) was performed. For microtubule tyrosination experiments, incubation with 
mouse anti-tyrosinated α-tubulin (Sigma) and rabbit anti- anti-β-tubulin III (Sigma) was 
performed also at 4ºC overnight. As secondary antibodies anti-mouse-Alexa-488 
(1:1000; Sigma) and anti-rabbit-Alexa-633 (1:2000; Sigma) were used 1 h at RT. 
Finally, dissociated DRGs were mounted in  DAPI-fluoromount G. 
 
name comercial reference dilution
β-tubulin III Sigma T 2200 1/1000
Cytochrome c Invitrogen 33-8200 1/200
ATPaseV Invitrogen 459240 1/500
Tom20 Sigma HPA011562 1/300
acetylated α-tubulin Sigma T7451 1/20000
tyrosinated α-tubulin Sigma T 9028 1/2000
 
Table M4. Antibodies used in adult Dorsal Root Ganglia cultures characterization. References and 
dilutions are shown. 
 
 
Soma area and morphology study. 
Imaging of neurons for morphology study was performed on a Leica True Confocal 
Scanning SP2 imaging system (DMIRE2 microscope, Leica DFC280 camera, 63x 
1.4NA apochromat oil immersion objective). Images were acquired with Leica Confocal 
Software. For morphology characterization number of processes was counted at 
acquiring time. Z axis was used to be sure how many neurites belonged to one neuron. 
Images were scaled and binarized with ImageJ software version 1.48a (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015) to do the measurements.  
This study was done with 5 and 7 months mice. At list 30 neurons for each condition 
was counted.  
 
 
Mitochondria distribution inside neurites. 
Imaging of neurons for morphology study was performed on a Leica True Confocal 
Scanning SP2 imaging system (DMIRE2 microscope, Leica DFC280 camera, 63x 
1.4NA apochromat oil immersion objective). Images were acquired with Leica Confocal 
Software at same time as morphology study.  
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Neurite length and microtubule stability quantitative analysis. 
For fluorescence quantification all the immunostained coverslips were kept at 4°C for 
48h prior to image capture. In order to avoid variations because of the time spent to take 
the images, same day were imaged wild type and Gdap1-/-cultures, under same 
conditions. This study was done with 5 months mice. At list 60 neurons form 2 mice 
were imaged for each condition.  
Imaging of acetylated and tyrosinated tubulin was performed on a Leica True Confocal 
Scanning SP8 imaging system (DMI6000 microscope, 63x 1.4NA apochromat oil 
immersion objective plus 0,75 zoom). Stacks of z-axis were done with the purpose of 
collecting the fluorescence of the entire neurite instead of working only with one axis. 
Stacks of 6 images separated by 0.21 µm along the z-axis were acquired using multi-
channel imaging on LAS AF 3 software. 
All image processing was performed in ImageJ software version 1.48a (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015).Maximum projections for each stack was used to 
quantification. Neurite was select in the β-tubulin III channel and fluorescence intensity 
was measured in acetylated or tyrosinated tubulin channel. Data was expressed in 
arbitrary units of fluorescence per micron of length (AU/µm). As same time as neurite 
was select, length of 3 longest was quantified. Length was expressed in micron (µm). 
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Postnatal DRG and SCG cultures experiments 
Animals for ganglia cultures. 
All these experiments were done in Babraham Institute, under the supervision of Dr. 
M.P. Coleman (Gilley 2010; Milde 2014). Head and spinal column of 1 Gdap1+/+ (wild 
type) and 3 Gdap1-/- mice were sent from Valencia. The same tissues from 3 C57BL/6J 
Babr control animals were obtained in Babraham and subject to the same time on ice. 
 
 
Postnatal DRG and SCG cultures. 
SCG and DRG were dissected from P1-P2 pups and keep in L15 medium at 4ºC until 
dissociation. For ganglia cultures from Valencia mice, head and spinal column of each 
animal were shipped in Hibernate A medium (Gibco) plus2 mM glutamine, 1% 
penicillin/streptomycin, 100 ng/ml 7S NGF (all Invitrogen), and 2% B27 50X (Gibco) 
in a low temperature box (cool but not frozen). When the tissues arrived to Babraham, 
dissection of SCG -from the head- and DRG -from the spinal column- was done.  
Dissected SCG and DRG ganglia were incubated in 0.025% trypsin (Sigma) in PBS 
(without CaCl2 and MgCl2) for 30 min at RT. The following incubation was in 0.2% 
collagenase type II (Gibco) in PBS for 30 min at 37ºC. Ganglia were then gently 
triturated using a pipette. Dissociated ganglia were incubated 2 hours as a pre-plating 
stage in a non treated plastic dish (37ºC, 5% CO2). After this pre-plating stage non-
neuronal cells attached to plastic dish and neurons were recollected and plated in a 1 
cm2 poly-L-lysine and laminin-coated area of normal 3.5 cm dishes ibidi m-dishes 
(Thistle Scientific) for microinjection experiments. 
SCG cultures were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) high 
glucose with 4,500 mg/L glucose and 110 mg/L sodium pyruvate (Sigma), 2 mM 
glutamine, 1% penicillin/streptomycin, 100 ng/ml 7S NGF (all Invitrogen), and 10% 
fetal bovine serum (Sigma). 100 ng/L Aphidicolin (Calbiochem) was used to reduce 
proliferation and viability of non-neuronal cells. 
DRG cultures were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) high 
glucose with 4,500 mg/L glucose and 110 mg/L sodium pyruvate(Sigma), 2 mM 
glutamine, 1% penicillin/streptomycin, 100 ng/ml 7S NGF (all Invitrogen), and 2% B27 
50X (Gibco). As same as SCG, 100 ng/L Aphidicolin (Calbiochem) was used to reduce 
proliferation and viability of non-neuronal cells (Gilley & Coleman 2010). 
 
 
Plasmids for microinjection. 
GDAP1 plasmids (Pedrola et al. 2008) were shipped in Watman paper from Valencia 
(Spain) to Babraham (United Kingdom). Watman paper was put into an eppendorf with 
MilliQ water for several hours prior to transform subcloning efficiency DH5alfa 
competent cells (Invitrogen). 
QIAprep Spin Miniprep Kit (Qiagen) was used in order to obtain again plasmids. All 
constructs were verified by DNA sequencing (Cogenics Lark UK) to be sure that 
mutations of Gdap1 and Gdap1 not mutated were maintained and cloned properly.  
EndoFree Plasmid Maxi Kit (Qiagen) was used to obtain endotoxin free plasmids more 
concentrated than the Miniprep products.  
For mitochondria marker, mito-tagRFP (Milde et al. 2013) was kindly provided by Dr 
Stefan Milde (Brabraham, UK). 
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Microinjection of ganglia cultures. 
Microinjection was performed on a Zeiss Axiovert 200 microscope with an Eppendorf 
5171 transjector and 5246 micromanipulator system and Eppendorf Femtotips. Plasmids 
were diluted in 0.5xPBS and passed through a Spin-X filter (Costar). The mix of one 
GDAP1 plasmid plus mito-tagRFP  was injected directly into the nuclei of SCG and 
DRG neurons in dissociated cultures (Gilley & Coleman 2010).  
In order to use the same animals for SCG and DRG cultures, dissection and plating of 
SCG and DRG was done the same time. Microinjection of DRG was done after 4 days 
"in vitro"(div) and SCG after 6 div. 
Thirty to sixty neurons were injected per dish. Few neurons injected per dish facilitated 
visualization of individual labelled neurite as it tend to cluster together in bundles. 
 
 
Live imaging of mitochondria transport in ganglia cultures. 
Imaging of mitochondria transport in SCG and DRG neurons in dissociated cultures 
was performed on an Olympus CellR imaging system (IX81 microscope, Hamamatsu 
ORCA ER camera, 100x 1.45 NA apochromat objective). During imaging, dissociated 
cultures were maintained in the proper medium at 37°C in an environment chamber 
(Solent Scientific). Images were captured at 1 frame per second for 2 min (Gilley & 
Coleman 2010; Milde et al. 2015). Five to ten individual movies (often containing 
multiple neurites) were captured for each primary culture. The live imaging was done 
one day after microinjection, 5div for DRG and 7div for SCG cultures.  
 
 
Image processing and quantification of ganglia cultures mitochondria. 
Individual neurites were straightened using the Straighten plugin in ImageJ software 
version 1.48a (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, 
Maryland, USA, http://imagej.nih.gov/ij/, 1997-2015). Axonal transport parameters 
were determined for individual axons using the Difference Tracker set of ImageJ 
plugins (Andrews et al. 2010). Analysis parameters were set up for those images in 
order to not lose fast mitochondria (Enhance Contrast, Saturated=5, Normalized all; 
Minimum difference=10; Difference frame offset=4; Minimum tracked intensity=20;  
Minimum feature size=2; Initial flexibility=15; Subsequent flexibility=7; Min track 
length= 4).Number of mitochondria in 1000 pixels, average speed, maximum speed and 
particle volume data were used to calculate number of moving mitochondria in 
100µm/sec, average speed (µm/sec), maximum speed (µm/sec), moving mitochondria 
size (µm).  
Total track count and the total particle count from binarized first image of the stack was 
use to calculate the percentage of moving mitochondria. With the same binarized first 
image of the stack we calculate the maximum diameter of static mitochondria. 
 
 
Data analysis and statistics for ganglia cultures mitochondria. 
At list 30-40 neurites were analysed in this experiment for each condition (Wild Type, 
Gdap1-/-and rescued).  15-45 neurites were analysed for mutations.  
As wild type population is a mix data of one animal from Valencia and 3 animals from 
Babraham, normality and comparison test were done in order to check the data for each 
parameter were not statistically different (p-value > 0.05) in between this two group of 
animals.   
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Sciatic nerve explants experiments 
Animals for Sciatic nerve explants. 
All these experiments were done in Centro de Investigación Principe Felipe (CIPF). 
Animal work was approved by the CIPF's Experimentation Committee and carried out 
in accordance with the Real Decreto 53/2013.  
 
Gdap1-/-mice were crossed with mito-Dendra2 homozygotes (B6;129S6-
Gt(ROSA)26Sortm1.1(mito-Dendra2)Dcc/J from Jackson Laboratory) in order to label 
sciatic nerve mitochondria for live imaging. Dendra 2 is a green-to-red irreversible 
photoswitchable monomeric protein, it's fusion with the mitochondrial targeting 
signalling of subunit VIII of cytochrome c oxidase generates "mito-Dendra2", capable 
of mitochondrial-specific fluorescence. In this strain mito-Dendra2 is introduced into 
the ubiquitously-expressed Gt(ROSA)26Sor gene downstream of a CAG (CMV-βactin) 
promoter. All organs isolated from these animals exhibit bright green fluorescence 
localized specifically to the mitochondrial compartment. . 
(http://jaxmice.jax.org/strain/018397.html) 
 
Male mice of 1 month old heterozygous for mito-Dendra2 and homozygous for Gdap1 
were used for this experiment comparison. Thus, 3 Gdap1+/+/mito-Dendra2+/- and 2 
Gdap1-/-/mito-Dendra2+/- were compared.  
 
 
Sciatic nerve explants. 
Mice were humanely killed by cervical dislocation. Sciatic nerves were dissected 
rapidly and immersed immediately into pre-warmed (37°C), pre-oxygenated 
Neurobasal-A medium (Gibco) (Milde et al. 2015).  
 
 
Live imaging of axonal transport in Sciatic nerve. 
Imaging of axonal transport in sciatic explants was performed on a Leica TCS SP2 
AOBS (Leica Microsystems Heidelberg GmbH, Mannheim, Germany) inverted laser 
scanning confocal microscope using 63X Plan-Apochromat-Lambda Blue oil objective 
(1.4 N.A.) 
Images were captured at 1 frame each 2 second for 2 min and all confocal images were 
acquired using the same settings. During imaging sciatic nerve were maintained in 
oxygenated Neurobasal A medium at 37ºC in an enviroment chamber (PECON 
System). Six to ten individual movies (containing multiple axons) were captured for 
each sciatic nerve explant.  
The order of imaging was varied randomly between animals of different genotype. 
 
 
Image processing and quantification of sciatic nerve mitochondria. 
Individual axons were straightened using the Straighten plugin in software version 1.48 
(Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2015).Axonal transport parameters were determined for 
individual axons using the Difference Tracker set of ImageJ plugins (Andrews et al., 
2010).  
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Analysis parameters were set up for those images in order to not lose fast mitochondria 
(Enhance Contrast, Saturated=5, Normalized all; Minimum difference=39; Difference 
frame offset=1; Minimum tracked intensity=30;  Minimum feature size=4; Initial 
flexibility=22; Subsequent flexibility=17; Min track length= 4).  
Number of mitochondria in 1000pixels, average speed, maximum speed and particle 
volume data were used to calculate number of moving mitochondria in 100µm/sec, 
average speed (µm/sec), maximum speed (µm/sec), moving mitochondria size (µm).  
The total particle count from binarized first image of the stack and total track count 
were used to calculate the percentage of moving mitochondria. With the same binarized 
first image of the stack the maximum diameter of static mitochondria was calculated.  
 
A total number of axons of 143 for wild type and 130 for Gdap1-/-were analysed in this 
experiment.  
 
 
 
Statistical analysis of data 
Normality test were used for each evaluated parameter in order to use the proper 
comparison test (Student's t test or Mann–Whitney U test). Statistical differences were 
assumed when p-value of appropriate comparison test was under 0.05 (*), 0.01 (**) or 
0.001(***). 
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Type Gene Age of onset Evocative phenotypes 
Autosomal dominant CMT1 (AD-CMT1) 
CMT1A 
PMP22 
(dup) All ages Classic form. Hypertrophy of nerves 
HNPP PMP22 (del) 2 to 64 years 
Recurrent entrapment neuropathies. Multifocal 
neuropathies 
CMT1B MPZ 1st–2nd decade Clinically more severe than CMT1A 
CMT1C LITAF Childhood 
Abnormal gait. Occasional nerve hypertrophy. 
Rarely deafness 
CMT1D EGR2 1st decade 
DSS/CHN. Possible cranial nerve involvement. 
Scoliosis 
CMT1E PMP22 Childhood Associated with deafness 
CMT1F NEFL 1–13 years CMT1 with early onset. Severe disease 
CMT ‘plus’ FBLN5 4th–5th decade 
Skin hyperelasticity. Age-related macular 
degeneration 
  
Autosomal dominant CMT2 (AD-CMT2) 
CMT2A MFN2 
6 months to 
50 years 
Prominent distal weakness. Late proximal weakness. 
Optic atrophy. CNS involvement 
CMT2B RAB7 2nd decade 
Severe sensory loss. Foot ulcers. Arthropathy and 
amputations 
CMT2C TRPV4 Birth to 60 years 
Younger more severe. Motor predominance. Vocal 
cord, diaphragm, respiratory involvement/dHMN 
CMT2D GARS 16 to 30 years Distal upper limb predominance dHMN 
CMT2E NEFL 1st–5th decade Hearing loss. Hyperkeratosis 
CMT2F HSPB1 Adult Classic/dHMN 
CMT2G 12q12-q13.2 2nd decade Classic 
CMT2I MPZ Late Classic 
CMT2J MPZ Late Deafness and pupillary abnormalities 
CMT2K GDAP1 Variable vocal paralysis and pyramidal features 
CMT2L HSPB8 15 to 33 years Classic/dHMN 
CMT2M DNM2 1st–2nd decade Tremor 
CMT2N AARS 15 to 50 years Classic 
CMT2O DYNC1H1 Early childhood Sometimes learning difficulties 
CMT2P LRSAM1 27 to 40 years Mild. Sometimes asymmetry 
CMT2Q DHTKD1 13 to 25 years Classic CMT 
HMSN-P TFG 17 to 55 years Proximal involvement. Tremor. Diabetes mellitus 
CMT2 HARS Late onset Sensory predominant 
CMT2 MARS Late onset Motor-sensory 
CMT2 MT-ATP6 1st–2nd decade Motor predominant. Pyramidal signs 
  
Dominant and recessive X linked CMT 
CMTX1 GJB1 1st–2nd decade Classic. Occasional deafness 
CMTX4 AIFM1 Early childhood Mental retardation. Deafness 
CMTX5 PRPS1 Childhood 
Mild–moderate neuropathy. Deafness. Late optic 
atrophy 
CMTX6 PDK3 Childhood Classic CMT 
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Type Gene Age of onset Evocative phenotypes 
Dominant intermediate CMT 
DI-CMTA 
10q24.1-
q25.1 7 to 72 years Classic CMT 
DI-CMTB 
(CMT2M) DNM2 1st-2nd decade 
Classic CMT with neutropenia and early onset 
cataract 
DI-CMTC YARS 7–59 years Classic CMT 
DI-CMTD MPZ 30–50 years Sensory loss and weakness. Deafness/pupil disorders 
DI-CMTE INF2 5 to 28 years Glomerulosclerosis and proteinuria 
DI-CMTF GNB4 5 to 45 years Classic CMT 
  
Autosomal recessive CMT1 AR-CMT1 (CMT4) 
AR-CMT1A GDAP1 < 2 years 
Severe and progressive. Vocal cord and diaphragm 
paralysis in some cases 
AR-
CMT1B1 MTMR2 3 years Severe CMT1. Facial/bulbar weakness. Scoliosis 
AR-
CMT1B2 
MTMR13 
(SBF2) 4–13 years Severe CMT1. Glaucoma. Kyphoscoliosis 
AR-
CMT1B3 
MTMR5 
(SBF1) 5–11 years Pes planus. Scoliosis 
AR-CMT1C SH3TC2 
Early onset 1st–
2nd decade Severe to moderate CMT1. Scoliosis. Deafness 
AR-CMT1D NDRG1 < 10 years Severe CMT1. Deafness. Tongue atrophy 
AR-CMT1E EGR2 Birth 
Congenital hypotonia. Respiratory failure. 
Arthrogryposis 
AR-CMT1F PRX 
Birth to first 
decade CMT1. Prominent sensory involvement 
AR-CMT1G 
(HMSN-
Russe) HK1 8–16 years Severe to moderate CMT1 
AR-CMT1H FGD4 < 2 years Delayed milestones. Scoliosis. Severe course 
AR-CMT1J FIG4 
Congenital, 
childhood or 
adult Severe disorder. Similarities to motor neuron disease 
AR-CMT1 SURF1 Childhood 
Severe. Associated to cerebellar ataxia, brain MRI 
abnormalities and lactic acidosis 
  
Autosomal recessive CMT2 AR-CMT2 (CMT2) 
AR-CMT2A 
(CMT2B1) LMNA 2nd decade Severe course. Distal and proximal weakness 
AR-CMT2B 
(CMT2B2) MED25 28 to 42 years Classic CMT2 
AR-CMT2C 
(CMT2B5) NEFL 1st decade Severe form 
AR-CMT2F/ HSPB1 Variable Sometimes proximal leg weakness 
AR-CMT2H GDAP1 1st decade Pyramidal involvement. Vocal cord involvement 
AR-CMT2K 
(rarely AD) GDAP1 
Early-onset 
form 
Severe form. Vocal cord paralysis. Skeletal 
deformities. Milder dominant form 
AR-CMT2P LRSAM1 3rd–4th decade Cramps. Erectile dysfunction 
(HMSN VI) MFN2 Early onset Optic atrophy 
ARAN-NM HINT1 1st decade Neuromyotonia 
GAN GAN Childhood 
Severe axonal neuropathy with early onset CNS 
involvement. Milder form CMT-like 
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Table A1. Classification of HMSN or Charcot–Marie–Tooth (CMT) diseases. Abbreviations: DEL, 
deletion; DUP, duplication; AARS, alanyl-tRNAsynthetase; AD, autosomal dominant; AIFM1, 
apoptosis-inducing factor mitochondrion-associated 1; AR, autosomal recessive; CHN, congenital 
hypomyelinating neuropathy; CNS, central nervous system; DHTKD1, dehydrogenase E1 and 
transketolase domain-containing 1; DI, dominant intermediate; DNM2, dynamin 2; DSS, DejerineSottas 
Syndrome; DYNC1H1, dynein cytoplasmic 1 heavy chain 1; EGR2, early growth response 2; FBLN5, 
fibulin 5; FGD4, actin filament-binding protein frabin; FIG4, FIG4homolog SAC1 lipid phosphatase 
domain containing; GAN, Giant axonal neuropathy; GJB1, gap-junction protein β-1; GARS, glycyl-
tRNAsynthetase; GDAP1, ganglioside-induced differentiation-associated protein 1; HARS, histidyl-
tRNAsynthetase; HK1, hexokinase 1; dHMN, distal hereditary motor neuropathy; HMSN, 
hereditarymotor and sensory neuropathy; HNPP, hereditary neuropathy with liability to pressure palsies; 
HSPB1, heat shock protein B1; HSPB8, heat shock protein B8; LITAF, lipopolysaccharide-induced 
tumor necrosis factor; LMNA, lamin A/C; LRSAM1, leucine-rich repeats and sterile alpha motif-
containing 1; MARS, methionyl-tRNAsynthetase; MED25, meditor complex subunit 25; INF2, inverted 
formin 2; MFN2, mitofusin 2; MPZ, myelin protein zero; MT-ATP6, ATP6 subunit of the mitochondrial 
ATP synthase; MTMR2, myotubularin-related protein 2; MTMR5, myotubularin-related protein 5; 
MTMR13, myotubularin-related protein 13; NDRG1, N-myc downstream-regulated gene 1 protein; 
NEFL, neurofilament light chain; PDK3, pyruvate dehydrogenase kinase isoenzyme 3; PMP22, 
peripheralmyelin protein 22; PRPS1, phosphoribosyl pyrophosphate synthetase 1; PRX, periaxin; RAB7, 
RAS-associated protein RAB7; SBF1, SET binding factor 1; SBF2, SET binding factor 2; SH3TC2, SH3 
domain and tetratricopeptides repeats 2; SURF1, Surfeit 1; TFG, TRK-fused gene; TRPV4, transient 
receptor potential cation channel subfamily V member 4; YARS, tyrosyltRNAsynthetase (Tazir et al. 
2014). 
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Table A2. Gdap1 genetic variants. Cassereau database. Sequence variations are described basically as 
recommended by the Ad-Hoc Committee for Mutation Nomenclature (AHCMN), with the recently 
suggested additions (den Dunnen JT and Antonarakis SE [2000], Hum.Mut. 15:7-12); for a summary see 
GDAP1 DB-ID: Database Identifier. DNA change: Variation at DNA-level (cDNA). Type: Type of 
variant at DNA level. Location: Variant location at DNA level. Exon: Exon numbering. Affected domain: 
Affected domain of the protein. RNA change: Variation at RNA-level, (?) unknown but probably 
identical to DNA. Protein: Variation at protein level. Reference: Reference describing the variation. 
(Cassereu database:LOVD v.2.0 Build 36©2004-2014 Leiden University Medical Center ) 
DB-ID DNA Change Type Location Exon Affected  Protein change Reference
GDAP1_00001 c.27_28del Deletion Exon 1 Non-specific  p.(Gly10Glufs*15) Crimella et al. (2010)
GDAP1_00009 c.92G>A Substitution Exon 1 GST-N  p.(Trp31*) Baxter et al. (2002)
GDAP1_00003 c.101C>G Substitution Exon 1 GST-N  p.(Ser34Cys) Crimella et al. (2010)
GDAP1_00047 c.102C>G Substitution Exon 1 GST-N  p.(=) Sahin-Calapoglu et al. (2009)
GDAP1_00049 c.172_173delinsTTA Ins/Del Exon 2 GST-N  p.(Pro59Alafs*4) Sevilla et al. (2008)
GDAP1_00010 c.174_176delinsTGTG Ins/Del Exon 2 GST-N  p.(Pro59Valfs*4) Auer-Grumbach et al. (2008)
GDAP1_00027 c.233C>T Substitution Exon 2 GST-N  p.(Pro78Leu) Bouhouche et al. (2007b)
GDAP1_00011 c.295C>T Substitution Exon 2 GST-N  p.(Gln99*) Moroni et al. (2009)
GDAP1_00035 c.311-1G>A Substitution Intron 2 - p.? Kabzinska et al. (2005)
GDAP1_00053 c.332C>A Substitution Exon 3 GST-N  p.(Pro111His) Chung et al. (2011)
GDAP1_00012 c.341_344del Deletion Exon 3 GST-N  p.(Glu114Alafs*32) Claramunt et al. (2005)
GDAP1_00028 c.347T>C Substitution Exon 3 GST-N  p.(Met116Thr) Kabzinska et al. (2006a)
GDAP1_00029 c.347T>G Substitution Exon 3 GST-N  p.(Met116Arg) Di Maria et al. (2004)
GDAP1_00015 c.349dup Duplication Exon 3 GST-N  p.(Tyr117Leufs*13) Senderek et al. (2003)
GDAP1_00004 c.358C>T Substitution Exon 3 Non-specific  p.(Arg120Trp) Claramunt et al. (2005)
GDAP1_00031 c.359G>A Substitution Exon 3 Non-specific  p.(Arg120Gln) Boerkoel et al. (2003)
GDAP1_00032 c.364C>A Substitution Exon 3 Non-specific  p.(Gln122Lys) Moroni et al. (2009)
GDAP1_00055 c.368A>G Substitution Exon 3 Non-specific  p.(His123Arg) Zimon et al. (2011)
GDAP1_00017 c.373C>T Substitution Exon 3 Non-specific  p.(Arg125*) Fusco et al. (2011)
GDAP1_00034 c.389C>G Substitution Exon 3 GST-N  p.(Ser130Cys) Kabzinska et al. (2005)
GDAP1_00018 c.439del Deletion Exon 3 Non-specific  p.(Thr147Leufs*5) Georgiou et al. (2006)
GDAP1_00036 c.445G>T Substitution Exon 3 Non-specific  p.(Asp149Tyr) Parman et al. (2004)
GDAP1_00037 c.458C>T Substitution Exon 3 α4α5 loop p.(Pro153Leu) Kabzinska et al. (2007)
GDAP1_00056 c.467C>G Substitution Exon 3 α4α5 loop p.(Ala156Gly) Zimon et al. (2011)
GDAP1_00005 c.469A>C Substitution Exon 3 α4α5 loop p.(Thr157Pro) Claramunt et al. (2005)
GDAP1_00038 c.482G>A Substitution Exon 3 α4α5 loop p.(Arg161His) Baxter et al. (2002)
GDAP1_00019 c.485-2A>G Substitution Intron 3 α4α5 loop p.? De Sandre-Giovannoli et al. (2003)
GDAP1_00013 c.487C>T Substitution Exon 4 α4α5 loop p.(Gln163*) Claramunt et al. (2005)
GDAP1_00020 c.507T>C Substitution Exon 4 α4α5 loop p.(=) Boerkoel et al. (2003)
GDAP1_00016 c.507T>G Substitution Exon 4 α4α5 loop p.(=) Senderek et al. (2003)
GDAP1_00051 c.533A>G Substitution Exon 4 α4α5 loop p.(Asn178Ser) Zhang et al. (2004)
GDAP1_00023 c.558del Deletion Exon 4 α4α5 loop p.(Ile186Metfs*20) Stojkovic et al. (2004)
GDAP1_00044 c.571C>T Substitution Exon 4 α4α5 loop p.(Arg191*) Barankova et al. (2007)
GDAP1_00050 c.579+1G>A Substitution Intron 4 α4α5 loop p.? Senderek et al. (2003)
GDAP1_00021 c.581C>G Substitution Exon 5 α4α5 loop p.(Ser194*) Cuesta et al. (2002) Sevilla et al. (2003) Claramunt et al. (2005) Sevilla et al. (2008)
GDAP1_00006 c.652C>G Substitution Exon 5 GST-C  p.(Gln218Glu) Chung et al. (2008)
GDAP1_00039 c.656T>A Substitution Exon 5 GST-C  p.(Val219Asp) Moroni et al. (2009)
GDAP1_00054 c.656T>G Substitution Exon 5 GST-C  p.(Val219Gly) Chung et al. (2011)
GDAP1_00059 c.664G>A Substitution Exon 5 GST-C  p.(Glu222Lys) Kabzinska et al. (2014)
GDAP1_00025 c.668T>A Substitution Exon 5 GST-C  p.(Leu223*) De Sandre-Giovannoli et al. (2003)
GDAP1_00007 c.678A>T Substitution Exon 5 GST-C  p.(Arg226Ser) Crimella et al. (2010)
GDAP1_00040 c.679A>G Substitution Exon 5 GST-C  p.(Asn227Asp) Kabzinska et al. (2010)
GDAP1_00041 c.692C>T Substitution Exon 5 GST-C  p.(Pro231Leu) Xin et al. (2008)
GDAP1_00046 c.694+24C>T Substitution Intron 5 - p.(=) Sahin-Calapoglu et al. (2009)
GDAP1_00014 c.715C>T Substitution Exon 6 GST-C  p.(Leu239Phe) Ammar et al. (2003)
GDAP1_00008 c.719G>A Substitution Exon 6 GST-C  p.(Cys240Tyr) Cassereau et al. (2009)
GDAP1_00052 c.767A>G Substitution Exon 6 GST-C  p.(His256Arg) Zhang et al. (2004)
GDAP1_00026 c.786del Deletion Exon 6 GST-C  p.(Phe263Leufs*22) Nelis et al. (2002)
GDAP1_00002 c.805G>A Substitution Exon 6 GST-C  p.(Gly269Arg) Crimella et al. (2010)
GDAP1_00030 c.811G>A Substitution Exon 6 GST-C  p.(Gly271Arg) Ammar et al. (2003)
GDAP1_00042 c.817C>G Substitution Exon 6 GST-C  p.(Arg273Gly) Kabzinska et al. (2010)
GDAP1_00057 c.821C>T Substitution Exon 6 GST-C  p.(Pro274Leu) Zimon et al. (2011)
GDAP1_00045 c.836A>G Substitution Exon 6 GST-C  p.(Tyr279Cys) Sahin-Calapoglu et al. (2009)
GDAP1_00043 c.844C>T Substitution Exon 6 GST-C  p.(Arg282Cys) Kabzinska et al. (2010)
GDAP1_00058 c.845G>A Substitution Exon 6 GST-C  p.(Arg282His) Lin et al. (2011)
GDAP1_00022 c.862dup Duplication Exon 6 Non-specific  p.(Thr288Asnfs*3) Cuesta et al. (2002)Sevilla et al. (2003)Claramunt et al. (2005)Sevilla et al. (2008)
GDAP1_00033 c.891C>G Substitution Exon 6 HD p.(Asn297Lys) Moroni et al. (2009)
GDAP1_00024 c.929G>A Substitution Exon 6 Non-specific  p.(Arg310Gln) Azzedine et al. (2003)
GDAP1_00048 c.980G>A Substitution Exon 6 TMD p.(Gly327Asp) Kabzinska et al. (2011)
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606598: GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1;  GDAP1 
Name Condition(s) Clinical significance (Last reviewed) 
GDAP1, IVS4DS, G-A, +1 CMTRIA Pathogenic(Mar 1, 2003) 
GDAP1, 1-BP INS, 349T CMTRIA Pathogenic(Mar 1, 2003) 
GDAP1, 1-BP INS, 863A AR-CMT2 +cvp Pathogenic(Jan 1, 2002) 
GDAP1:c.92G>A (p.Trp31Ter) CMT4A Pathogenic(Jan 1, 2002) 
GDAP1:c.169A>C (p.Ser57Arg) CMT4A Uncertain significance(May 22, 2015) 
GDAP1:c.347T>G 
(p.Met116Arg) CMT4A Pathogenic(Sep 13, 2012) 
GDAP1:c.358C>T (p.Arg120Trp) CMT2K; CMT4A Pathogenic(Jun 6, 2015) 
GDAP1:c.368A>G 
(p.His123Arg) CMT2K Pathogenic(Aug 9, 2011) 
GDAP1:c.372C>G (p.Tyr124Ter) not provided Likely pathogenic 
GDAP1:c.373C>T (p.Arg125Ter) CMT4A Pathogenic(May 27, 2014) 
GDAP1:c.431C>T 
(p.Pro144Leu) not provided Likely pathogenic 
GDAP1:c.467C>G (p.Ala156Gly) CMT2K Pathogenic(Aug 9, 2011) 
GDAP1:c.469A>C 
(p.Thr157Pro) CMT2K Pathogenic(Apr 1, 2005) 
GDAP1:c.482G>A 
(p.Arg161His) CMT4A Pathogenic(Jan 1, 2002) 
GDAP1:c.487C>T (p.Gln163Ter) AR-CMT2 +cvp Pathogenic(Sep 13, 2012) 
GDAP1:c.556A>G (p.Ile186Val) CMT4A Uncertain significance(Apr 4, 2015) 
GDAP1:c.581C>G (p.Ser194Ter) 
CMT2K; AR-CMT2 
+cvp;CMT4A Pathogenic(Apr 1, 2003) 
GDAP1:c.652C>G 
(p.Gln218Glu) CMT2K Pathogenic(Jan 1, 2008) 
GDAP1:c.678A>T (p.Arg226Ser) CMT2K Pathogenic(Oct 1, 2010) 
GDAP1:c.692C>T 
(p.Pro231Leu) CMT2K Pathogenic(Sep 1, 2008) 
GDAP1:c.715C>T 
(p.Leu239Phe) 
CMT2K; CMT4A; 
CMTRIA Pathogenic(Feb 28, 2013) 
GDAP1:c.719G>A 
(p.Cys240Tyr) CMT2K Pathogenic(Apr 1, 2009) 
GDAP1:c.821C>T 
(p.Pro274Leu) CMT2K Pathogenic(Aug 9, 2011) 
GDAP1:c.844C>T (p.Arg282Cys) CMTRIA Pathogenic(Dec 24, 2002) 
GDAP1:c.980G>A 
(p.Gly327Asp) CMTRIA Pathogenic(May 1, 2011) 
Table A3. Some Gdap1 pathogenic variants and related CMT diseases. cvp: vocal cord 
paresis(OMIM® and Online Mendelian Inheritance in Man® are registered trademarks of the Johns 
Hopkins University. Copyright® 1966-2015 Johns Hopkins University) 
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